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Experimental Section 
Unless otherwise noted, all reactions were carried out under argon or nitrogen 
using flame or oven dried glassware. Tetrahydrofuran (THF) and dichloromethane 
(CH2Cl2) were dried by passage through a column of activated alumina as described by 
Grubbs.
1
 Molecular sieves (spheres, 4Å) were activated at 400 ºC and then stored at room 
temperature in an air-tight container. 
Flash column chromatography was performed using Sorbent Technologies 40-63 
mm, pore size 60 Å silica gel with solvent systems indicated. Analytical thin layer 
column chromatography was performed using Sorbent Technologies 250 mm glass-
backed UV254 silica gel plates that were visualized by fluorescence upon 250 nm 
radiation and/or the by use of ceric ammonium molybdate or potassium permanganate. 
Solvent removal was effected by rotary evaporation under vacuum (~ 25-40 mmHg). 
  IR spectra were recorded on a Nicolet Avatar 360 spectrophotometer and are reported in 
wavenumbers (cm
-1
). Liquids and oils were analyzed as neat films on a NaCl plate 
(transmission), whereas solids were applied to a diamond plate (ATR). Proton nuclear 
magnetic resonance spectra were recorded on either a Varian INOVA-400 (400 MHz), 
VXR-400 (400 MHz) or Bruker DRX-500 (500 MHz) spectrometers and are recorded in 
parts per million from residual undeuterated chloroform and are reported as follows: 
chemical shift (multiplicity [s=singlet, d=doublet, t=triplet, q=quartet, qu=quintet, 
m=multiplet], coupling constant(s), integration). 
13
C NMR data were recorded on a 
Bruker DRX-500 spectrometer. Ratios of diastereomers and isomeric products were 
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measured directly from integration of 
1
H NMR absorptions of protons common to the 
components.  
Characterization data for few compounds included here have been reported earlier.
2
 
Optimized reaction conditions and yields for these compounds are included here in this 
section. 
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(S)-tert-Butyl-3-(2-bromopyridin-3-yl)-2-(diphenylmethyleneamino)propanoate 
(18a).  
To a 500 mL round bottom flask equipped with a mechanical stirrer was added the Schiff 
base (17.0 g, 57.5 mmol), the cinchonidine derived catalyst A (2.32 g, 3.87 mmol) and 
dichloromethane (100 mL). The dibromo pyridine (9.63 g, 38.4 mmol) was added, cooled 
to -78 °C and the mixture was stirred for 15 minutes. Hand pulverized CsOH•H2O was 
added (9.66 g, 57.5 mmol), the reaction was cooled in a dewar to -60 °C using a cold 
finger and stirred for 3 d. The reaction was diluted with Et2O, the organic layer was 
washed with water, dried (Na2SO4), and concentrated to an oil. The crude oil was purified 
by flash chromatography (Al2O3, 5-50% diethyl ether in hexanes) to afford the Schiff 
base as a white solid (18.3 g, 90% yield). HPLC (Chiralcel AD, 2% i- PrOH/Hexanes, 1 
mL/min) tR (R) = 7.3 m, tR (S) = 8.5 m. (S) = 89% ee.
3  
 
                                                          
3
 The alkylation product can be triturated with hexanes to provide the material >99% 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
(R)-tert-Butyl 3-(2-bromopyridin-3-yl)-2-((diphenylmethylene)amino)propanoate 
(18b). 
To a 500 mL round bottom flask equipped with a mechanical stirrer was added the Schiff 
base (31.9 g, 108 mmol), the cinchonine derived catalyst A (4.36 g, 7.20 mmol) and 
dichloromethane (180 mL). The dibromo pyridine (18.1 g, 72.0 mmol) was added, cooled 
to -78 °C and the mixture was stirred for 15 minutes. Hand pulverized CsOH•H2O was 
added (18.1 g, 72.0 mmol), the reaction was cooled in a dewar to -60 °C using a cold 
finger and stirred for 3 d. The reaction was diluted with Et2O, the organic layer was 
washed with water, dried (Na2SO4), and concentrated to an oil. The crude oil was purified 
by flash chromatography (Al2O3, 5-50% diethyl ether in hexanes) to afford the Schiff 
base as a white solid (28.9 g, 88% yield). HPLC (Chiralcel AD, 2% i- PrOH/Hexanes, 1 
mL/min) tR (R) = 7.3 m, tR (S) = 8.5 m. (S) = 88% ee.
1
 
 
tert-Butyl-1-benzhydryl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate (19a 
and 19b).  
A flame dried 5 L round bottom flask was charged with benzene (4.1 L). The solution 
was degassed by freeze-pump-thaw cycles, and then Schiff base (19.0 g, 40.9 mmol). The 
solution was warmed to 80 °C and a benzene solution (25 mL) of 
n
Bu3SnH (11.6 mL, 
43.8 mmol) and AIBN (2.87 g, 17.5 mmol) was added over 4 h. The reaction was then 
allowed to stir at 82 °C for 12 h. The reaction was cooled to rt, and toluene was removed 
by vacuum. The oily residue was diluted with Et2O (100 mL) and a saturated KF solution 
 
 
 
 
 
 
3 
 
(ca 20 equiv) was added. The mixture was stirred for 3 hours, during which a precipitate 
formed at the interface. The organic layer was separated, dried, and concentrated to an 
oil. The crude mixture was purified via flash chromatography (SiO2, 0-40% ethyl acetate 
in hexanes) and subsequent trituration with hexanes afforded the indoline as a white solid 
(8.70 g, 55%). HPLC (Chiralcel AD, 10% i-PrOH-Hexanes, 1 mL/min) tR (S) = 5.9 min, 
tR (R) = 11.8 min (S) = >99% ee. Analytical data was identical to that in the literature. 
When the enantiomeric Schiff base was substituted into the procedure above, (R)- 
indoline (19b) was isolated as a white solid (9.9 g, >99% ee, 48% yield). 
 
2-Carboxy-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-1-ium-2,2,2-trifluroacetate (20a 
and 20b).  
Protected (S)-azaindoline (5.52 g, 14.3 mmol) was treated with trifluoroacetic 
acid (14.5 mL, 186 mmol) and triethylsilane (2.95 mL, 35.8 mmol) in CH2Cl2 (29.0 mL). 
The reaction was stirred overnight and then concentrated under vacuum. Et2O (20.0 mL) 
was added to the oily residue to precipitate a white solid that was filtered, triturated with 
Et2O and dried to afford the product as the trifluoroacetate salt (3.90 g, 99% yield). 
Analytical data was identical to that in the literature. 
Substitution of (R)-azaindoline (19b, 1.75 g, 4.54 mmol) into the procedure above 
provided 20b as a white solid (5.81 g, 98%). 
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(R)-2,3-Dihydro-1H-indole-2-carboxylic acid (21b).  
To a solution of trifluoroacetic acid (1.25 mL, 16.2 mmol) and triethylsilane (0.26 mL, 
3.12 mmol) in CH2Cl2 (2.5 mL) was added the indoline (0.48 g, 1.25 mmol). The reaction 
was stirred for 8 h at rt and solvent was removed in vacuo. Et2O (5 mL) was added to the 
oily residue to precipitate a white solid that was filtered, triturated with Et2O, and dried to 
afford the product as a white solid. (134 mg, 66%).
4
 
 
Methyl indoline-2-carboxylate hydrochloride (22a and 22b).  
To a 0 °C solution of the amino acid (1.01 g, 6.13 mmol) in methanol (10.2 mL) was 
added thionyl chloride (670 μL, 9.19 mmol) over 5 minutes. The solution was slowly 
warmed to room temperature and stirred for 4 h. The solvent was removed in vacuo and 
the residue obtained was treated with diethyl ether. The resulting oil was dried under 
vacuum for 24 h to afford the title compound as a brown viscous oil (1.29 g, 100%). Rf = 
0.43 (50% EtOAc/hexanes); [α] 24D  –15.7 (c 3.05, CHCl3); IR (film) 3388, 2468, 1747, 
1486, 1440, 1033 cm
-1
; 
1
H NMR (500 MHz, DMSO-d6) δ 9.23 (s, 2H), 7.16 (d, J = 7.0 
Hz, 1H), 7.09 (d, J = 7.5 Hz, 1H), 6.84 (m, 2H), 4.60 (dd, J = 10.0, 6.5 Hz, 1H), 3.71 (s, 
3H) 3.38 (dd, J = 16.0, 10.0 Hz, 1H), 3.18 (dd, J = 16.0, 6.5 Hz, 1H); 
13
C NMR (125 
MHz, DMSO-d6) ppm 172.7, 146.5, 129.1, 128.0, 125.0, 121.7, 112.5, 59.4, 52.7, 33.3; 
HRMS (EI): Exact mass calcd for C10H11NO2 [M-HCl]
+ 
177.0790, found 177.0789.  
Substitution of (R)-indoline amino acid (500 mg, 3.06 mmol) into the above 
procedure furnished the enantiomeric product (620 mg, 100%). Rf = 0.43 (50% 
                                                          
4
 Commercially available 
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EtOAc/hexanes); [α] 24D  +14.8 (c 1.6, CHCl3); IR (film) 3390, 2474, 1748, 1440, 1248 cm
-
1
; 
1
H NMR (400 MHz, MeOD-d4) δ 7.55-7.44 (m, 4H), 5.16-5.11(m, 2H), 5.08 (dd, J = 
9.6, 7.2 Hz, 1H), 3.90 (s, 3H) 3.72 (dd, J = 16.4, 9.6 Hz, 1H), 3.53 (dd, J = 16.4, 7.2 Hz, 
1H); 
13
C NMR (100 MHz, MeOD-d4) ppm 169.8, 136.7, 134.9, 131.3, 130.0, 127.3, 
120.4, 61.2, 54.2, 33.9; HRMS (EI): Exact mass calcd for C10H12ClNO2 [M-HCl]
+ 
177.0790, found 177.0798. 
 
(S)-Methyl-1-((S)-2-(tert-butoxycarbonylamino)propanoyl)indoline-2-carboxylate 
(23a).  
To a 0 °C solution of the carboxylic acid (22.0 mg, 117 µmol), the methyl ester (25.0 mg, 
117 µmol) and diisopropyl ethylamine (80.0 μL, 469 µmol) in CH2Cl2 (1 mL) was added 
BOP-Cl (213 μL, 1.64 mmol). The reaction was slowly warmed to rt and stirred for 12 h. 
The reaction was diluted with CH2Cl2 and washed with water, 1 N HCl, and brine. The 
organic layer was dried, filtered, and concentrated to a brown oil. Column 
chromatography (SiO2, 0-10-20% ethyl acetate in hexanes) afforded the desired dipeptide 
as a 1:1 mixture of cis-trans rotamers (14 mg, 35%). Rf = 0.19 (20% EtOAC/hexanes); 
[α] 24D  -133.8 (c 1.80, CHCl3); IR (film) 3330, 2979, 1742, 1665, 1511, 1478 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.0 Hz, 1H), 7.26-7.12 (m, 5H), 7.09-7.05 (m, 
2H), 5.46-5.43 (m, 2H), 5.25 (dd, J = 11.2, 3.5 Hz, 1H), 5.04 (t, J = 7.1 Hz, 1H), 4.95 (d, 
J = 10.3 Hz, 1H), 4.45 (t, J = 7.0 Hz, 1H), 3.75 (s, 3H), 3.73 (s, 3H), 3.61 (dd, J = 16.8, 
10.7 Hz, 1H), 3.49 (dd, J = 16.5, 11.1 Hz, 1H), 3.34 (d, J = 16.6 Hz, 1H), 3.12 (dd, J = 
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16.5, 3.3 Hz, 1H), 1.54 (d, J = 7.0 Hz, 3H), 1.44 (s, 18H), 1.39 (d, J = 6.9 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3) ppm 171.9, 171.6, 155.3, 154.9, 142.5, 140.1, 131.2, 128.8, 
128.4, 128.2, 126.0, 124.8, 124.6, 124.2, 117.7, 114.3, 79.9, 79.8, 60.5, 60.4, 53.4, 52.7, 
48.8, 48.5, 33.7, 31.4, 28.5, 20.0, 18.9; HRMS (ESI): Exact mass calcd for C18H24N2O5 
[M]
+ 
349.1758, found 349.1763. 
 
(S)-Methyl-1-(S)-((2-(tert-butoxycarbonylamino)-3-phenylpropanoyl)indoline-2-
carboxylate (23b).  
To a 0 °C solution of the carboxylic acid (560 mg, 2.10 mmol), the methyl ester (300 mg, 
1.40 mmol), and diisopropyl ethylamine (910 µL, 5.18 mmol) in CH2Cl2 (3 mL) was 
added PyBrOP (980 mg, 2.10 mmol). The reaction was slowly warmed to room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, filtered, and 
concentrated to a brown oil. Column chromatography (SiO2, 20% ethyl acetate in 
hexanes) afforded the dipeptide as a mixture of 5:1 cis/trans rotamers (480 mg, 81%). Rf 
= 0.23 (20% EtOAC/hexanes); [α] 24D  -25.5 (c 1.30, CHCl3);  IR (film) 3345, 2975, 2929, 
1742, 1710, 1658, 1481, 1169 cm
-1
; 
1
H NMR (600 MHz, CDCl3, cis- rotamer) δ 8.24 (d, 
J = 8.4 Hz, 1H), 7.32 (d, J = 4.2 Hz, 1H), 7.26-7.21 (m, 5H), 7.07-7.02 (m, 2H), 5.53 (d, 
J = 8.4 Hz, 1H), 4.59 (ddd, J = 9.3, 9.3, 5.4 Hz, 1H), 4.10 (dd, J = 10.8, 1.8 Hz, 1H), 3.67 
(s, 3H), 3.12 (dd, J = 13.2, 5.4 Hz, 1H), 3.05-2.99 (m, 2H), 2.80 (dd, J = 16.2, 10.8 Hz, 
1H), 1.44 (s, 9H); 
13
C NMR (150 MHz, CDCl3, cis and trans) ppm 171.1, 170.8, 154.7, 
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141.5, 136.2, 129.7, 129.4, 129.1, 128.7, 128.4, 128.3, 127.8, 127.1, 126.9, 125.9, 124.6, 
124.3, 124.2, 117.6, 114.1 79.7, 60.5, 60.3, 54.6, 53.1, 52.5, 41.6, 38.2, 32.7, 31.3, 28.3, 
28.2; HRMS (ESI): Exact mass calcd for C24H28N2NaO5 [M+Na]
+ 
447.1896, found 
447.1897. 
 
NOESY was performed to confirm the absolute conformation of trans and cis 
rotamers.  H7c/H4a and H9/H1 correlations confirmed the presence of trans rotamer. In 
the trans-amide isomer, the 6-keto group lies close to the H4f resulting in the downfield 
shift (δ 8.24 ppm) of this aromatic hydrogen. A stong H7c/H1 correlation is consistent 
with the prolyl cis-amide bond. 
 
(R)-Methyl 1-((S)-2-(tert-butoxycarbonylamino)propanoyl)indoline-2-carboxylate 
(23c).  
To a 0 °C solution of the carboxylic acid (39.7 mg, 210 µmol), the methyl ester (30.0 mg, 
140 µmol), and diisopropyl ethylamine (90.2 µL, 518 µmol) in CH2Cl2 (0.6 mL) was 
added PyBrOP (98.0 mg, 210 mmol). The reaction was slowly warmed to room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
Conformational analysis of Boc-L-Phe-L-Ind-OMe 
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with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, filtered, and 
concentrated to a brown oil. Column chromatography (SiO2, 20% ethyl acetate in 
hexanes) afforded the dipeptide as a mixture of  4:1 cis/trans rotamers (36.7 mg, 75%). Rf 
= 0.20 (20% EtOAC/hexanes); [α] 24D  +115.2 (c 0.61, CHCl3); IR (film) 3330, 2978, 2933, 
1747, 1701, 1659, 1482, 1249, 1168 cm
-1
; 
1
H NMR (600 MHz, CDCl3, cis- rotamer) δ 
8.19 (d, J = 7.8 Hz, 1H), 7.26-7.14 (m, 2H), 7.05 (t, J = 7.2 Hz, 1H), 5.66 (br d, J = 10.2 
Hz, 1H), 5.15 (br d, J = 7.2 Hz, 1H), 4.40 (dt, J = 7.2, 7.2 Hz, 1H), 3.76 (s, 3H), 3.63 (dd, 
J = 15.6, 10.8 Hz, 1H), 3.32 (d, J = 16.2 Hz, 1H), 1.45-142 (m, 12H); 
13
C NMR (150 
MHz, CDCl3, cis- rotamer) ppm 172.2, 172.0, 155.3, 142.2, 129.5, 127.7, 124.5, 124.3, 
117.8, 80.0, 61.0, 52.9, 48.1, 33.2, 28.3, 18.2; HRMS (ESI): Exact mass calcd for 
C18H25N2O5 [M+H]
+ 
349.1763, found 349.1764.  
 
(R)-Methyl 1-((S)-2-(tert-butoxycarbonylamino)-3-phenylpropanoyl)indoline-2-
carboxylate (23d).  
To a 0 °C solution of the carboxylic acid (560 mg, 2.10 mmol), the methyl ester (300 mg, 
1.40 mmol), and diisopropyl ethylamine (910 µL, 5.18 mmol) in CH2Cl2 (3 mL) was 
added PyBrOP (980 mg, 2.10 mmol). The reaction was slowly warmed to room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, filtered, and 
concentrated to a brown oil. Column chromatography (SiO2, 20% ethyl acetate in 
hexanes) afforded the dipeptide as a mixture of 2.5:1 cis/trans rotamers (480 mg, 81%). 
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Rf = 0.23 (20% EtOAC/hexanes); [α]
24
D  +62.5 (c 0.80, CHCl3); IR (film) 3314, 2977, 
2967, 1746, 1702, 1655, 1482, 1250, 1169 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.21 (d, J 
= 8.4 Hz, 1H), 7.48 (d, J = 8.8 Hz, 1H), 7.40-7.01 (m, 18 H), 5.66 (d, J = 10.8 Hz, 1H), 
5.50 (br s, 1H), 5.01 (br d, J = 9.0 Hz, 1H), 4.93 (br d, J = 10.2 Hz, 1H), 4.60 (ddd, J = 
9.6, 9.6, 4.2 Hz, 1H), 3.70 (s, 3H), 3.69 (s, 3H), 3.62 (dd, J = 16.8, 10.8  Hz, 1H),  3.33 
(br d, J = 16.2 Hz, 1H), 3.24 (dd, J = 14.4, 4.2 Hz, 1H), 3.13 (dd, J = 15.6, 10.8 Hz, 1H), 
2.99-2.92 (m, 3H), 1.45 (s, 9H), 1.32 (s, 9H); 
13
C NMR (150 MHz, CDCl3, cis and trans) 
ppm 172.0, 171.4, 171.2, 170.2, 155.4, 155.1, 142.2, 140.0, 137.0, 135.7, 129.6, 129.3, 
129.2, 128.4, 128.1, 127.8, 126.7 (2C), 125.5, 124.9, 124.6, 124.4, 124.2, 80.0, 79.9, 
61.1, 60.5, 53.8, 53.1, 52.9, 52.5, 39.7, 38.2, 33.2, 31.5, 28.3, 28.2; HRMS (ESI): Exact 
mass calcd for C24H29N2O5 [M+H]
+ 
425.2076, found 425.2067. 
 
Methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate hydrochloride (24a 
and 24b).  
To a solution of the amine salt (100 mg, 360 µmol) in methanol (0.6 mL) at 0 °C was 
added thionyl chloride (40.1 μL, 546 µmol) over 2 minutes. The solution was slowly 
warmed to room temperature and stirred for 4 h. The solvent was removed in vacuo and 
the residue obtained was treated with diethyl ether. The resulting oil was dried under 
vacuum for 24 h to afford the title compound as a brown viscous oil (76 mg, 99%). Rf  = 
0.47 (10% MeOH/CH2Cl2); [α]
24
D  –13.5 (c 1.55, CHCl3); IR (film) 3281, 3083, 2948, 
2868, 1736, 1647, 1548, 1200, 1021 cm
-1
; 
1H NMR (500 MHz, MeOD) δ 7.23 (d, J = 7.0 
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Hz, 1H), 7.64 (d, J = 6.5 Hz, 1H), 6.85 (t, J = 7.0 Hz, 2H), 4.82 (dd, J = 11.0, 5.0 Hz, 
1H), 3.83 (s, 2H), 3.62 (dd, J = 18.0, 11.0 Hz, 1H), 3.41 (dd, J = 18.0, 5.0 Hz, 1H), 3.33 
(s, 3H); 
13
C NMR (125 MHz, MeOD) ppm 169.7, 154.8, 135.1, 129.9, 127.1, 111.6, 57.1, 
50.6, 28.8, 33.3; HRMS (EI): Exact mass calcd for C9H11N2O2 [M-Cl]
+ 
179.0821, found 
179.0820.  
Substitution of 20b (500 mg) into the above procedure furnished the enantiomeric 
product as a colorless oil (391 mg, 100%); [α] 24D  +7.9 (c 1.9, CHCl3).
5
 
 
(S)-Methyl-1-((S)-2-(tert-butoxycarbonylamino)propanoyl)-2,3-dihydro-1H-
pyrrolo[2,3-b]pyridine-2-carboxylate (25a).  
To a 0 °C solution of the carboxylic acid (530 mg, 2.80 mmol), the methyl ester (400 mg, 
1.87 mmol), and diisopropyl ethylamine (1.22 mL, 6.91 mmol) in CH2Cl2 (3 mL) was 
added PyBrOP (1.31 g, 2.80 mmol). The reaction was slowly warmed to room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, filtered, and 
concentrated to a brown oil. Column chromatography (SiO2, 30% ethyl acetate in 
hexanes) afforded the dipeptide as ≥99% trans-rotamer (470 mg, 71%). Rf =0.37 (50% 
EtOAC/hexanes); [α] 24D  -26.7 (c 2.25, CHCl3); IR (film) 3395, 2921, 1654, 1422 cm
-1
; 
1
H 
NMR (300 MHz, CDCl3) δ 8.18 (d, J = 4.9 Hz, 1H), 7.44 (d, J = 7.2 Hz, 1H), 6.91 (t, J = 
                                                          
5
 The difference in the optical rotation values might have been caused by the residual thionyl chloride from 
the reaction. 
 
 
 
 
 
 
11 
 
12.5, 5.5 Hz, 1H), 6.00-5.93 (m, 1H), 5.33 (d, J = 8.0 Hz, 1H), 5.13 (dd, J = 10.4, 4.3 Hz, 
1H), 3.75 (s, 3H), 3.46 (dd, J = 16.8, 11.5 Hz, 1H), 3.07 (dd, J = 17.0, 3.9 Hz, 1H), 1.47 
(d, J = 6.9 Hz, 3H), 1.43 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 173.6, 171.5, 155.6, 
154.9, 147.3, 133.6, 123.2, 118.7, 79.6, 57.9, 52.7, 49.4, 29.3, 28.5, 18.9; HRMS (ESI): 
Exact mass calcd for C17H23N3NaO5 [M+Na]
+ 
372.1535, found 372.1535. 
 
(S)-Methyl-1-(S)-((2-(tert-butoxycarbonylamino)-3-phenylpropanoyl)-2,3-dihydro-
1H-pyrrolo[2,3-b] pyridine-2-carboxylate (25b).  
To a 0 °C solution of the carboxylic acid (480 mg, 1.82 mmol), the methyl ester (260 mg, 
1.21 mmol), and diisopropyl ethylamine (780 µL, 4.48 mmol) in CH2Cl2 (2.5 mL) was 
added PyBrOP (850 mg, 1.82 mmol).  The reaction was slowly warmed to room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, filtered, and 
concentrated to a brown oil. Column chromatography (SiO2, 30% ethyl acetate in 
hexanes) afforded the title product as ≥99% trans-rotamer (430 mg, 84%). Rf = 0.45 
(50% EtOAC/hexanes); [α] 24D  -19.1 (c 1.10, CHCl3); IR (film) 3332, 2975, 1750, 1712, 
1663, 1595, 1425, 1170 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.27 (d, J = 4.5 Hz, 1H), 
7.46 (d, J = 7.0 Hz, 1H), 7.41 (d, J = 7.5 Hz, 2H), 7.31 (t, J = 7.5 Hz, 2H),  7.22 (t, J = 
7.5 Hz, 1H), 6.96 (m, 1H), 6.24 (dt, J = 10.0, 3.5 Hz, 1H), 5.16 (m, 2H), 3.77 (s, 3H), 
3.49 (m, 2H), 3.11 (dd, J = 17.0, 3.5 Hz, 1H), 2.75 (dd, J = 14.0, 10.0 Hz, 1H), 1.32 (s, 
9H); 
13
C NMR (125 MHz, CDCl3) ppm 172.2, 171.3, 155.5, 154.8, 147.0, 137.2, 133.5, 
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129.6, 128.1, 126.4, 123.2, 118.7, 79.3, 57.8, 54.2, 52.6, 38.1, 29.2, 28.2; HRMS (ESI): 
Exact mass calcd for C23H27N3NaO5 [M+Na]
+ 
448.1848, found 448.1838. 
 
A NOESY correlation for H4e/H7c and H9/H1 is consistent with the prolyl trans-
amide bond. No H7c’/H1 correlation was observed, supporting the assignment 
exclusively as trans-amide rotamer. 
 
(R)-Methyl-1-((S)-2-(tert-butoxycarbonylamino)propanoyl)-2,3-dihydro-1H-
pyrrolo[2,3-b]pyridine-2-carboxylate (25c).  
To a 0 °C solution of the carboxylic acid (530 mg, 2.80 mmol), the methyl ester (400 mg, 
1.87 mmol) and diisopropyl ethylamine (1.22 mL, 6.91 mmol) in CH2Cl2 (3.6 mL) was 
added PyBrOP (1.31 g, 2.80 mmol). The reaction was slowly warmed to room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, filtered, and 
concentrated to a brown oil. Column chromatography (SiO2, 20% ethyl acetate in 
hexanes) afforded the title product as ≥99% trans-rotamer (430 mg, 70%). Rf = 0.38 
(50% EtOAC/hexanes); [α] 24D  +56.7 (c 1.85, CHCl3); IR (film) 3357, 2977, 1750, 1712, 
Conformational analysis of Boc-L-Phe-L-N
7
Ind-OMe 
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1426, 1301, 1024 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.12 (d, J = 4.4 Hz, 1H), 7.42 (d, J 
= 7.2 Hz, 1H), 6.87 (m, 1H), 6.03 (s, 1H), 5.55 (d, J = 7.6 Hz, 1H), 4.94 (dd, J = 11.2, 3.6 
Hz, 1H), 3.67 (s, 3H), 3.39 (dd, J = 16.8, 11.2 Hz, 1H), 3.02 (dd, J = 17.2, 3.2 Hz, 1H), 
1.45 (s, 9H), 1.30 (d, J = 6.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 172.9, 171.1, 
154.8, 154.4, 147.0, 133.5, 123.1, 118.6, 79.1, 58.3, 52.4, 49.4, 29.5, 29.1, 28.3, 19.3. 
HRMS (ESI): Exact mass calcd for C17H23N3NaO5 [M+Na]
+ 
372.1535, found 372.1530. 
 
(R)-Methyl-1-(S)-((2-(tert-butoxycarbonylamino)-3-phenylpropanoyl)-2,3-dihydro-
1H-pyrrolo[2,3-b] pyridine-2-carboxylate (25d).  
To a 0 °C solution of the carboxylic acid (810 mg, 3.03 mmol), the methyl ester (430 mg, 
2.02 mmol) and diisopropyl ethylamine (1.32 mL, 7.48 mmol) in CH2Cl2 (4.0 mL) was 
added PyBrOP (1.41 g, 3.03 mmol).  The reaction was slowly warmed to room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, filtered, and 
concentrated to a brown oil. Column chromatography (SiO2, 20% ethyl acetate in 
hexanes) afforded the title product as ≥99% trans-rotamer (690 mg, 81%). Rf = 0.42 
(50% EtOAC/hexanes); [α] 24D  +68.5 (c 3.65, CHCl3); IR (film) 3331, 2977, 1748, 1713, 
1666, 1204 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.25 (d, J = 5.2 Hz, 1H), 7.43 (d, J = 7.2 
Hz, 1H), 7.41-7.22 (m, 5H), 6.94 (m, 1H),  6.49 (d, J = 5.6 Hz, 1H), 5.41 (d, J = 8.4 Hz, 
1H), 4.94 (dd, J = 11.2, 3.6 Hz, 1H), 3.78 (s, 3H), 3.37 (dd, J = 17.2, 11.2 Hz, 1H), 3.14 
(dd, J = 12.8, 5.2 Hz, 1H), 3.05 (dd, J = 17.2, 3.6 Hz, 1H), 2.87 (dd, J = 13.6, 8.0 Hz, 
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1H), 1.38 (s, 9H); 
13
C NMR (125 MHz, CDCl3) ppm 171.5, 171.0, 154.8, 154.5, 146.9, 
136.6, 133.5, 129.5, 127.9, 126.5, 123.2, 118.7, 79.1, 58.3, 54.0, 52.5, 39.9, 29.2, 28.2; 
HRMS (ESI): Exact mass calcd for C23H27N3NaO5 [M+Na]
+ 
448.1848, found 448.1852. 
 
Methyl-1-(2-((S)-2-(tert-butoxycarbonylamino)propanamido)-3-phenylpropanoyl)-
2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate (28aa, and 28ab).  
To a 0 °C solution of the amine salt (750 mg, 3.50 mmol) and the carboxylic acid (1.77 g, 
5.25 mmol) in CH2Cl2 (8 mL) was added diisopropylethylamine (2.26 mL, 12.96 mmol) 
and PyBrOP (2.45 g, 5.26 mmol). The reaction was slowly warmed to the room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
with satd aq NH4Cl, satd aq NaHCO3, and brine. The organic layer was dried, filtered, 
and concentrated to a brown oil. Column chromatography (SiO2, 0-20-40% ethyl acetate 
in hexanes) afforded the tetrapeptide as an inseparable mixture of diastereomers (1.22 g, 
70%), which was characterized as a 3:1 ratio of diastereomers. Rf  = 0.66 (10% 
MeOH/CH2Cl2); IR (film) 3330, 3063, 2101, 2933, 1660, 1167, 1120 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) δ 8.26 (d, J = 5.0 Hz, 1H), 8.24 (d, J = 5.0 Hz, 1H), 7.46 (d, J = 7.0 Hz, 
1H), 7.42 (d, J = 7.0 Hz, 1H), 7.33 (d, J = 7.5 Hz, 1H), 7.26 (d, J = 7.5 Hz, 1H), 7.24 (d, 
J = 5.2 Hz, 1H), 7.19 (d, J = 5.6 Hz, 1H), 7.16-7.08 (m, 6H), 6.96-6.91 (m, 2H), 6.86 (s, 
1H), 6.67 (d, J = 6.0 Hz,1H), 6.55 (d, J = 6.0 Hz ,1H), 6.45 (m, 1H), 5.11 (dd, J = 11.5, 
4.0 Hz, 1H), 5.03 (s, 1H), 4.89 (dd, J = 11.5, 4.2 Hz, 1H), 4.81 (s, 1H), 4.15-4.04 (m, 
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2H), 3.75 (s, 3H), 3.68 (s, 3H), 3.52-3.45 (m, 2H), 3.34 (dd, J = 16.5, 11.0 Hz, 1H), 3.15 
(dd, J = 13.5, 5.5 Hz, 1H),  3.09 (dd, J = 17.0, 4.0 Hz, 1H), 3.02 (dd, J = 17.0, 3.5 Hz, 
1H), 2.93 (dd, J = 13.5, 7.0 Hz, 1H), 2.85 (dd, J = 14.0, 9.0 Hz, 1H), 1.40 (s, 9H), 1.39 (s, 
9H), 1.23 (d, J = 7.0 Hz, 3H), 1.13 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 
172.0, 170.9, 170.8, 170.7, 154.9, 154.8, 154.2, 154.0, 146.4, 146.3, 136.6, 136.1, 133.5 
(2C), 129.3, 129.0, 127.7, 127.6, 126.2, 126.1, 123.1, 123.0, 118.7, 118.5, 79.0, 64.2, 
60.0, 58.0, 57.5, 52.9, 52.6, 52.1 (2C), 49.6, 37.7, 37.3, 33.1, 28.7, 27.9, 20.1, 18.6, 18.3, 
14.1, 13.8; HRMS (EI): Exact mass calcd for C26H33N4O6 [M+H]
+ 
497.2400, found 
497.2400.  
Substitution of 24b (0.89 mg, 4.16 mmol) into the above procedure afforded the 
product as an inseparable mixture of diastereomers (28ba, and 28bb, 1.41 g, 69%), 
which was characterized as a 10:9 ratio of diastereomers. Rf  = 0.64 (10% 
MeOH/CH2Cl2); IR (film) 3300, 2977, 2931, 1745, 1710, 1650, 1482, 1169 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.31 (d, J = 4.8 Hz, 1H), 8.26 (d, J = 4.8 Hz, 1H), 7.49 (d, J = 
7.6 Hz, 1H), 7.43 (d, J = 7.6 Hz, 1H), 7.36 (d, J = 7.2 Hz, 2H), 7.30-7.26 (m, 2H), 7.23-
7.11 (m, 6H), 6.98 (dd, J = 7.6, 5.2 Hz, 1H), 6.94 (dd, J = 7.6, 5.2 Hz, 1H),  6.85 (s, 1H), 
6.66 (br s, 2H), 6.48 (m, 1H), 5.14 (dd, J = 11.2, 4.4 Hz, 1H), 4.99 (br s, 2H), 4.92 (dd, J 
= 11.2, 4.4 Hz, 1H), 4.14-4.06 (m, 2H), 3.77 (s, 3H), 3.70 (s, 3H), 3.56-3.46 (m, 2H), 
3.35 (dd, J = 17.2, 11.2 Hz, 1H), 3.18 (dd, J = 13.2, 5.6 Hz, 1H),  3.11 (dd, J = 11.2, 4.0 
Hz, 1H), 3.03 (dd, J = 17.2, 4.0 Hz, 1H), 2.97 (dd, J = 13.6, 7.2 Hz, 1H), 2.85 (dd, J = 
14.0, 9.2 Hz, 1H), 1.43 (s, 9H), 1.39 (s, 9H), 1.26 (d, J = 7.2 Hz, 3H), 1.14 (d, J = 6.8 Hz, 
3H); 
13
C NMR (125 MHz, CDCl3) ppm 172.2, 171.7, 171.4, 171.2, 171.0, 170.6, 155.2, 
154.6, 154.4, 147.1, 147.1, 147.0, 136.8, 136.3, 133.7, 133.6, 129.6, 129.5, 128.2, 128.0, 
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126.7, 123.3, 123.2, 118.9, 79.7, 60.3, 58.4, 57.9, 53.4, 53.1, 52.8, 52.6 (2C), 50.1, 49.9, 
38.5, 37.8, 29.3 (2C), 28.3, 21.0, 18.8, 18.7, 14.2;  HRMS (EI): Exact mass calcd for 
C26H33N4O6 [M+H]
+ 
497.2400, found 497.2411. 
 
1-(2-((S)-2-(tert-butoxycarbonylamino)propanamido)-3-phenylpropanoyl)-2,3-
dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid (31aa and 31ab).  
To a solution of the methyl ester (760 mg, 1.53 mmol) in MeOH-H2O (30 mL, 4:1) was 
added an aqueous solution (2.0 mL) of LiOH (66.0 mg, 2.75 mmol) and the reaction was 
stirred for 2 h at rt. The solvent was removed in vacuo and the resulting residue acidified 
to pH = 2 with 1M HCl. The acidic solution was extracted with CH2Cl2 and the combined 
organic layers were washed with brine, dried, and filtered. The filtrate was evaporated to 
afford the desired product as a white solid (628 mg, 85%); IR (film) 3360, 3314, 2936, 
2852, 1652, 1428 cm
-1
; 
1
H NMR experiment analysis revealed poorly resolved, broad 
peaks. 
  Substitution of 28ba and 28 bb (1.41 g, 2.83 mmol) into the above procedure afforded 
the product as a white solid (31ba and 31bb ,1.12 g, 83%). 
1
H NMR experiment analysis 
revealed in poorly resolved, broad peaks. HRMS (EI): Exact mass calcd for C25H31N4O6 
[M+H]
+ 
483.2244, found 483.2243. 
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tert-Butyl(2S)-1-(1-(2-(S)-1-(methylamino)-1-oxopropan-2-ylcarbamoyl)-
2,3)dihydro-1H-pyrrolo[2,3-b]pyridine-1-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-
oxopropan-2-ylcarbamate (33aa and 33ab).  
To a solution of the carboxylic acid (630 mg, 1.30 mmol), EDC (240 mg, 1.56 mmol) and 
HOBT (210 mg, 1.56 mmol) in CH2Cl2 (10 mL) was added the amine (130 mg, 1.30 
mmol). The reaction was stirred for 24 h at rt and quenched with satd aq NaHCO3. The 
mixture was extracted with CH2Cl2 and washed with satd aq NH4Cl, satd aq NaHCO3 and 
brine. The organic layers were combined, dried, filtered, and concentrated to a brown oil. 
Column chromatography (SiO2, 1-3-5% MeOH in CH2Cl2) afforded the diastereomers as 
colorless oils (480 mg, 66%). 
More polar diastereomer 33aa  
(160 mg, 22%). Rf = 0.36 (10% MeOH/CH2Cl2); [α]
24
D  –7.8 (c 1.90, CHCl3); IR (film) 
3411 (br), 1662, 1428, 1026 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 8.28 (d, J = 4.5 Hz, 1H, 7e), 7.51 (d, J = 7.5 
Hz, 1H, 7c), 7.38 (s, 1H, 5), 7.33-7.24 (m, 5H, 10c, 
10c', 10d, 10d', 11), 7.17 (t, J = 7.5 Hz, 1H, 10e), 7.00 
(dd, J = 7.5, 4.5  Hz, 1H, 7d), 6.51 (br s, 1H, 10), 6.32 
(d, J = 4.0 Hz, 1H, 2), 5.10 (br s, 1H, 14), 5.01 (dd, J = 
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10.5, 3.0 Hz, 1H, 7), 4.43 (dq, J = 7.5, 7.5 Hz, 1H, 4), 4.28 (br s, 1H, 13), 3.44-3.34 (m, 
2H, 7a, 10a), 3.22 (dd, J = 17.0, 3.0 Hz, 1H, 7a), 2.93 (dd, J = 12.5, 8.5 Hz, 1H, 10a), 
2.76 (d, J = 4.5 Hz, 3H, 1), 1.42 (s, 9H, 17), 1.27 (d, J =7.0 Hz, 3H, 4a), 1.22 (d, J = 7.0 
Hz, 3H, 13a); 
13
C NMR (125 MHz, CDCl3) ppm 172.4, 172.2, 172.1, 170.4, 154.7, 
146.8, 136.6, 133.8, 129.7, 128.3, 126.7, 124.4, 119.3, 79.9, 59.1, 52.5, 49.8, 49.0, 38.1, 
29.2, 28.3, 26.3, 19.3, 17.7; HRMS (ESI): Exact mass calcd for C29H38N6NaO6 [M+Na]
+ 
589.2750, found 589.2747. 
Conformational Analysis of Boc-L-Ala-D-Phe-L-
N7
Ind-L-Ala-NMe (33aa) 
The crosspeaks could be separated into three local regions and a long range correlation. 
Beginning from the C-terminal methyl amide, crosspeaks for H2/H4 and H2/H5 defined 
the s-trans conformation of the methyl amide. However a weaker NOESY correlation for 
H2/H4 suggests that the peptide chain C-terminal to 
N7
Ind does not fold back upon itself 
by 180°. A similar s-trans assignment for the alanine amide could be made by 
observation of a H5/H7 cross peak.    
  
Observed Regional (a-c) and Long Range (d) NOESY Correlation (33aa) 
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The s-trans conformation of the azaindoline amide bond was determined by observation 
of crosspeaks between H10/H10c and H10c/H7e. Complementary to these are crosspeaks 
for H10/H11 and H11/H10c', although crosspeaks could not be observed to definitively 
assign the local conformation of the alanine amide bond as trans. Long range crosspeak 
H17/H10c is consistent with syn conformation of the tert-butyl group such that it is 
positioned at the exterior of the turn. Absence of crosspeak H10/H5 confirms the 
configuration of phenylalanine as (R). Absence of H17/H1, H17/H2, H13a/H2 or 
H13a/H1 crosspeaks are also indicative of the fact that the peptide chain does not fold 
back on itself by 180°. 
Identification of Intramolecular Hydrogen Bonding in (33aa) 
The experiment clearly showed the presence of three NH signals (NH11, NH5, NH14) 
that were affected minimally by the increasing addition of DMSO-d6. This study 
indicated the presence of 
a hydrogen bond between 
NH11 and O3 to form an 
11-membered ring and a 
hydrogen bond between 
NH5 and O9 to form a 7-
membered ring (δ-turn). In contrast, NH2 shifted appreciably with increasing amounts of 
DMSO-d6 indicating that this hydrogen was solvent exposed and not involved in 
hydrogen bonding. 
Less polar diastereomer: 33ab.  
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(320 mg, 44%). Rf = 0.40 (10% MeOH/CH2Cl2); [α]
24
D  –45.4 (c 1.85, CHCl3); IR (film) 
3327, 2957, 2921, 2846, 1653 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) δ 8.24 (d, J = 4.5 Hz, 1H, 7e), 7.48 (d, 
J = 7.5 Hz, 1H, 7c), 7.41 (d, J = 8.0 Hz, 1H, 5), 7.31-
7.18 (m, 6H, 10c, 10c', 10d, 10d', 10e, 11), 6.99 (dd, 
J = 7.5, 4.5 Hz, 1H, 7d), 6.67 (br s, 1H, 2), 6.55 (br 
s, 1H, 10), 5.11 (s, 1H, 14), 5.04 (dd, J = 11.5, 5.0 
Hz, 1H, 7), 4.45 (dq, J = 8.0, 8.0 Hz, 1H, 4), 4.13 (t, J = 8.0 Hz, 1H, 13), 3.43 (dd, J = 
17.5, 2.8 Hz, 1H, 7a), 3.22-3.18 (m, 2H, 7a, 10a), 2.86 (dd, J = 13.5, 10.0 Hz, 1H, 10a), 
2.80 (d, J = 4.5 Hz, 3H, 1), 1.45 (s, 9H, 17), 1.39 (d, J = 7.5 Hz, 3H, 4a), 1.22 (d, J = 7.0 
Hz, 3H, 13a); 
13
C NMR (125 MHz, CDCl3) ppm 173.7, 173.3, 172.8, 170.6, 154.5, 
146.6, 136.0, 134.0, 129.2, 128.5, 127.1, 124.1, 119.3, 80.4, 60.0, 53.9, 49.3 (2C), 36.4, 
29.6, 28.4, 26.4, 16.7, 16.3; HRMS (EI): Exact mass calcd for C29H38N6O6 [M]
+ 
566.2853, found 566.2853. 
Conformational Analysis of Boc-L-Ala-L-Phe-L-
N7
Ind-L-Ala-NMe (33ab) 
Assignment of both phenyl alanine configuration (as L-Phe) and tetrapeptide 
conformation was made using NOESY data and molecular models. The crosspeaks could 
again be separated into three local regions and long range correlations. Beginning from 
the C-terminal methyl amide, crosspeaks for H2/H4 and H2/H5 defined the s-trans 
conformation of the methyl amide. A long range weak correlation between H7/H2 
suggests the folding of C-terminal peptide chain (L-Ala) such that a 10-membered 
hydrogen bond exists between H2/O9. A similar s-trans assignment for the alanine amide 
could be made by observation of an H5/H7 cross peak. 
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  The s-trans conformation of the azaindoline amide bond was determined by observation 
of crosspeaks between H10/H10c and H10c/H7e. Complementary to these are crosspeaks 
for H10/H11 and H11/H10c', although crosspeaks could not be observed to definitively 
assign the local conformation of the alanine amide bond as trans. This assignment is 
supported, however, by a long range crosspeak H1/H13a for which such a geometry 
would be necessary. Additional long range crosspeaks H14/H1 and H1/H17 are 
consistent with anti-conformation of the tert-butyl group such that it is positioned at the 
interior of the turn. The presence of crosspeak H10/H5 confirms the configuration of 
phenylalanine as (S). 
 
Identification of Intramolecular Hydrogen Bonding in (33ab) 
The experiment suggested the presence 
of a hydrogen bond between NH5 and 
O12 to form a 10-membered ring (β-
turn) and another hydrogen bond 
between NH2 and O9 to form a 10-
Observed Regional (a-c) and Long Range (d) NOESY Correlation (33ab) 
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membered ring (β-turn). The experiment showed the presence of two NH signals (NH5 
and NH2) that were affected minimally by the increasing addition of DMSO-d6. In 
contrast, NH11 and NH14 shifted appreciably with increasing amounts of DMSO-d6 
indicating that these hydrogens were solvent exposed, also consistent with the β-turn 
conformation.  
 
tert-Butyl(2S)-1-(1-(2-(S)-1-(methylamino)-1-oxopropan-2-ylcarbamoyl)-
2,3)dihydro-1H-pyrrolo[2,3-b]pyridine-1-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-
oxopropan-2-ylcarbamate (33ba and 33bb).  
To a solution of the carboxylic acid (1.12 g, 2.32 mmol), EDC (430 mg, 2.78 mmol) and 
HOBT (380 mg, 2.78 mmol) in CH2Cl2 (18 mL) was added the amine (240 mg, 2.33 
mmol). The reaction was stirred for 24 h at rt and quenched with satd aq NaHCO3. The 
mixture was extracted with CH2Cl2 and washed with satd aq NH4Cl, satd aq NaHCO3 and 
brine. The organic layers were combined, dried, filtered, and concentrated to a brown oil. 
Column chromatography (SiO2, 1-5% MeOH in CH2Cl2) afforded the individual 
diastereomers as colorless oils (751 mg, 57%). 
More polar diastereomer: 33ba  
(291 mg, 22%). Rf = 0.36 (10% MeOH/CH2Cl2); [α]
24
D  +37.6 (c 1.25, CHCl3); IR (film) 
3341, 2963, 2952, 1641, 1115 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.24 (d, J = 4.8 Hz, 
1H, 7e), 7.44 (d, J = 6.6 Hz, 1H, 7c), 7.25-7.22 (m, 4H, 10c, 10c', 10d, 10d'), 7.18 (t, J = 
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7.2 Hz, 1H, 10e), 7.11 (br s, 1H, 5), 6.97 (dd, J = 7.2, 4.8 Hz, 1H, 7d), 6.73 (br s, 1H, 11), 
6.72 (br s, 1H, 2), 6.41 (d, J =4.8 Hz, 1H, 10), 5.10 
(d, J = 6.6 Hz, 1H, 14), 4.92 (dd, J = 15.6, 8.4 Hz, 
1H, 7), 4.49 (dq, J = 7.8, 7.8 Hz, 1H, 4), 4.12 (br s, 
1H, 13), 3.39 (dd, J = 13.8, 4.2 Hz, 1H, 10a), 3.24 
(m, 2H, 7a), 2.93 (dd, J = 14.4, 7.8 Hz, 1H, 10a), 
2.58 (d, J = 4.8 Hz, 3H, 1), 1.42 (d, J =7.2 Hz, 3H, 
4a), 1.40 (s, 9H, 17), 1.18 (d, J = 7.2  Hz, 3H, 13a); 
13
C NMR (150 MHz, CDCl3) ppm 172.4, 172.2, 172.1, 170.4, 155.2, 154.6, 146.8, 
136.1,133.8, 129.8, 129.5, 128.4, 126.8, 124.2, 119.2, 79.9, 59.7, 52.8, 50.0, 49.1, 37.6, 
29.0, 28.3, 26.3, 18.7, 17.7; HRMS (EI): Exact mass calcd for C29H38N6O6 [M]
+ 
566.2853, found 566.2849. 
Conformational Analysis of Boc-L-Ala-D-Phe-D-
N7
Ind-L-Ala-NMe (33ba) 
The s-trans conformation of the azaindoline amide bond was determined by observation 
of crosspeaks between H7/H10, H10/H10c and H10c/H7e. Complementary to these are 
crosspeaks for H10/H11 and H11/H10c', although crosspeaks could not be observed to 
definitively assign the local conformation of the alanine amide bond as trans. This 
assignment is supported, however, by a long range crosspeak H1/H17 for which such a 
geometry would be necessary.  Additional long range crosspeaks H1/H11 and H1/H10c' 
are consistent with (Z)-O-carbamate geometry and an anti conformation of the tert-butyl 
group such that it is positioned at the interior of the turn. Since the Ala-NH residue is 
oriented by the azaindoline ring, crosspeak H1/H10C' between the methyl and phenyl can 
be used to assign the configuration of phenylalanine as (R). 
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Identification of Intramolecular Hydrogen Bonding in 33ba 
The experiment suggested the presence of a hydrogen bond between NH2 and O9 to form 
a 10-membered ring (β turn) and 
another hydrogen bond between 
NH14 and O9 to form an eight 
membered ring (δ turn). The 
experiment clearly showed the 
presence of two NH signals 
(NH14 and NH2) that were affected minimally by the increasing addition of DMSO-d6. 
In contrast, NH11 and NH5 shifted appreciably with increasing amounts of DMSO-d6 
indicating that these hydrogens were solvent exposed, also consistent with the β-turn 
conformation.  
Observed Regional (a-c) and Long Range (d) NOESY Correlation (33ba) 
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DMSO-Denatured Conformational Analysis of Boc-L-Ala-D-Phe-D-
N7
Ind-L-Ala-NMe 
(33ba) 
  To ascertain the extent to which intramolecular hydrogen bonding dictates the 
conformation of the 
tetrapeptide, the 
conformational analysis 
was repeated with the 
tetrapeptide as a solution in DMSO-d6. Most peaks in the 
1
H NMR spectrum could be 
assigned on the basis of coupling patterns and chemical shift relative to the sample in 
CDCl3. NOESY was used to assign the amide protons that shifted appreciably by the 
change of solvent. Crosspeaks observed for Boc-L- Ala-D-Phe-D-
N7
In-L-Ala-NMe in 
DMSO-d6 were generally similar to those in CDCl3 with the following exception- 
correlations between H1/H17 and H1/H10c were not present. Since all remaining 
crosspeaks were conserved, and disruption of the H2 intramolecular hydrogen bond by 
solvation follows from the DMSO-d6 titration experiment, a conformational change, 
perhaps by rotation about C6-C7 has occurred. The observation of H4a/H2 crosspeak 
also supports rotation about the C3-C4 bond.  
Less polar diastereomer: 33bb  
(460 mg, 35%). Rf = 0.38 (10% MeOH/CH2Cl2); [α]
24
D  +67.1 (c 1.55, CHCl3); IR (film) 
3411 (br), 1657, 1152 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.22 (d, J = 4.8 Hz, 1H, 7e), 
7.46 (d, J = 7.2 Hz, 1H, 7c), 7.19-7.13 (m, 6H, 10c, 10c', 10d, 10d', 10e, 5), 6.98 (dd, J = 
7.6, 5.2  Hz, 1H, 7d), 6.82 (br s, 1H, 11), 6.61 (dd, J = 13.6, 6.4 Hz, 1H, 10), 6.48 (br s, 
1H, 2), 5.00 (dd, J = 10.8, 3.2 Hz, 1H, 7), 4.88 (br s, 1H, 14), 4.36 (dq, J = 7.2, 7.2 Hz, 
DMSO-d6 titration experiment 
 
 
26 
 
1H, 4), 4.18 (s, 1H, 13), 3.38 (dd, J = 12.8, 2.8 Hz, 1H, 7a), 3.15(m, 2H, 7a, 10a), 2.94 
(dd, J = 13.6, 5.2 Hz, 1H, 10a), 2.71 (d, J = 4.8 
Hz, 3H, 1), 1.42 (s, 9H, 17), 1.40 (d, J =7.2 Hz, 
3H, 4a), 1.28 (d, J = 6.8 Hz, 3H, 13a); 
13
C NMR 
(600 MHz, CDCl3) ppm 172.9, 172.3 (2C), 170.1, 
155.4, 154.2, 146.5, 135.8, 134.0, 129.2 (2C), 
128.3, 127.0, 124.7, 119.5, 80.1, 59.8, 53.5, 50.0, 
49.6, 37.2, 28.6, 28.3, 26.3, 18.1, 17.6; HRMS 
(ESI): Exact mass calcd for C29H38N6NaO6 [M+Na]
+ 
589.2750, found 589.2748.  
Conformational Analysis of Boc-L-Ala-L-Phe-D-
N7
Ind-L-Ala-NMe (33bb) 
Assignment of both phenylalanine configurations (as L-Phe) and tetrapeptide 
conformation was made using NOESY data and molecular models. Definitive 
assignments were possible. The crosspeaks could be separated into three local regions (a-
c) and a long range correlation (d). Beginning from the C-terminal methyl amide, 
crosspeaks for H2/H4 and H2/H5 defined the s-trans conformation of the methyl amide. 
A similar s-trans assignment for the alanine amide could be made by observation of a 
H5/H7 cross peak. 
  The s-trans conformation of the azaindoline amide bond was determined by observation 
of crosspeaks between H10/H10c and H10c/H7e. Complementary to these are crosspeaks 
for H10/H11 and H11/H10c', although crosspeaks could not be observed to definitively 
assign the local conformation of the alanine amide bond as trans. This assignment is 
supported, however, by a long range crosspeak H1/H13a for which such a geometry 
would be necessary. Additional long range crosspeaks H13/H17 and H10c/H17 are 
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consistent with syn conformation of the tert-butyl group such that it is positioned at the 
exterior of the turn. Assignment of phenylalanine as (S) configuration was made by 
exclusion: whereas a positive definite crosspeak (H7/H10) was observed for its epimer, 
the only crosspeak observed here between Phe and D-
N7
Ind was H7e/H10c. 
 
Identification of Intramolecular Hydrogen Bonding in 33bb 
The experiment suggested the presence of a hydrogen bond between NH2 and O9 to form 
a 10-membered ring (β turn). 
The experiment showed the 
presence of one NH signal 
(NH2) that was affected 
minimally by the increasing 
addition of DMSO-d6. In 
contrast, NH11 and NH14, and NH5 shifted appreciably with increasing amounts of 
DMSO-d6 indicating that these hydrogens were solvent exposed.  
Observed Regional (a-c) and Long Range (d) NOESY Correlation (33bb) 
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Methyl-1-(2-((S)-2-(tert-butoxycarbonylamino)propanamido)-3-
phenylpropanoyl)indoline-2-carboxylate (34aa, 34ab, 34ba, and 34bb).  
To a 0 °C solution of the amine salt (1.00 g, 4.69 mmol) and the carboxylic acid (2.37 g, 
7.04 mmol) in CH2Cl2 (9.5 mL) was added diisopropylethylamine (3.03 mL, 17.36 mmol) 
and PyBrOP (3.28 g, 7.04 mmol). The reaction was slowly warmed to the room 
temperature and stirred for 2 days. The reaction was diluted with CH2Cl2 and washed 
with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, filtered, and 
concentrated to a brown oil. Column chromatography (SiO2, 0-20-40% ethyl acetate in 
hexanes) furnished each diastereomer as a colorless oil (1.69 g, 73%). 
Less polar diastereomer: 34aa  
(798 mg, 34%). Rf = 0.55 (50% EtOAc/hexanes); [α]
24
D  –35.7 (c 1.45, CHCl3); IR (film) 
3317, 3299, 2976, 2933, 1746, 1649, 1512, 1498, 1463 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 8.19 (d, J = 8.1 Hz, 1H), 7.29-7.17 (m, 5H), 7.12-7.04 (m, 3H), 6.69 (d, J = 6.4 
Hz, 1H), 5.74 (d, J = 10.0 Hz, 1H), 4.94-4.77 (m, 2H), 4.11-4.04 (m, 1H), 3.78-3.60 (m, 
5H), 3.38-3.28 (m, 1H), 3.06-2.98 (m, 1H), 1.45 (d, J = 4.4 Hz, 3H), 1.40 (s, 9H); HRMS 
(ESI): Exact mass calcd for C27H33N3NaO6 [M+Na]
+ 
518.2267, found 518.2264. 
More polar diastereomer: 34ab  
(896 mg, 39%).  Rf = 0.37 (50% EtOAc/hexanes); [α]
24
D  –51.1 (c 0.90, CHCl3); IR (film) 
3329, 3316, 2976, 1744, 1649, 1511, 1498, 1481 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
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8.27 (d, J = 8.1 Hz, 1H), 7.32-7.26 (m, 5H), 7.10-7.08 (m, 3H), 7.02 (d, J = 8.0 Hz, 1H), 
5.05 (br s, 1H), 4.93-4.86 (m, 1H), 4.22-4.18 (m, 2H), 3.71 (s, 3H), 3.20-3.00 (m, 3H), 
2.82 (dd, J = 16.4, 10.6 Hz, 1H), 1.51 (s, 9H), 1.41 (d, J = 7.2 Hz, 3H); HRMS (ESI): 
Exact mass calcd for C27H33N3NaO6 [M+Na]
+ 
518.2267, found 518.2248. 
 
   Substitution of the enantiomeric amine salt (450 mg, 2.11 mmol) into the above 
procedure furnished the corresponding diastereomers as colorless oils. 
Less polar diastereomer: 34ba  
(264 mg, 25%). Rf = 0.49 (50% EtOAC/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 8.19 (d, 
J = 8.0 Hz, 1H), 7.28-7.16 (m, 5H), 7.11-7.06 (m, 3H), 6.67 (d, J = 8.4 Hz, 1H), 5.69 (br, 
1H), 4.86-4.79 (m, 1H), 4.65 (br s, 1H), 4.16 -4.04 (m, 1H), 3.72-3.59 (m, 5H), 3.37-3.28 
(m, 1H), 3.06-2.98 (m, 1H), 1.46 (d, J = 2.6 Hz, 3H), 1.40 (s, 9H). 
More polar diastereomer: 34bb  
(517 mg, 49%). Rf = 0.44 (50% EtOAC/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 8.23 (d, 
J = 8.2 Hz, 1H), 7.28-7.22 (m, 5H), 7.10-7.04 (m, 3H), 6.96 (d, J = 7.4 Hz, 1H), 4.94 (br 
s, 1H), 4.91-4.83 (m, 1H), 4.22-4.04 (m, 2H), 3.66 (s, 3H), 3.15-2.96 (m, 3H), 2.81 (dd, J 
= 16.2, 10.6 Hz, 1H), 1.47 (s, 9H), 1.36 (d, J = 7.1 Hz, 3H). 
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1-[2-(2-tert-Butoxycarbonylamino-propionylamino)-3-phenyl-propionyl]-2,3-
dihydro-1H-indole-2-carboxylic acid (35aa, 35ab, 35ba and35bb).  
To the methyl ester (580 mg, 1.18 mmol) in MeOH-H2O (25 mL, 4:1) at rt was added 
LiOH (51 mg, 2.1 mmol) and the reaction was stirred for 2 h.  The solvent was removed 
in vacuo and the resulting residue acidified to pH = 2 with 1M HCl. The acidic solution 
was extracted with CH2Cl2 and the combined organic layers were washed with brine, 
dried, and filtered. The filtrate was evaporated to afford the desired product as a white 
solid (540 mg, 96%). 
1
H NMR experiment analysis revealed poorly resolved, broad 
peaks. 
  Substitution of 34ab (560 mg, 1.13 mmol), 34ba (190 mg, 0.38 mmol), and 34bb (511 
mg, 1.03 mmol) into the above procedure resulted in 35ab (515 mg, 93%), 35ba (165 
mg, 90%), and 35bb (493 mg, 99%), respectively.  
 HRMS (EI): Exact mass calcd for C26H32N3O6 [M+H]
+ 
482.2291, found 482.2291. 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
 
tert-Butyl-(2(S))-1-(1-(2)-((S)-1-(methylamino)-1-oxopropan-2-ylcarbamoyl)indolin-
1-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylcarbamate (36aa, 36ab).  
To a solution of the carboxylic acid (515 mg, 1.07 mmol), EDC (199 mg, 1.28 mmol) and 
HOBT (173 mg, 1.28 mmol) in CH2Cl2 (9 mL) was added the amine (109 mg, 1.07 
mmol). The reaction was stirred for 24 h and 
quenched with satd aq NaHCO3. The mixture was 
extracted with CH2Cl2 and washed with satd aq 
NH4Cl, satd aq NaHCO3, and brine. The organic 
layers were combined, dried, filtered, and 
concentrated to a brown oil. Flash chromatography 
(SiO2, 1-2-3% MeOH in CH2Cl2) furnished the 
tetrapeptide as a colorless oil (498 mg, 82%). Rf = 0.72 (5% MeOH/CH2Cl2); [α]
24
D  –
146.5 (c 1.6, CHCl3); IR (film) 3299, 3062, 2978, 2934, 1650, 1542, 1483, 1415, 1167 
cm
-1
. 
1
H NMR experiment resulted in poorly resolved, broad peaks and the 2D NMR 
experiments failed to provide well-resolved cross peaks, indicating that the tetrapeptide 
might have been aggregated in solution. As a result, the compound could not be fully 
characterized. HRMS (EI): Exact mass calcd for C30H39N5NaO6 [M+Na]
+ 
588.2798, 
found 588.2800.  
  Substitution of 35ab  
(540 mg, 1.12 mmol) into the above procedure furnished the product (501 mg, 79%) as ≥ 
9:1 cis/trans rotamers. Rf  = 0.63 (5% MeOH/CH2Cl2); [α]
24
D  –70.8 (c 1.3, CHCl3); IR 
(film) 3307, 2959, 2922, 2847, 1653, 1536, 1410 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 
8.09 (d, J = 7.8 Hz, 1H, 7f), 7.31-7.18 (m, 7H, 10c, 10c', 10d, 10d', 10e, 7d, 7e), 7.08 (s, 
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1H, 7c), 6.97 (s, 1H, 11), 6.86 (br s, J = 6.6 Hz, 1H, 5), 6.65 (s, 1H, 2), 5.01 (s, 1H, 14),  
4.69 (dd, J = 9.0, 6.0 Hz, 1H, 10), 4.24-4.15 (m, 3H, 4, 
13, 7), 3.12-3.02 (m, 3H, 10a, 10a, 7a), 2.77 (d, J = 4.8 
Hz, 3H, 1), 2.75 (dd, J = 15.6, 9.6 Hz, 1H, 7a), 1.46 (s, 
9H, 17), 1.37 (d, J = 7.2 Hz, 3H, 13a), 1.21 (d, J = 7.2 
Hz, 3H, 4a); 
13
C NMR (125 MHz, CDCl3) ppm 173.0, 
172.3, 170.5, 169.8, 140.8, 135.0, 130.1, 129.3.0, 
129.0, 127.6 (2C), 125.2, 124.5, 118.4, 80.1, 61.9, 53.5, 50.2, 39.4, 34.0, 28.3, 26.2, 17.6; 
HRMS (EI): Exact mass calcd for C30H40N5O6 [M+H]
+ 
566.2976, found 566.3001. 
Conformational analysis of Boc-L-Ala-L-Phe-L-
 
Ind- L-Ala-NMe (36ab) 
Assignment of both phenylalanine configuration (as L-Phe) and tetrapeptide 
conformation was made using NOESY data and molecular models. Definitive 
assignments were possible.  
 
Observed Regional (a-c) and Long Range (d) NOESY Correlation (36ab) 
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The crosspeaks could be separated into three local regions and a long range correlation. 
Beginning from the C-terminal methyl amide, crosspeaks for H2/H4 and H2/H3 defined 
the s-trans conformation of the methyl amide. A similar s-trans assignment for the 
alanine amide could be made by observation of a H5/H7 cross peak. The s-cis 
conformation of the indoline amide bond was determined by observation of crosspeaks 
between H10/H10c, H7/H10 and H10c/H7. Complementary to these are crosspeaks for 
H10/H11 and H11/H10c', although crosspeaks could not be observed to definitively 
assign the local conformation of the alanine amide bond as trans. This assignment is 
supported, however, by a long range crosspeak H17/H1 and H17/H14a for which such 
geometry would be necessary. Additional long range crosspeaks H11/H13, H13/H15, 
H15/H17 are consistent with syn conformation of the tert-butyl group such that it is 
positioned at the exterior of the turn. Assignment of phenyl alanine as (S) configuration 
was made by the observation of H7/H10 crosspeak.  
Identification of Intramolecular Hydrogen Bonding in 36ab 
The experiment suggested the presence of a hydrogen bond between NH2 and O15 to 
form a 16-membered ring  and 
another weak hydrogen bond 
between NH5 and O12 to form 
a ten membered ring (β turn) 
where L-Ind is present as i+2 
residue. The experiment clearly showed the presence of one NH signal (NH2) that was 
affected minimally by the increasing addition of DMSO-d6 and the other NH signal 
(NH5) which was affected less than the other two NH signal (NH11 and NH14). In 
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contrast, NH11 and NH14 shifted appreciably with increasing amounts of DMSO-d6 
indicating that these hydrogens were solvent exposed.  
 
tert-Butyl-(2(S))-1-(1-(2)-((R)-1-(methylamino)-1-oxopropan-2-ylcarbamoyl)indolin-
1-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylcarbamate (36ba, 36bb).  
To a solution of the carboxylic acid (104 mg, 216 µmol), EDC (40.2 mg, 259 µmol) and 
HOBT (35.1 mg, 259 µmol) in CH2Cl2 (2 mL) was added the amine (22.1 mg, 216 µmol). 
The reaction was stirred for 24 h at rt and was quenched with satd aq NaHCO3. The 
mixture was extracted with CH2Cl2 and washed with satd aq NH4Cl, satd aq NaHCO3 and 
brine. The organic layers were combined, dried (Na2SO4), filtered, and concentrated to a 
brown oil. Flash chromatography (SiO2, 1-2-3% MeOH in CH2Cl2) yielded the desired 
tetrapeptide as a colorless oil (92 mg, 75%). Rf = 0.68 (5% MeOH/CH2Cl2). IR (film) 
3299, 2965, 2933, 1656, 1548, 1483, 1417 cm
-1
. 
1
H NMR experiment analysis revealed 
poorly resolved, broad peaks and the 2D NMR experiments failed to provide well-
resolved cross peaks, indicating that the tetrapeptide might have been aggregated in 
solution. As a result, the compound could not be further characterized.  
   Substitution of 35bb (420 mg, 870 µmol) into the above procedure resulted in the 
tetrapeptide (410 mg, 83%) as a 4:1 cis/trans rotamer mixture. Rf  = 0.63 (5% 
MeOH/CH2Cl2); [α]
24
D  +75.0 (c 1.32, CHCl3); IR (film) 3297 (br), 3057, 2975, 2976, 
2929, 1653, 1533, 1481 cm
-1
; 
1
H NMR (400 MHz, CDCl3, cis-rotamer) δ 8.13 (d, J = 8.0 
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Hz, 1H), 7.61 (br s, 1H), 7.45 (br s, 1H), 7.29-7.04 (m, 8H), 6.24 (br s, 1H), 5.29 (d, J = 
7.1 Hz, 1H), 4.69-4.67 (m, 1H), 4.39-4.21 (m, 3H), 3.15-3.06 (m, 3H), 2.80 (dd, J = 15.5, 
10.8 Hz, 1H), 2.66 (d, J = 4.1 Hz, 3H), 1.50 (s, 9H), 1.34-1.29 (m, 6H); 
13
C NMR (100 
MHz, CDCl3) ppm 173.0, 172.7, 170.8, 170.0, 155.9, 141.6, 135.8, 130.0, 129.5, 129.1, 
127.8, 127.6, 125.2, 124.6, 118.4, 80.6, 61.8, 54.5, 50.1, 49.7, 39.7, 34.1, 28.5, 26.4, 18.1, 
17.6; HRMS (EI): Exact mass calcd for C30H40N5O6 [M+H]
+ 
566.2976, found 566.2957. 
 
(+)-Serratezomine A ((+)-37).  
To a solution of the ester (13.2 mg, 25.5 μmol) in MeOH (600 µL) at 0 °C was added 
sodium hydroxide (220 µL, 0.1 M in H2O). The reaction was stirred for 30 min before 
being warmed to 34 °C and stirred for another 10 h. The solvent was removed in vacuo 
and the resulting residue was dissolved in CH2Cl2. The organic layer was washed once 
with H2O and then satd aq NH4Cl and dried, filtered, and concentrated to a yellow oil. To 
the crude oil in THF (300 µL) was added TBAF (63.8 µL, 1.0 M in THF). The reaction 
was stirred for 15 min before being warmed to 40 °C and stirred for another 20 h. The 
solvent was evaporated and the resulting crude oil was subjected to mass directed LC 
purification (15% CH3CN/0.1% TFA) to afford (+)-serratezomine A as a white solid (2.4 
mg, 33%). Rf = 0.22 (10% MeOH/CH2Cl2); [α]
24
D  +9.5 (c 0.3, MeOH); IR (film) 3423, 
2920, 2850, 1720, 1463, 1200, 1134 cm
-1
; 
1H NMR (400 MHz, MeOD) δ 4.32 (dd, J = 
5.6, 2.8 Hz, 1H), 3.81 (dd, J = 11.2, 6.4 Hz, 1H), 3.77 (dd, J = 3.6, 3.6 Hz, 1H), 3.54 
(ddd, J = 9.6, 9.6, 9.6 Hz, 1H), 3.36-3.34 (m, 1H), 3.28-3.25 (m, 1H), 3.14 (dd, J = 20.0, 
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8.0 Hz, 1H), 2.98 (ddd, J = 13.2, 13.2, 3.6 Hz, 1H), 2.83 (br d, J = 13.6 Hz, 1H), 2.62-
2.61 (m, 1H), 2.46 (d, J = 20.0 Hz, 1H), 2.29-2.13 (m, 4H), 2.05-1.99 (m, 1H), 1.85-1.74 
(m, 4H), 1.40 (ddd, J = 13.6, 13.6, 3.2 Hz, 1H), 1.01 (d, J = 6.4 Hz, 3H); 
13
C NMR (125 
MHz, MeOD) ppm 173.2, 83.5, 76.2, 66.7, 56.0, 48.7, 37.3, 37.1, 34.3, 34.2, 27.0, 23.6, 
22.0, 20.6, 19.7, 17.3. 
The intermediate TBS protected lactone was also isolated. 
Data for latone 277:  
Rf = 0.35 (10% MeOH/CH2Cl2); [α]
24
D  +3.5 (c 0.5, MeOH); IR 
(film) 2927, 2855, 1738, 1672, 1196, 1039 cm
-1
; 
1
H NMR (600 
MHz, CDCl3) δ 4.18 (s, 1H), 3.75 (s, 1H), 3.57 (br d, J = 9.0, 
1H), 3.48 (br d, J = 9.6, 1H), 3.37 (dd, J = 20.4, 7.8 Hz, 1H), 3.17 (br s, 1H), 2.87 (d, J = 
13.8 Hz, 1H), 2.79 (br s, 1H), 2.72 (d, J = 14.4 Hz, 1H), 2.63 (d, J = 10.8 Hz, 1H), 2.37 
(d, J = 20.4 Hz, 1H), 2.28-2.25 (m, 1H), 2.16-2.04 (m, 4H), 1.85-1.82 (m, 2H), 1.79-1.74 
(m, 2H), 1.63-1.60 (m, 1H), 0.94 (d, J = 6.6 Hz, 3H), 0.89 (s, 9H), 0.14 (s, 3H), 0.07 (s, 
3H); 
13
C NMR (150 MHz, CDCl3) ppm 170.0, 81.3, 75.9, 64.0, 53.9, 46.6, 45.8, 35.7, 
35.4, 33.4, 30.7, 26.0, 22.4, 21.0, 19.5, 18.0, 16.9, 14.1, -4.3, -5.2; HRMS (EI): Exact 
mass calcd for C22H39NO3Si [M]
+
 393.2699, found 393.2774.  
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2-((1R,2S,5S)-2-Allyl-6-(tert-butyldimethylsilyloxy)-2-(3,4-dihydro-2H-pyrrol-5-yl)-
3-hydroxy-5-methylcyclohexyl)ethyl pivalate (221).  
Dess-Martin periodinane (342 mg, 805 µmol) was added to the alcohol (200 mg, 366 
µmol) in CH2Cl2 (4 mL) at rt and stirred for 3 h. The reaction was quenched by the 
addition of an aqueous solution containing 2:1 satd aq Na2S2O3:NaHCO3 and was stirred 
until both layers became clear (~20 min). The two layers were separated and the aqueous 
layer was extracted with CH2Cl2. The combined organic layers were washed with brine, 
dried, filtered, and concentrated to a cloudy oil. Column chromatography (SiO2, 10-15% 
ethyl acetate in hexanes) provided the desired product as thick colorless oil (199 mg, 
100%). Rf = 0.47 (25% EtOAc/hexanes); [α]
24
D  -85.9 (c 1.5, CHCl3); IR (film) 2956, 
2928, 2858, 1744, 1709 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 5.73 (dddd, J = 16.7, 10.5, 
8.3, 6.3 Hz, 1H), 5.09 (d, J = 17.3 Hz, 1H), 5.08 (d, J = 10.1 Hz, 1H), 4.53 (dd, J = 9.2, 
3.8 Hz, 1H), 4.11 (dq, J = 10.8, 7.2 Hz, 1H), 4.04 (dq, J = 10.8, 7.2 Hz, 1H), 3.88-3.77 
(m, 2H), 2.99 (dd, J = 13.9, 6.1 Hz, 1H), 2.91-2.85 (m, 1H), 2.75 (dd, J = 14.1, 5.2 Hz, 
1H), 2.54 (dd, J = 17.0, 7.4 Hz, 1H), 2.49-2.32 (m, 3H), 2.32-2.20 (m, 2H), 2.29 (dd, J = 
16.9, 3.2 Hz, 1H), 1.83-1.67 (m, 2H), 1.22 (t, J = 7.2 Hz, 3H), 0.94 (d, J =  6.8 Hz, 3H), 
0.87 (s, 9H), 0.11 (s, 3H), 0.07 (s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 209.1, 176.9, 
173.1, 133.7, 119.3, 73.5, 61.8, 61.2, 60.4, 44.3, 40.8, 38.0, 36.6, 35.3, 35.1, 26.1, 22.3, 
18.3, 14.3, 14.0, -4.2, -4.4; HRMS (CI): Exact mass calcd for C24H41NO4Si [M]
+
 
435.2799, found 435.2800. 
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Ethyl 2-((1S,2R,3S,Z)-2-(tert-butyldimethylsilyloxy)-3-methyl-5-oxo-6-(pyrrolidin-2-
ylidene)cyclohexyl)acetate (222).  
Ceric ammonium nitrate (16.8 g, 30.6 mmol) was added in one portion to the substrate 
(8.10 g, 15.3 mmol) in CH3CN/H2O (5:1, 765 mL) at rt. After 5 min, the reaction was 
quenched with satd aq NaHCO3 and extracted with EtOAc. The combined organic layers 
were washed once with brine, and dried, filtered, and concentrated to an orange/brown 
oil. The crude oil was subsequently chromatographed (SiO2, 10-32-38% ethyl acetate in 
hexanes) to provide the product as a yellow/brown oil (2.8 g, 46%). Analytical data was 
identical to that in the literature.  
 
(2E,4S,5S,8E)-Ethyl 4-(tert-butyldimethylsilyloxy)-8-(1-(1-(4-methoxyphenyl)ethyl)-
pyrrolidin-2-ylidene)-5-methyl-7-oxooct-2-enoate (223). 
Preparation of the β-stannylenamine: To a flame-dried 1L round bottom flask fitted with 
a reflux condenser was added the alkynyl imine (5.8 g, 27 mmol) and the flask was 
evacuated and refilled with nitrogen three times. Benzene (660 mL) was added via 
cannula to the flask, along with 
n
Bu3SnH (1.6 mL, 10% of total 59.6 mmol) and the 
contents were heated in an oil bath to 90-95 °C. In a separate flask, AIBN (4.4 g, 27 
mmol) was added and the flask was evacuated and refilled with nitrogen three times. 
Then benzene (110 mL, 1.5 mL benzene/60 mg AIBN) and 
n
Bu3SnH (14.4 mL, 90% of 
total 59.6 mmol) was added and the solution was added dropwise to the reaction vessel 
over 5-7 hours. After the addition is complete, the reaction is stirred an additional 1 h and 
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then cooled to ~ 40 °C. The solvent was removed in vacuo and the crude oil was 
redissolved in THF (192 mL, 0.14M) and cooled to 0 °C. 
Preparation of the acid chloride: When the above reaction is cooled and ready for solvent 
removal, the preparation of the acid chloride is then initiated. To the carboxylic acid (5.0 
g, 15 mmol) in CH2Cl2 (150 mL) at 0 °C was added oxalyl chloride (6.6 mL, 75 mmol). 
After several minutes, catalytic DMF was added (20 μL). The reaction was stirred for 30 
min at 0 °C and 15 min at rt. The solvent is removed in vacuo and the crude orange oil is 
placed under high vacuum for at least 30 min. The crude acid chloride is then dissolved 
in THF (108 mL), cooled to 0 °C, and then cannulated, quick dropwise, to the β-stannyl 
enamine solution in THF. After the addition was complete, the reaction is allowed to stir 
an additional 5 min at 0 °C and then warmed to rt and stirred overnight. The solvent is 
removed in vacuo and the crude dark orange oil is loaded directly for column 
chromatography (SiO2,10-20-25-30-35-40% ethyl acetate in hexanes to provide the 
desired vinylogous amide 4.95 g (68%). Analytical data was identical to that in the 
literature. 
   
(4R,5S,E)-Ethyl 4-(tert-butyldimethylsilyloxy)-5-methylhepta-2,6-dienoate (232).  
Crotylation, step 1:1 A 3 L three necked, round bottom flask, fitted with a mechanical 
stirrer and pressure addition funnel, was charged with KO
t
Bu (52.6 g, 468 mmol), trans-
2-butene (63.8 mL, 710 mmol), and THF (425 mL) and cooled to -78 °C (CO2, 
i
PrOH). 
n
BuLi (188 mL, 2.5 M in hexanes) was added dropwise via the addition funnel and the 
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reaction becomes yellow. After the addition was complete, the bath was changed to a – 
60 °C bath (CO2, 80/20 EtOH/H2O) for 45 min, at which time the reaction mixture turned 
orange in color. The bath was then changed back to the -78 °C bath, this time using a 
large insulated container. To the round bottom was cannulated a solution of the (-)-
Ipc2BOMe (150 g, 474 mmol) in ether (474 mL) and the reaction was stirred an 
additional one hour, at which time the reaction becomes colorless. Then BF3·OEt2 (105 
mL, 829 mmol) was added via addition funnel and the reaction stirred an additional hour. 
The aldehyde (50.6 g, 395 mmol) in ether (10 mL) was added slowly via cannula and the 
reaction was stirred for 3 d before the addition of more aldehyde (22 g) and then stirred 
for 4 d more, maintaining the temperature at a constant -60 °C. The reaction was 
quenched using 3N NaOH (780 mL) and then 30% H2O2 (378 mL), both via addition 
funnel, and the cold bath was removed and the reaction warmed to rt and stirred for 12 h. 
To the crude reaction was added satd aq Na2S2O3 and it was extracted with ether. The 
combined organic layers were washed with brine, dried, filtered, and concentrated to a 
yellow oil. Subsequent distillation was utilized to remove a main portion of the (-)-IpcOH 
byproduct (full vacuum ~ 300 mTorr, 60-65 °C) which cools to a white solid. The 
remaining yellow oil contained a ~ 1.6:1 ratio of the (-)-IpcOH to homoallylic OH, crude 
oil weight (80.8 g, ~80% crude yield of the desired alcohol). The crude alcohols were 
then protected as their TBS ethers to allow for easier separation via chromatography. 
TBS protection, step 2: The crude alcohols (80.8 g, 487 mmol) and imidazole (49.7 g, 730 
mmol) were dissolved in DMF (1000 mL) and cooled to 0 °C. TBSCl (110 g, 730 mmol) 
was added and the reaction was stirred for 10 min at 0 °C and at least 4 h at rt. Water was 
added and the reaction was extracted with EtOAc and the combined organic layers were 
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washed with brine and then dried, filtered, and concentrated to a yellow oil. The oil was 
dissolved in CH2Cl2 and then extracted with H2O several times to remove the DMF and 
then placed under high vacuum for several hours. Column chromatography (SiO2, 1.5-3% 
ethyl acetate in hexanes) provided the desired TBS-protected product (53.1 g, 76% over 
two steps, dr 11:1, ee 92.3%). Analytical data was identical to that in the literature 
 
Ethyl 2-((1S,2S,5S,6S)-2-allyl-6-(tert-butyldimethylsilyloxy)-2-(3,4-dihydro-2H-
pyrrol-5-yl)- 5-methyl-3-oxocyclohexyl)acetate (250).  
Dess-Martin periodinane (737 mg, 1.74 mmol) was added to the alcohol (380 mg, 869 
µmol) in CH2Cl2 (10 mL) at rt and stirred for 3 h. The reaction was quenched by the 
addition of an aqueous solution containing 2:1 satd aq Na2S2O3:NaHCO3 and was stirred 
until both layers became clear (~20 min). The two layers were separated and the aqueous 
layer was extracted with CH2Cl2. The combined organic layers were washed with brine, 
dried, filtered, and concentrated to a cloudy oil. Column chromatography (SiO2, 10-15% 
ethyl acetate in hexanes) provided the desired product as pale yellow oil (361 mg, 96%). 
Rf = 0.47 (25% EtOAc/hexanes); [α]
24
D  -7.1 (c 0.3, CHCl3); IR (film) 2956, 2928, 2858, 
1744, 1709 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 5.73 (dddd, J = 16.7, 10.5, 8.3, 6.3 Hz, 
1H), 5.09 (d, J = 17.3 Hz, 1H), 5.08 (d, J = 10.1 Hz, 1H), 4.53 (dd, J = 9.2, 3.8 Hz, 1H), 
4.11 (dq, J = 10.8, 7.2 Hz, 1H), 4.04 (dq, J = 10.8, 7.2 Hz, 1H), 3.88-3.77 (m, 2H), 2.99 
(dd, J = 13.9, 6.1 Hz, 1H), 2.91-2.85 (m, 1H), 2.75 (dd, J = 14.1, 5.2 Hz, 1H), 2.54 (dd, J 
= 17.0, 7.4 Hz, 1H), 2.49-2.32 (m, 3H), 2.32-2.20 (m, 2H), 2.29 (dd, J = 16.9, 3.2 Hz, 
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1H), 1.83-1.67 (m, 2H), 1.22 (t, J = 7.2 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 0.87 (s, 9H), 
0.11 (s, 3H), 0.07 (s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 209.1, 176.9, 173.1, 133.7, 
119.3, 73.5, 61.8, 61.2, 60.4, 44.3, 40.8, 38.0, 36.6, 35.3, 35.1, 26.1, 22.3, 18.3, 14.3, 
14.0, -4.2, -4.4; HRMS (CI): Exact mass calcd for C24H41NO4Si [M]
+
 435.2799, found 
435.2800. 
 
(6aS,7S,8S,10S,10aS)-10a-Allyl-7-(tert-butyldimethylsilyloxy)-10-hydroxy-8-methyl-
2,3,6a,7,8,9,10,10a-octahydropyrrolo[2,1-a]isoquinolin-5(6H)-one (250).  
To a -12 °C solution of the carboxylic acid (14.6 mg, 35.7 µmol) and diisopropyl 
ethylamine (12.4 µL, 71.4 mmol) in CH2Cl2 (0.6 mL) was added PyBrOP (33.3 mg, 71.4 
µmol) and the reaction was stirred for 3 h. The reaction was diluted with CH2Cl2 and 
washed with satd aq NH4Cl, satd aq NaHCO3 and brine. The organic layer was dried, 
filtered, and concentrated to a brown oil. Column chromatography (SiO2, 30-50% ethyl 
acetate in hexanes) afforded the cyclic enamide (13.9 mg, 100%). Rf = 0.16 (50% 
EtOAc/hexanes); [α] 24D  -7.1 (c 0.3, CHCl3); mp 55.5-57.5 °C; IR (film) 3396 (br), 2956, 
2928, 2858, 1628 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.90-5.75 (m, 1H), 5.54 (br s, 1H), 
5.19-5.13 (m, 2H), 3.99 (br s, 1H), 3.81-3.72 (m, 2H), 3.38-3.37 (m, 1H), 2.66-2.41 (m, 
6H), 2.24 (dd, J = 14.1, 7.9 Hz, 1H), 2.04 (br s, 2H), 1.80 (br s, 1H), 1.68-1.65 (m, 1H), 
0.93 (d, J = 7.1 Hz, 3H), 0.86 (s, 9H), 0.00 (s, 3H), -0.03 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) ppm 165.2, 141.0, 132.5, 119.2, 108.7, 71.4, 67.5, 44.2, 43.8, 39.3, 36.5, 34.8, 
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34.2, 29.2, 27.1, 25.8, 18.0, 12.1, -4.5, -5.2; HRMS (EI): Exact mass calcd for 
C22H37NO3Si [M]
+
 391.2537, found 391.2539. 
 
2-((1R,2S,5S)-2-Allyl-6-(tert-butyldimethylsilyloxy)-2-(3,4-dihydro-2H-pyrrol-5-yl)-
3-hydroxy-5-methylcyclohexyl)acetic acid (251).  
To a solution of the ester (28.0 mg, 64.1 μmol) in MeOH (660 µL) at 0 °C was added 
sodium hydroxide (220 µL, 0.05 M in H2O). The reaction was stirred for 30 min before 
being warmed to 60 °C and stirred for 12 h. The solvent was removed in vacuo and the 
resulting residue acidified to pH = 2 with 1M HCl. The acidic solution was extracted with 
CH2Cl2 and the combined organic layers were washed with brine, dried, and filtered.  
Column chromatography (SiO2, 5-10% methanol in dichloromethane) provided the title 
compound as a pale yellow oil (20.6 mg, 79%). Rf = 0.40 (10% MeOH/CH2Cl2); [α]
24
D  -
40.5 (c 1.05, CHCl3); IR (film) 3396 (br), 2956, 2928, 2858, 1628 cm
-1
; 
1
H NMR (600 
MHz, CDCl3) δ 5.53-5.46 (m, 1H), 4.98-4.94 (m, 2H), 4.19 (s, 1H), 3.89 (ddd, J = 12.0, 
12.0, 12.0 Hz, 1H), 3.80 (ddd, J = 12.0, 12.0, 12.0 Hz, 1H), 3.66-3.64 (m, 1H), 2.99 (br s, 
1H), 2.64-2.58 (m, 1H), 2.51-2.48 (m, 2H), 2.38 (br d, J = 9.6 Hz, 1H), 2.32-2.29 (m, 
1H), 2.22-2.20 (m, 1H), 2.04-2.00 (m, 1H), 1.92-1.77 (m, 3H), 1.63-1.60 (m, 1H), 1.48 
(br d, J = 13.8 Hz, 1H), 0.93-0.92 (m, 12H), 0.15 (s, 3H), 0.06 (s, 3H), -COOH proton 
not observed; 
13
C NMR (150 MHz, CDCl3) ppm 176.7, 174.6, 134.2, 116.9, 75.0, 59.1, 
48.6, 43.2, 40.9, 34.1, 30.8, 26.0, 24.8, 22.7, 21.7, 18.2, 18.1, 14.1, -4.0, -5.2; HRMS 
(EI): Exact mass calcd for C22H40NO4Si [M+H]
+
 410.2727, found 410.2728. 
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2-((1R,2S,5S)-2-Allyl-6-(tert-butyldimethylsilyloxy)-2-(3,4-dihydro-2H-pyrrol-5-yl)-
5-methyl-3-(methylsulfonyloxy)cyclohexyl)ethyl pivalate (263).  
To a solution of the alcohol (400 mg, 834 μmol) and triethylamine (255 µL, 1.83 mmol) 
in CH2Cl2 (8 mL) at 0 °C was added methanesulfonyl chloride (124 µL, 1.08 mmol). The 
reaction was stirred for 30 min before it was warmed to rt and stirred for 15 min. The 
reaction was quenched with satd aq NH4Cl and extracted with CH2Cl2. The combined 
organic layers were dried, filtered, and concentrated to a pale yellow oil. Column 
chromatography (SiO2, 10-20% ethyl acetate in hexanes) provided the title compound as 
a pale yellow oil (464 mg, 100%). Rf = 0.70 (50% EtOAc/hexanes); [α]
24
D  +18.0 (c 1.0, 
CHCl3); IR (film) 3396 (br), 2956, 2928, 2858, 1628 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
5.48-5.38 (m, 1H), 5.20 (br s, 1H), 4.98-4.90 (m, 2H), 4.10-3.98 (m, 2H), 3.89-3.80 (m, 
1H), 3.78 (br s, 1H), 3.78-3.71 (m, 1H), 3.34 (dd, J = 15.0, 9.0 Hz, 1H), 3.07 (s, 3H), 
2.71-2.62 (m, 1H), 2.41 (ddd, J = 8.0, 8.0, 8.0 Hz, 1H), 2.30 (br s, 1H), 2.17 (dd, J = 
15.0, 4.0 Hz, 1H), 1.98 (br d, J = 11.5 Hz, 1H), 1.93-1.82 (m, 3H), 1.81-1.64 (m, 2H), 
1.50-1.40 (m, 1H), 1.20 (s, 9H), 0.96 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 0.07 (s, 6H); 
13
C 
NMR (125 MHz, CDCl3) ppm 178.4, 177.0, 133.2, 117.6, 83.3, 73.1, 63.3, 59.7, 49.0, 
44.5, 41.4, 38.8, 38.7, 33.7, 30.3, 30.0, 27.2, 25.9, 25.7, 22.4, 18.0 (2C), -3.9, -4.9; 
HRMS (ESI): Exact mass calcd for C28H52NO6SSi [M+H]
+
 558.3285, found 558.3278. 
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2-((1R,2S,5S)-6-(tert-Butyldimethylsilyloxy)-2-(3,4-dihydro-2H-pyrrol-5-yl)-2-(3-
hydroxypropyl)-5-methyl-3-(methylsulfonyloxy)cyclohexyl)ethyl pivalate (264). 
BH3·DMS (34.1 μL, 353 µmol) was added to the alkene (93.0 mg, 168 μmol) in THF 
(1.7 mL) at 0 °C. The reaction was stirred for 2 h before being warmed to rt and stirred 
for another 1 h. The reaction was stirred for 2 h before being warmed to rt and stirred for 
another 1 h. The reaction was cooled to 0 °C, quenched by the addition of 3 N NaOH 
(650 μmol) and 30% H2O2 (500 μmol) and was allowed to stir at rt overnight. The 
reaction was extracted with EtOAc and the combined organic layers were dried, filtered, 
and concentrated to an oily solid. The residue was redissolved in CH2Cl2 (1 mL) and 
treated with 4-dimethyl aminopyridine (205 mg, 1.68 mmol) at rt for 7 d before it was 
filtered, concentrated, and purified via flash column chromatography (SiO2, 20-35%-50% 
ethyl acetate in hexanes) to afford the product as a colorless oily solid (48 mg, 50%) in 
addition to mg of the alkene (22 mg, 23%). Rf = 0.30 (50% EtOAc/hexanes); [α]
24
D  -20.0 
(c 0.6, CHCl3); IR (film) 2956, 2928, 2858, 1744, 1709 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 5.27 (br s, 1H), 3.96 (br s, 1H), 3.85-3.81 (m, 2H), 3.68-3.63 (m, 2H), 3.48 (br 
s, 1H), 3.08 (s, 1H), 3.07 (br s, 1H), 2.81 (br s, 1H), 2.55-2.50 (m, 2H), 2.50-2.45 (m, 
1H), 2.07-2.84 (m, 7H), 1.87-1.84 (m, 1H), 1.40-1.36 (m, 1H), 1.19-1.16 (m, 10H), 0.95-
0.91 (m, 15H), 0.06 (s, 3H), 0.04 (s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 178.4 (2C), 
83.6, 72.5, 63.5, 63.0, 59.8, 48.5, 39.3, 38.7, 34.2, 32.9, 32.0, 31.3, 30.3, 28.1, 27.2, 26.0, 
22.3, 18.0, 17.9, 14.2, -3.8, -4.9; HRMS (ESI): Exact mass calcd for C28H54NO7SSi 
[M+H]
+
 576.3390, found 576.3378. 
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2-((1R,2S,3S,6S)-3-Allyl-3-(3,4-dihydro-2H-pyrrol-5-yl)-6-methyl-7-
oxabicyclo[2.2.1]heptan-2-yl)ethyl pivalate (266).  
TBAF (80.0 μL, 80.0 μmol) was added to the silyl ether (15.0 mg, 26.8 μmol) in THF 
(0.5 mL) and the reaction was refluxed for 2 h, quenched with satd aq. NaHCO3, and 
extracted with ether. The combined organic layers were dried, filtered, and concentrated 
to a crude oil that was purified via column chromatography (SiO2, 12-25-50% ethyl 
acetate in hexanes) to furnish the cyclic ether as a yellow oil (7.5 mg, 81%) in addition to 
the alkene (1.5 mg, 10%). Rf = 0.60 (50% EtOAc/hexanes); [α]
24
D  -12.6 (c 1.5, CHCl3); 
IR (film) 2956, 2928, 2858, 1744, 1709 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 5.56 (dddd, 
J = 16.8, 10.2, 7.8, 6.6 Hz, 1H), 5.04 (d, J = 16.8 Hz, 1H), 5.01 (d, J = 10.2 Hz, 1H), 4.28 
(d, J = 5.4 Hz, 1H), 4.07 (d, J = 4.8 Hz, 1H), 4.04-3.95 (m, 2H), 3.84-3.74 (m, 2H), 2.55-
2.49 (m, 2H), 2.33-2.25 (m, 3H), 2.13 (dddd, J = 9.0, 6.6, 6.6, 3.6 Hz, 1H), 2.06 (ddd, J = 
5.4, 5.4, 5.4Hz, 1H), 1.95 (dd, J = 12.0, 8.4 Hz, 1H), 1.81-1.70 (m, 3H), 1.20 (s, 9H), 
1.16 (ddd, J = 12.6, 5.4, 4.2 Hz, 1H), 0.97 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3) ppm 178.7, 177.7, 133.8, 117.8, 86.8, 84.2, 64.3, 60.5, 53.6, 47.2, 45.4, 38.7, 
37.5, 35.5, 29.7, 27.4, 27.2, 22.2, 21.2; HRMS (ESI): Exact mass calcd for C21H34NO3 
[M+H]
+
 348.2539, found 348.2533. 
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2-((1R,2S,5S)-2-Allyl-6-(tert-butyldimethylsilyloxy)-2-(3,4-dihydro-2H-pyrrol-5-yl)-
5-methyl-3-(methylsulfonyloxy)cyclohexyl)ethyl pivalate (269).  
To a solution of the alcohol (283 mg, 590 μmol) and triethylamine (181 µL, 1.30 mmol) 
in CH2Cl2 (7.0 mL) at 0 °C was added methanesulfonyl chloride (60.1 µL, 767 µmol). 
The reaction was stirred for 30 min before it was warmed to rt and stirred for 15 min. The 
reaction was quenched with satd aq NH4Cl and extracted with CH2Cl2. The combined 
organic layers were dried, filtered, and concentrated to a pale yellow oil.  Column 
chromatography (SiO2, 10-20% ethyl acetate in hexanes) provided the title product as a 
thick colorless oil (291 mg, 89%). Rf = 0.68 (50% EtOAc/hexanes); [α]
24
D  -44.8 (c 1.45, 
CHCl3); IR (film) 3396 (br), 2956, 2928, 2858, 1628 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
5.73 (dddd, J = 17.0, 10.0, 8.0, 6.0 Hz, 1H), 5.31 (dd, J = 12.0, 5.0 Hz, 1H), 4.94 (d, J = 
16.5, Hz, 1H), 4.87 (d, J = 10.0 Hz, 1H), 3.98-3.95 (m, 2H), 3.84-3.70 (m, 2H), 3.65 (br 
s, 1H), 3.48 (br s, 1H), 3.07 (s, 3H), 2.55 (ddd, J = 8.5, 8.5, 8.5 Hz, 1H), 2.40 (ddd, J = 
8.5, 8.5, 8.5 Hz, 1H), 2.33 (dd, J = 8.5, 8.0 Hz, 1H), 2.10-1.88 (m, 3H), 1.84-1.78 (m, 
2H), 1.65 (br s, 1H), 1.50-1.38 (m, 2H), 1.19 (s, 9H), 0.96 (d, J = 6.5 Hz, 3H), 0.93 (s, 
9H), 0.09 (s, 3H), 0.05 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 178.4 (2C), 136.9, 
115.5, 83.1, 72.5, 62.1, 59.6, 49.6, 47.9, 40.4, 39.3, 38.7, 34.6, 32.7, 31.1, 27.9, 27.2, 
26.0, 22.4, 18.0 (2C), -3.8, -4.9; HRMS (ESI): Exact mass calcd for C28H52NO6SSi 
[M+H]
+
 558.3285, found 558.3287. 
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2-((1R,2S,5S)-6-(tert-Butyldimethylsilyloxy)-2-(3,4-dihydro-2H-pyrrol-5-yl)-2-(3-
hydroxypropyl)-5-methyl-3-(methylsulfonyloxy)cyclohexyl)ethyl pivalate (270). 
 BH3·DMS (102 μL, 1.06 mmol) was added to the alkene (279 mg, 504 μmol) in THF 
(5.0 mL) at 0 °C. The reaction was stirred for 2 h before being warmed to rt and stirred 
for another 1 h. The reaction was cooled to 0 °C, quenched by the addition of 3 N NaOH 
(2.0 mL) and 30% H2O2 (1.5 mL) and was allowed to stir at rt overnight. The reaction 
was extracted with EtOAc and the combined organic layers were dried, filtered, and 
concentrated to an oily solid. The residue was redissolved in CH2Cl2 (3 mL) and treated 
with 4-dimethyl aminopyridine (610 mg, 5.01 mmol) at rt for 7 d before it was filtered, 
concentrated, and purified via flash column chromatography (SiO2, 20-40-60% ethyl 
acetate in hexanes) to yield a colorless oily solid (228 mg, 79%). Rf = 0.24 (50% 
EtOAc/hexanes); [α] 24D  -18.2 (c 0.55, CHCl3); IR (film) 2956, 2928, 2858, 1744, 1709 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 5.29 (br s, 1H), 3.96 (br s, 1H), 3.85-3.81 (m, 2H), 
3.68-3.63 (m, 2H), 3.48 (br s, 1H), 3.08 (s, 1H), 3.07 (br s, 1H), 2.81 (br s, 1H), 2.55-2.50 
(m, 2H), 2.50-2.45 (m, 1H), 2.07-2.84 (m, 7H), 1.87-1.84 (m, 1H), 1.40-1.36 (m, 1H), 
1.19-1.16 (m, 10H), 0.95-0.91 (m, 15H), 0.06 (s, 3H), 0.04 (s, 3H); 
13
C NMR (125 MHz, 
CDCl3) ppm 178.4 (2C), 83.6, 72.5, 63.5, 63.0, 59.8, 48.5, 39.3, 38.7, 34.2, 32.9, 32.0, 
31.3, 30.3, 28.1, 27.2, 26.0, 22.3, 18.0, 17.9, 14.2, -3.8, -4.9; HRMS (ESI): Exact mass 
calcd for C28H54NO7SSi [M+H]
+
 576.3390, found 576.3395. 
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(1S,2R,4S)-3-(tert-Butyldimethylsilyloxy)-4-methyl-6-(methylsulfonyloxy)-2-(2-
(pivaloyloxy)ethyl)-1',2',3',5',6',7'-hexahydrospiro[cyclohexane-1,8'-indolizin]-4'-
ium bromide (272).  
Bromine (25.2 μL, 493 μmol) was added to a solution of the alcohol (142 mg, 247 μmol), 
PPh3 (67 mg, 249 μmol), and imidazole (33.5 mg, 493 μmol) in benzene (8 mL) at rt. 
After 10 min, the reaction was quenched with satd aq Na2S2O3 and extracted with EtOAc. 
The combined organic layers were dried, filtered, and concentrated in vacuo to provide a 
pale yellow oily solid. The crude was dissolved in CHCl3 (5 mL) and allowed to sit for 1 
d (until TLC revealed the disappearance of the primary bromide). The solvent was 
removed and the resulting crude oil was purified by column chromatography (SiO2, 80% 
ethyl acetate in hexanes then 5-12% methanol in dichloromethane) to afford the title 
compound as a colorless oil (120 mg, 76%). Rf = 0.12 (10% MeOH/CH2Cl2); [α]
24
D  -21.4 
(c 1.05, CHCl3); IR (film) 2956, 2928, 2858, 1744, 1709 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 5.22 (dd, J = 9.0, 4.0 Hz, 1H), 5.85 (dd, J = 21.5, 9.0 Hz, 1H), 4.34-4.20 (m, 
2H), 4.18 (ddd, J = 6.0, 6.0, 6.0 Hz, 1H), 4.09 (ddd, J = 6.0, 6.0, 6.0 Hz, 1H), 3.98 (dd, J 
= 16.0, 7.0 Hz, 1H), 3.75 (br s, 1H), 3.75-3.62 (m, 1H), 3.39 (s, 3H), 3.35-3.22 (m, 1H), 
3.01 (br d, J = 13.5 Hz, 1H), 2.52-2.40 (m, 2H), 2.35-2.26 (m, 1H), 2.22 (ddd, J = 12.5, 
9.0, 9.0 Hz, 1H), 2.18-2.11 (m, 2H), 2.07 (ddd, J = 13.5, 3.0, 3.0 Hz, 1H), 2.03-1.90 (m, 
2H), 1.82-1.73 (m, 1H), 1.71-1.63 (m, 1H), 1.75-1.64 (m, 1H), 1.19 (s, 9H), 0.99 (d, J = 
6.0 Hz, 3H), 0.98 (s, 9H), 0.13 (s, 3H), 0.07 (s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 
193.0, 178.3, 78.2, 72.2, 62.9, 62.3, 49.6, 47.4, 45.8, 40.9, 39.1, 38.7, 31.0, 30.4, 29.7, 
28.7, 27.1, 25.7, 19.9, 19.0, 17.9, 16.8, -3.7, -5.0; HRMS (ESI): Exact mass calcd for 
C28H53NO6SSi [M-Br]
+
 558.3285, found 558.3292. 
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2-((1S,4S,6R)-5-(tert-Butyldimethylsilyloxy)-4-methyl-2-
(methylsulfonyloxy)hexahydro-1'H-spiro[cyclohexane-1,8'-indolizine]-6-yl)ethyl 
pivalate (273).  
PtO2 (71.0 mg, 313 μmol) was added to the iminium salt (91.1 mg, 143 μmol) in MeOH 
(4.0 mL) and a balloon atmosphere of hydrogen was administered. After 5 h, the reaction 
was complete by TLC and was filtered through Celite with MeOH and then concentrated. 
The crude oil was chromatographed (SiO2, 5-10% methanol in dichloromethane) to 
provide the amine as a colorless oil (45.3 mg, 57%). Rf = 0.30 (10% MeOH/CH2Cl2); 
[α] 24D  -11.4 (c 1.4, CHCl3); IR (film) 3396 (br), 2956, 2928, 2858, 1628 cm
-1
; 
1
H NMR 
(600 MHz, MeOD) δ 5.24 (br s, 1H), 4.14-4.06 (m, 2H), 3.88 (dd, J = 7.8, 3.6 Hz, 1H), 
3.09 (s, 3H), 3.05 (br s, 1H), 2.15-2.14 (m, 1H), 2.12-2.06 (m, 1H), 2.02 (ddd, J = 14.4, 
4.2, 4.2 Hz, 1H), 1.95 (ddd, J = 6.6, 6.6, 6.6 Hz, 1H), 1.91-1.70 (m, 12H), 1.59 (br s, 1H), 
1.49 (dddd, J = 13.8, 7.2, 7.2, 4.8 Hz, 1H), 1.19 (s, 9H), 1.09 (d, J = 6.6 Hz, 3H), 0.93 (s, 
9H), 0.12 (s, 3H), 0.10 (s, 3H); 
13
C NMR (150 MHz, MeOD) ppm 178.6, 82.0, 71.6, 
64.8, 63.6, 53.1, 46.7, 42.0, 40.9, 39.2, 31.3, 30.2, 29.7, 27.2, 25.9, 25.8, 25.7, 23.7, 18.9 
(2C), 18.5, 17.9, -3.6, -4.9; HRMS (ESI): Exact mass calcd for C28H54NO6SSi [M+H]
+
 
560.3434, found 560.3441. 
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(1S,2R,4S)-3-(tert-Butyldimethylsilyloxy)-2-(2-hydroxyethyl)-4-methylhexahydro-
1'H-spiro[cyclohexane-1,8'-indolizine]-6-yl methanesulfonate (274).  
To a solution of the ester (42.2 mg, 75.0 μmol) in CH2Cl2-toluene (1:1, 4.0 mL) at 78 °C 
was added DIBAL (375 µL, 375 μmol, 1.0 M solution in toluene). The reaction was 
stirred for 30 min before being warmed to -5 °C and stirred for 5 h. The reaction was 
quenched with satd aq NH4Cl and extracted with CH2Cl2. The combined organic layers 
were dried, filtered, and concentrated to a pale yellow oil. Column chromatography 
(SiO2, 10-15% methanol in dichloromethane) provided the alcohol as a yellow oil (18.0 
mg, 54%). Rf = 0.11 (10% MeOH/CH2Cl2); [α]
24
D  -32.1 (c 0.95, CHCl3); IR (film) 3396 
(br), 2956, 2928, 2858, 1628 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 4.72 (br d, J = 6.0 Hz 
1H), 3.82 (br d, J = 10.8 Hz 1H), 3.70 (s, 1H), 3.65 (dd, J = 7.8, 2.4 Hz, 1H), 3.40 (br s, 
1H), 3.35-3.31 (m, 1H), 3.06 (s, 3H), 2.79 (br d, J = 18.0 Hz, 1H), 2.71 (br s, 1H), 2.60 
(br t, J = 10.8 Hz, 1H), 2.35-2.28 (m, 2H), 2.22-1.85 (m, 7H), 1.72-1.60 (m, 5H), 0.94 (d, 
J = 6.0 Hz, 3H), 0.91 (s, 9H), 0.88-0.81 (m, 1H), 0.28 (s, 3H), 0.08 (s, 3H); 
13
C NMR 
(150 MHz, CDCl3) ppm 82.2, 73.4, 65.2, 60.6, 53.0, 46.8, 42.0, 41.4, 40.8, 31.9, 31.3, 
31.2, 30.4, 26.0, 22.7, 19.1, 18.0 (2C), 14.1, -3.9, -5.0; HRMS (EI): Exact mass calcd for 
C23H46NO5SSi [M+H]
+
 476.2866, found 476.2863. 
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Ethyl 2-((1S,2S,5S,6S)-2-allyl-6-(tert-butyldimethylsilyloxy)-2-(3,4-dihydro-2H-
pyrrol-5-yl)-3-hydroxy-5-methylcyclohexyl)acetate (279).  
To the ketone (61.0 mg, 140 μmol) in isopropanol (2.5 mL) at -3 °C was added NaBH4 
(7.40 mg, 196 µmol) and the reaction was stirred for 3 h. The reaction was quenched with 
butyraldehyde (20.6 μL, 240 µmol), and allowed to warm to rt for 20 min. The reaction 
mixture was extracted with EtOAc and the combined organic layers were dried, filtered, 
and concentrated to a pale yellow oil. Column chromatography (SiO2, 10-15-20-25-30-
50-70% ethyl acetate in hexanes) provided the desired alcohol (38.3 mg, 63%), epimeric 
alcohol (12.8 mg, 21%), tricyclic enamide (3.0 mg, 5%), and the epimeric tricyclic 
enamide (2.1 mg, 3%). 
Data for α-alcohol 279  
Rf = 0.50 (50% EtOAc/hexanes); [α]
24
D  -11.4 (c 1.85, CHCl3); IR (film) 3358 (br), 2955, 
2927, 2855, 1728 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 5.99-5.91 (dddd, J = 18.0, 10.8, 
10.8, 6.0 Hz, 1H), 4.83 (d, J = 17.0 Hz, 1H), 4.76 (d, J = 10.0 Hz, 1H), 4.17-4.06 (m, 
3H), 3.77-3.71 (m, 2H), 3.57 (br s, 1H), 3.35 (dd, J = 15.0, 6.0 Hz, 1H), 2.48-2.43 (m, 
3H), 2.21 (dd, J = 15.5, 9.0 Hz, 1H), 2.15 (dd, J = 16.5, 11.5 Hz, 1H), 1.88 (dd, J =16.5, 
1.0 Hz, 1H), 1.86-1.65 (m, 4H), 1.57 (ddd, J = 13.5, 3.0, 3.0 Hz, 1H), 1.26 (t, J = 7.0 Hz, 
3H), 0.93 (d, J = 7.0 Hz, 3H), 0.90 (s, 9H), 0.16 (s, 3H), 0.01 (s, 3H), -OH proton not 
observed; 
13
C NMR (125 MHz, CDCl3) ppm 183.4, 172.6, 137.9, 114.3, 73.9, 71.6, 60.7, 
59.4, 50.5, 45.5, 39.4, 34.7, 34.1, 31.8, 31.3, 26.0, 22.1, 18.1, 18.0, 14.2, -4.0, -5.4; 
HRMS (ESI): Exact mass calcd for C24H44NO4Si [M+H]
+
 438.3040, found 438.3028.  
Data for β-alcohol 249:  Rf = 0.62 (50% EtOAc/hexanes); [α]
24
D  +65.3 (c 1.0, CHCl3); IR 
(film) 3385 (br), 2949, 2932, 2862, 1730 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.66 (br s, 
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1H), 5.49-5.36 (m, 1H), 4.98 (d, J = 17.2 Hz, 1H), 4.94 (d, J = 10.9 Hz, 1H), 4.20 (br s, 
1H), 4.14 (dq, J = 10.8, 7.1 Hz, 1H), 4.09 (dq, J = 10.8, 7.1 Hz, 1H), 3.95-3.86 (m, 1H), 
3.82-3.72 (m, 1H), 3.67(br s, 1H), 3.33 (dd, J = 15.2, 8.2 Hz, 1H), 2.63 (dd, J = 16.9, 
11.4 Hz, 1H), 2.57-2.45 (m, 2H), 2.34 (br d, J = 11.4 Hz, 1H), 2.26-2.19 (m, 1H), 2.18 
(dd, J = 16.1, 6.0 Hz, 1H), 1.97 (br d, J =17.0 Hz, 1H), 1.90-1.70 (m, 3H), 1.50 (ddd, J = 
14.0, 3.0, 3.0 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H), 1.01-0.88 (m, 12H), 0.19 (s, 3H), 0.05 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) ppm 183.6, 173.4, 134.4, 116.9, 74.6, 69.4, 60.4, 59.6, 
48.0, 44.1, 41.8, 36.3, 33.9, 30.1, 26.0, 25.1, 21.9, 18.3, 18.1, 14.2, -3.9, -5.3; HRMS 
(EI): Exact mass calcd for C24H43NO4Si [M]
+
 437.2956, found 437.2949.   
Data for cyclic enamide 282: See 250 for characterization data 
Data for epimeric cyclic enamide . See 283 for characterization data. 
 
Ethyl 2-((1S,2S,5S)-2-allyl-6-(tert-butyldimethylsilyloxy)-2-(3,4-dihydro-2H-pyrrol-
5-yl)-5-methyl-3-(methylsulfonyloxy)cyclohexyl) acetate (280).  
To a solution of the alcohol (283 mg, 647 μmol) and triethylamine (198 µL, 1.42 mmol) 
in CH2Cl2 (15 mL) at 0 °C was added methanesulfonyl chloride (65.1 µL, 842 µmol). 
The reaction was stirred for 30 min before it was warmed to rt and stirred for 15 min. The 
reaction was quenched with satd aq NH4Cl and extracted with CH2Cl2. The combined 
organic layers were dried, filtered, and concentrated to a pale yellow oil. Column 
chromatography (SiO2, 10-20% ethyl acetate in hexanes) provided the title compound as 
a pale yellow oil (328 mg, 98%). Rf = 0.64 (50% EtOAc/hexanes); [α]
24
D  -26.2 (c 1.45, 
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CHCl3); IR (film) 2956, 2930, 1731, 1343, 1173 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 
5.74-5.68 (dddd, J = 16.8, 9.9, 7.8, 6.0 Hz, 1H), 5.23 (dd, J = 12.0, 4.8 Hz, 1H), 4.92 (d, J 
= 17.2 Hz, 1H), 4.84 (d, J = 10.2 Hz, 1H), 4.14-4.01 (m, 2H), 3.77-3.70 (m, 2H), 3.52 (br 
s, 1H), 3.44 (br d, J = 12.6, 1H), 3.03 (s, 3H), 2.54-2.50 (m, 2H), 2.36 (dd, J = 16.2, 7.8 
Hz, 1H), 2.31 (dd, J = 16.8, 8.4 Hz, 1H), 2.08-1.98 (m, 3H), 1.94 (ddd, J = 13.2, 4.2, 4.2 
Hz, 1H), 1.90-1.82 (m, 1H), 1.80-1.70 (m, 2H), 1.21 (t, J = 7.2 Hz, 3H), 0.98-0.93 (m, 
12H), 0.15 (s, 3H), 0.00 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 178.2, 172.2, 136.8, 
115.5, 82.8, 73.4, 60.7, 59.5, 48.9, 46.5, 39.9, 39.1, 34.5, 34.3, 32.5, 31.1, 25.9, 22.3, 
17.9, 17.6, 14.1, -4.1, -5.4; HRMS (ESI): Exact mass calcd for C25H46NO6SSi [M+H]
+
 
516.2815, found 516.2811. 
 
Ethyl 2-((1S,2S,5S)-6-(tert-butyldimethylsilyloxy)-2-(3,4-dihydro-2H-pyrrol-5-yl)2-
(3-hydroxypropyl)-5-methyl-3-(methylsulfonyloxy)cyclohexyl) acetate (281).  
BH3·DMS (119 μL, 1.26 mmol) was added to the alkene (309 mg, 601 μmol) in THF (6.0 
mL) at 0 °C. The reaction was stirred for 2 h before it was warmed to rt and stirred for 
another 1 h. The reaction was cooled to 0 °C, quenched by the addition of 3 N NaOH (2.4 
mL) and 30% H2O2 (1.8 mL) and was allowed to stir at rt overnight. The reaction was 
extracted with EtOAc and the combined organic layers were dried, filtered, and 
concentrated to an oily solid. The residue was redissolved in CH2Cl2 (3 mL) and treated 
with 4-dimethyl aminopyridine (732 mg, 6.01 mmol) at rt for 2 d before it was filtered, 
concentrated, and purified via flash column chromatography (SiO2, 20-40-60% ethyl 
acetate in hexanes) to yield a colorless oily solid (141 mg, 44%) in addition to the alkene 
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(44.7 mg, 14%). Rf = 0.20 (50% EtOAc/hexanes); [α]
24
D -41.1 (c 0.9, CHCl3); IR (film) 
2955, 2930, 2856, 1730, 1633, 1336, 1292, 1172 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
5.23 (br d, J = 8.0 Hz, 1H), 4.12 (dq, J = 11.0, 7.0 Hz, 1H), 4.08 (dq, J = 10.8, 7.2 Hz, 
1H), 3.81 (br t, J = 6.0, 2H), 3.61 (ddd, J = 9.5, 7.0, 7.0 Hz, 1H), 3.53 (br s, 1H), 3.47 
(ddd, J = 9.5, 7.0, 7.0 Hz, 1H), 3.07 (s, 3H), 2.83 (br s, 1H), 2.58-2.48 (m, 2H), 2.45-2.34 
(m, 1H), 2.10-2.02 (m, 3H), 1.99 (br s, 1H), 1.94-1.78 (m, 4H), 1.72-1.50 (m, 2H), 1.22 
(t, J = 7.0 Hz, 3H), 1.19-1.09 (m, 1H), 0.95-0.93 (m, 12H), 0.16 (s, 3H), 0.03 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) ppm 178.6, 172.4, 83.4, 73.6, 63.4, 60.8, 59.8, 47.6, 39.2, 34.6, 
34.2, 32.8, 31.6, 31.4, 30.3, 29.7, 26.0, 22.3, 18.0, 17.7, 14.2, -4.0, -5.3; HRMS (ESI): 
Exact mass calcd for C25H48NO7SSi [M+H]
+
 534.2921, found 534.2910. 
 
(6aS,7S,8S,10R,10aS)-10a-Allyl-7-(tert-butyldimethylsilyloxy)-10-hydroxy-8-methyl-
2,3,6a,7,8,9,10,10a-octahydropyrrolo[2,1-a]isoquinolin-5-(6H)-one (283).  
SiO2 (500 mg) was added to the alcohol (20.0 mg, 45.8 µmol) in EtOAc (1.0 mL) at rt 
and the reaction was stirred for 24 h. The reaction was concentrated in vacuo and the 
residual solid was purified via flash column chromatography (SiO2, 40-70% ethyl acetate 
in hexanes) to afford the desired product as a colorless oil (17 mg, 91%). : Rf = 0.12 (50% 
EtOAc/hexanes); [α] 24D  -19.0 (c 1.0, CHCl3); IR (film) 3396 (br), 2956, 2928, 2858, 1628 
cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 5.85-5.73 (m, 1H), 5.13-5.03 (m, 2H), 4.84 (br s, 
1H), 3.96 (br s, 1H), 3.88-3.85 (m, 2H), 3.43 (br s, 1H), 2.82-2.12 (m, 7H), 2.12-1.75 (m, 
3H), 1.70 (dd, J = 13.8, 5.4 Hz, 1H), 1.09 (br s, 3H), 0.90 (s, 9H), 0.45 (s, 3H), 0.02 (s, 
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3H); 
13
C NMR (150 MHz, CDCl3) ppm 165.7, 142.2, 134.1, 118.1, 106.8, 72.8, 68.7, 
47.0, 44.4, 43.1, 39.8, 32.9, 29.7, 27.2, 27.0, 26.0, 18.1, 14.1, -4.5, -5.0; HRMS (EI): 
Exact mass calcd for C22H38NO3Si [M+H]
+
 392.2621, found 392.2621. 
 
(8aR,9R,10S,12S)-9-(tert-Butyldimethylsilyloxy)-10-methyl-7-oxo-
1,2,3,5,6,7,8,8a,9,10,11,12-dodecahydrobenzo[e]pyrrolo[3,2,1-ij]quinolin-12-
ylmethanesulfonate (286).  
Bromine (12.8 μL, 249 μmol) was added to a solution of the alcohol (66.0 mg, 124 
μmol), PPh3 (67 mg, 249 μmol), and imidazole (16.9 mg, 249 μmol) in benzene (4 mL) at 
rt. After 10 min, the reaction was quenched with satd aq Na2S2O3 and extracted with 
EtOAc. The combined organic layers were dried, filtered, and concentrated in vacuo to 
provide a pale yellow oily solid. The crude was dissolved in CH2Cl2 (5 mL) and allowed 
to sit for 2 d (until TLC revealed the disappearance of the primary bromide). SiO2 (500 
mg) was added to the reaction and stirred for 24 h. The solvent was removed and the 
resulting crude solid was purified by column chromatography (SiO2, 80% ethyl acetate in 
hexanes then 5-12% methanol in dichloromethane) to afford the vinylogous amide as a 
pale yellow oil (36 mg, 62%). Rf = 0.43 (10% MeOH/CH2Cl2); [α]
24
D  -45.3(c 0.75, 
CHCl3); IR (film) 2956, 2928, 2858, 1744, 1709 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
5.23 (dd, J = 12.0, 4.0 Hz, 1H), 3.64 (ddd, J = 11.5, 11.5, 4.0 Hz, 1H), 3.50 (br s, 1H), 
3.36-3.25 (m, 2H), 2.93-2.82 (m, 5H), 2.58 (ddd, J = 14.5, 11.5, 11.5 Hz, 1H), 2.42-2.30 
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(m, 2H), 2.30-2.22 (m, 2H), 2.15-2.09 (m, 1H), 2.06 (ddd, J = 12.0, 12.0, 12.0 Hz, 1H), 
1.86 (ddd, J = 12.0, 3.5, 3.5 Hz, 1H), 1.75-1.64 (m, 1H), 1.42 (ddd, J = 9.5, 9.5, 4.5 Hz, 
1H), 0.98 (d, J = 6.5 Hz, 3H), 0.91 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H); 
13
C NMR (150 
MHz, CDCl3) ppm 187.2, 170.6, 180.9, 85.8, 73.3, 54.8, 50.6, 46.8, 39.4, 38.3, 37.3, 
32.1, 32.0, 29.6, 28.6, 26.0, 23.5, 20.0, 18.1, 17.6, -4.1, -5.1; HRMS (ESI): Exact mass 
calcd for C23H40NO5SSi [M+H]
+
 470.2397, found 470.2392.  
  A HMBC correlation was observed between the 
geminal quaternary carbon and geminal methylene 
protons to the vinylogous amide ketone. Other coupling 
constants, including the hydrogen adjacent to the TBS 
and mesylate, establish the chair conformation of the cyclohexane ring. 
 
Ethyl 2-((1S,4S,5R,6R)-5-(tert-butyldimethylsilyloxy)-4-methyl-2-
(methylsulfonyloxy) hexahydro-1'H-spiro[cyclohexane-1,8'-indolizine]-6-
yl)acetate(291).  
To a solution of the alcohol (50.0 mg, 93.6 μmol) and triethylamine (26.0 µL, 186 µmol) 
in CH2Cl2 (1 mL) at 0 °C was added methanesulfonyl chloride (12.4 µL, 159 µmol). The 
reaction was stirred for 40 min and quenched with satd aq NH4Cl. This reaction mixture 
was stirred for 24 h and then extracted with CH2Cl2. The combined organic layers were 
dried, filtered, and concentrated in vacuo to provide a white solid. The crude iminium salt 
was dissolved in MeOH (2 mL) and the solution was cooled to 0 °C. NaBH3CN (17.3 
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mg, 275 μmol) was added to the solution and the reaction was stirred for 30 minutes. The 
reaction was poured into H2O (10 mL) and extracted with CH2Cl2. The combined organic 
layers were washed with satd aq NaHCO3, and then dried, filtered, and concentrated in 
vacuo to provide a yellow oil. Column chromatography (SiO2, 80% ethyl acetate in 
hexanes then 5-12% methanol in dichloromethane) furnished the tertiary amine as a 
yellow oil (47.9 mg, 97%). Rf = 0.29 (10% MeOH/CH2Cl2); [α]
24
D -6.8 (c 2.35, CHCl3); 
IR (film) 2954, 2927, 2855, 1733, 1252 cm
-1
; The 
1
H NMR experiment resulted in poorly 
resolved, broad peaks, and as a result the amine could not be characterized; HRMS (ESI): 
Exact mass calcd for C25H48NO6SSi [M+H]
+
 518.2972, found 518.2991. 
 
tert-Butyl 2-benzhydryl-6,6-dimethyl-7-oxo-2,6,7,8-tetrahydrobenzo[cd]indole-1-
carboxylate (448).  
A solution of indoline (100 mg, 214 μmol) and DDQ (51.0 mg, 225 μmol) in EtOAc-
benzene (1:2, 2 mL) was stirred for 8 hours at 60 °C. The reaction mixture was then 
cooled to room temperature, diluted with EtOAc, and washed with satd aq NaHCO3, 
dried, filtered, and concentrated. The resulting yellow residue was purified by flash 
column chromatography (SiO2, 5-15% ether in hexanes) to afford the desired product as a 
viscous oil (59.8 mg, 60%) in addition to ca. 19.6 mg of the indoline (ca. 20%). Rf = 0.44 
(20% Et2O/hexanes); IR (film) 2973, 2925, 1696, 1655, 1604, 1450, 1396, 1368, 1324, 
1211, 1171, 1132 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.29 (s, 1H), 7.33-7.28 (m, 6H), 
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7.23-7.21 (m, 4H), 7.02 (dd, J = 12.0, 6.5 Hz, 1H), 6.94 (d, J = 6.0 Hz, 1H), 6.50 (d, J = 
7.0 Hz, 1H), 4.06 (s, 2H), 1.57 (s, 9H), 1.45 (s, 6H); 
13
C NMR (125 MHz, CDCl3) ppm 
211.1, 161.6, 139.9, 139.8, 136.7, 128.4 (2C), 127.4, 126.3, 123.8, 123.6, 118.5, 114.3, 
112.2, 81.9, 62.4, 48.1, 38.2, 28.5, 26.3; HRMS (EI): Exact mass calcd for C31H30BrNO3 
[M]
+ 
465.2304, found 465.2298. 
 
5-Bromo-1,1-dimethylnapthalen-2(1H)-one (463).  
To a solution of 5-bromo-1,1-dimethyl-3,4-dihydronapthalen-2(1H)-one (2.62 g, 10.3 
mmol) in toluene/DMSO (2:1, 140 mL) was added IBX (11.56 g, 41.30 mmol) and the 
mixture was stirred at 85 °C for 16 h. The reaction mixture was then cooled to room 
temperature, diluted with Et2O, and washed with 5% aq NaHCO3, H2O, and brine, and 
then dried, filtered, and concentrated. The resulting yellow residue was purified by flash 
column chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the desired 
product as a yellow oil (1.92 g, 65%). Rf  = 0.32 (10% EtOAc/hexanes); IR (film) 2973, 
2928, 2867, 1664, 1613, 1583, 1551, 1458, 1438, 1385, 1291, 1216, 1197 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 7.91 (d, J = 10.0 Hz, 1H), 7.45 (d, J = 8.0 Hz, 1H), 7.36 (d, J = 8.0 
Hz, 1H), 7.19 (t, J = 8.0 Hz, 1H),  6.18 (d, J = 10.0 Hz, 1H), 1.41 (s, 6H); 
13
C NMR (125 
MHz, CDCl3) ppm 203.3, 149.8, 141.9, 131.0, 130.7, 127.6, 125.5 (2C), 124.6, 47.3, 
27.6; HRMS (EI): Exact mass calcd for C12H11BrO [M]
+
 249.9993, found 249.9998. 
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4-(2-Bromophenyl)-1-diazobutan-2-one (464).  
To a 0 °C solution of 3-(2-bromophenyl)propanoic acid  (8.00 g, 34.9 mmol) in 
dichloromethane (0.5 M), was added oxalyl chloride (5.90 mL, 69.8 mmol) over 5 
minutes. The solution was slowly warmed to room temperature and stirred until complete 
conversion was achieved, as evidenced by 1H NMR. The solvent was removed in vacuo 
to give the title compound, which was used without further purification. 
  The acid chloride (8.50 g, 34.6 mmol) in diethyl ether (80 mL) was added dropwise over 
20 min to an ethereal diazomethane solution [prepared from N-methyl-N-nitrosourea 
(14.24 g, 138.2 mmol)], at -40 °C while stirring under nitrogen. The solution was allowed 
to warm to room temperature, and it was then stirred for an additional 6 h. The ether and 
residual diazomethane were evaporated under reduced pressure at room temperature, 
using a rotary evaporator fitted with an acetic acid trap. The resulting yellow residue was 
purified by flash column chromatography (SiO2, 15% ethyl acetate in hexanes) to afford 
the desired product as a yellow oil (7.76 g, 88%). Rf = 0.27 (20% EtOAc/hexanes); IR 
(film) 3087, 2101, 1641 cm-1; 
1
H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 8.0 Hz, 1H), 
7.22 (m, 2H), 7.06 (m, 1H), 5.27 (s, 1H), 3.05 (t, J = 4.5 Hz, 2H), 2.62 (s, 2H); 
13
C NMR 
(125 MHz, CDCl3) ppm 193.5, 139.8, 132.8, 130.6, 128.0, 127.61, 124.2, 54.5, 40.5, 
31.4; HRMS (EI): Exact mass calcd for C10H9BrO [M]
+
 223.9837, found 223.9839. 
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.
5-Bromo-3,4-dihydronapthalen-2(1H)-one (466).  
The α-diazo ketone (7.70 g, 30.4 mmol) in CH2Cl2 (200 mL) was added dropwise over 1 
h to a refluxing solution of rhodium(II) acetate (80 mg, 180 µmol) in  CH2Cl2 (2 L).The 
reaction was monitored by TLC and was complete once the diazoketone had been added. 
The solution was cooled, washed with water and satd aq NaHCO3, dried, and 
concentrated to 500 mL solution. This solution was treated with trifluoroacetic acid (3 
mL) and the solution was stirred for 4 h at room temperature, washed with water and satd 
aq NaHCO3, and dried. After solvent removal, the red residue was purified by flash 
column chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the desired 
product as a viscous oil (4.80 g, 70%). Rf  = 0.30 (10% EtOAc/hexanes); IR (film) 2960, 
2923, 1705, 1393, 1301 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.45 (dd, J = 6.0, 3.0 Hz, 
1H), 7.04 (m, 2H), 3.57(s, 2H), 3.20 (t, J = 6.5 Hz, 2H), 2.53 (t, J = 6.5 Hz, 2H); 
13
C 
NMR (125 MHz, CDCl3) ppm 211.1, 136.1, 135.3, 130.9, 128.1, 127.5, 123.7, 45.0, 37.6, 
28.0; HRMS (EI): Exact mass calcd for C10H9BrO [M]
+
 223.9837, found 223.9840. 
 
5-Bromo-1,1-dimethyl-3,4-dihydronapthalen-2(1H)-one (472). 
 To a 0 °C solution of β-tetralone (800 mg, 4.36 mmol) in tert-butanol (7 mL), was added 
potassium tert-butoxide (480 mg, 4.28 mmol) in small portions over 10 minutes. The 
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reaction was stirred for 10 minutes at 0 °C, and methyl iodide (357 µL, 7.14 mmol) in 
THF (1 mL) was added to the solution. The reaction was allowed to warm to room 
temperature and the reaction stirred for 2 h at room temperature. MeI (268 µL, 5.36 
mmol) in THF (1mL) was added to the solution and the reaction stirred for another 6 h at 
room temperature. The reaction was quenched with satd aq NH4Cl, the layers were 
separated, and the aqueous layer was extracted with Et2O. The combined organic layers 
were washed with water, dried, filtered, and concentrated. The resulting red residue was 
purified by flash column chromatography (SiO2, 5-10% ethyl acetate in hexanes) to 
afford the dimethylated product as a colorless oil (634 mg, 71% yield). Rf  = 0.34 (10% 
EtOAc/hexanes); IR (film) 2971, 2929, 2867, 1716, 1560, 1461, 1301 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 7.45 (dd, J = 8.0, 0.5 Hz, 1H), 7.31 (d, J = 8.0 Hz, 1H), 7.13 (t, J = 
8.0 Hz, 1H), 3.22 (t, J = 7.0 Hz, 2H), 2.70 (t, J = 7.0 Hz, 2H), 1.43 (s, 6H); 
13
C NMR 
(125 MHz, CDCl3) ppm 213.7, 146.1, 134.6, 130.7, 128.3, 125.6, 124.4, 47.7, 36.5, 28.7, 
27.2; HRMS (EI): Exact mass calcd for C12H13BrO [M]
+
 252.0150, found 252.0144. 
 
 
tert-Butyl 2-(8-bromo-4,4-dimethyl-3-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)-2-
(diphenylmethyleneamino)acetate (473).  
The enone (50.0 mg, 199 µmol), Schiff base (88.0 mg, 119 µmol), and benzyl triethyl 
ammonium chloride (13.6 mg, 59.6 µmol) were dissolved in CH2Cl2 (1 mL). 50% KOH 
(140 µL) was then added and the mixture was stirred vigorously for 8 h. The reaction 
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mixture was diluted with CH2Cl2, and the organic layer was separated, washed with 
water, dried (NaSO4), filtered, and concentrated. Flash column chromatography (SiO2, 5-
15% ether in hexanes) of the resulting oil furnished the desired Michael adduct as a white 
solid (85.4 mg, 79%) in addition to ca. 6.1 mg of the enone (ca. 12%). A single 
diastereomer was detected by 
1
H NMR. mp 172-174 °C; Rf  = 0.20 (20% Et2O/hexanes); 
IR (film) 3059, 2976, 2918, 2849, 1719, 1623, 1447, 1368, 1266, 1152 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 7.47 (d, J = 8.0 Hz, 1H), 7.41 (d, J = 7.0 Hz, 2H), 7.32 (m, 2H), 
7.28-7.21 (m, 5H), 7.15 (t, J = 8.0 Hz, 1H), 6.36 (d, J = 5.0 Hz, 2H), 4.50 (d, J = 2.0 Hz, 
1H), 4.41 (m, 1H), 2.95 (m, 2H), 1.43 (s, 9H), 1.33 (s, 3H), 1.12 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) ppm 210.9, 172.5, 169.1, 148.5, 138.8, 136.2, 133.6, 130.9, 130.4, 130.1, 
129.5, 128.7, 128.2 (2C), 127.7, 127.1, 126.9, 124.8, 81.7, 67.8, 47.0, 44.1, 38.2, 33.5, 
29.7, 28.1, 25.7; HRMS (ESI): Exact mass calcd for C31H32BrNO3Na [M+Na]
+
 568.1463, 
found 568.1440. 
 
tert-Butyl 1-benzhydryl-5,5-dimethyl-4-oxo-1,2,2a,3,4,5-hexahydrobenzo[cd]indole-
2-carboxylate (474).  
To a refluxing (90 °C) benzene (12 mL) solution of the ketimine  (65.0 mg, 119 μmol) 
and 
n
Bu3SnH (34.1 μL, 125 μmol) was added AIBN (23.6 mg, 143 μmol) and 
n
Bu3SnH 
(34.1 μL, 125 μmol) dissolved separately in benzene (1 mL) via a syringe pump over 4 h. 
The solution was stirred for an additional 6 h at 90 °C and the solvent was removed in 
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vacuo. The residue was treated with a 1:1 (v/v) solution of Et2O (5 mL) and satd aq KF,
6
 
and the mixture was stirred vigorously until a white solid precipitated. The organic layer 
was washed with water, dried (NaSO4), filtered, and concentrated. The resulting white 
residue was purified by flash column chromatography (SiO2, 15% ether in hexanes) to 
afford the product as a viscous oil (36 mg, 66%) in addition to ca. 8.5 mg of the aryl 
bromide (ca. 13%). The indoline was characterized as a 5:3 ratio of diastereomers (
1
H 
NMR). Rf  = 0.33 (20% Et2O/hexanes); IR (film) 2975, 2927, 2855, 1730, 1711, 1596, 
1454, 1367, 1276, 1238, 1217, 1150 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.5 
Hz, 2H), 7.50 (d, J = 7.5 Hz, 2H), 7.40-7.36 (m, 4H), 7.32-7.20 (m, 12H), 6.96-6.90 (m, 
2H), 6.63 (d, J = 7.5 Hz, 1H), 6.59 (d, J = 7.5 Hz, 1H), 5.96 (d, J = 7.5 Hz, 1H), 5.78 (d, 
J = 7.5 Hz, 1H), 5.59 (s, 1H), 5.55 (s, 1H), 4.20 (d, J = 9.5 Hz, 1H), 3.94 (d, J = 9.5 Hz, 
1H), 3.89 (ddd, J = 11.0, 11.0, 5.5 Hz, 1H), 3.61 (ddd, J = 11.0, 11.0, 5.5 Hz, 1H), 2.91 
(dd, J = 15.5, 5.5 Hz, 1H), 2.75 (dd, J = 15.5, 5.5 Hz, 1H), 2.52 (dd, J = 16.0, 12.0 Hz, 
1H), 2.43 (dd, J = 16.0, 12.0 Hz, 1H), 1.45 (s, 3H), 1.39 (s, 3H), 1.38 (s, 9H), 1.36 (s, 
3H), 1.32 (s, 3H), 1.27 (s, 9H) ; 
13
C NMR (125 MHz, CDCl3) ppm 214.2, 213.5, 171.6, 
169.3, 149.7, 149.6, 142.6, 140.5 (2C), 139.8, 139.5, 139.0, 130.4, 129.5, 129.4, 129.1, 
128.8, 128.7, 128.4, 128.3, 127.6 (2C), 127.4, 127.0, 126.7, 126.4, 125.9, 114.8, 114.7, 
107.7, 107.6, 81.8, 81.6, 74.3, 70.7, 67.9, 67.1, 46.9, 46.5, 42.9, 40.9, 40.0, 38.5, 28.0 
(2C), 27.3, 26.9, 26.3, 24.6; HRMS (ESI): Exact mass calcd for C31H33NO3Na [M+Na]
+
 
490.2358, found 490.2376.
 
                                                          
6
 Complete saturation by KF is necessary.   
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N-(Diphenylmethylene)-2,2-dimethylbut-3-en-1-amine (478).  
To an anhydrous solution of benzene (18 mL) and crushed 4Å molecular sieves were 
added the amine (501 mg, 1.88 mmol) and DDQ (430 mg, 1.88 mmol). The reaction 
mixture was stirred at 60 °C for 1 h. The deep red solution became light orange over the 
course of the reaction. The solution was cooled to room temperature and quickly filtered 
through a pad of neutral alumina. The filtrate was concentrated and the resulting red 
residue was column chromatographed (Al2O3, 0-5% diethyl ether in hexanes) to afford 
the desired product as a pale yellow oil (230 mg, 45%). Rf = 0.52 (10% Et2O/hexanes); 
IR (film) 3080, 3059, 3023, 2996, 2958, 2925, 2854, 1626, 1463, 1445, 1376, 1313, 1287 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.66 (dd, J = 7.5, 1.0 Hz, 2H), 7.65-7.43 (m, 3H), 
7.40-7.18 (m, 3H), 7.15 (dd, J = 7.5, 1.0 Hz, 2H), 5.97 (dd, J = 17.5, 11.0 Hz, 1H), 4.93 
(dd, J = 17.5, 1.5 Hz, 1H), 4.89 (dd, J = 11.0, 1.5 Hz, 1H), 3.17 (s, 2H), 1.04 (s, 6H); 
13
C 
NMR (125 MHz, CDCl3) ppm 167.7, 147.5, 140.2, 137.0, 129.7, 128.4 (2C), 128.2, 
128.0 (2C), 110.8, 64.3, 38.8, 25.2; HRMS (EI) Exact mass calcd for C19H21N [M]
+
 
263.1674, found 263.1669. 
 
N-Benzhydryl-2, 2-dimethylbut-3-enamide (483).  
The acid (3.00 g, 17.5 mmol), 1,3-dicyclohexylcarbodiimide (DCC) (3.98 g, 19.3 mmol), 
and 1-hydroxybenzotriazole (HOBT) (2.61 g, 19.3 mmol) were dissolved in 
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dichloromethane (1 M). Benzhydrylamine (3.02 mL, 17.5 mmol) was added to the 
solution, and the mixture was stirred at room temperature for 36 h. The reaction was 
diluted with CH2Cl2 (20 mL) and filtered off through a pad of celite. The organic layer 
was washed with 1 M HCl, brine, and 1 M sodium bicarbonate, then dried (Na2SO4), 
filtered, and concentrated. The crude material was purified by flash column 
chromatography (SiO2, 0-15% ethyl acetate in hexanes) to give the product as a colorless 
oil (4.15 g, 85%). Rf = 0.32 (20% EtOAc/hexanes); IR (film) 3307, 3025, 2978, 1646, 
1635, 1523, 1494, 1450 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.33 (t, J = 7.5 Hz, 4H), 
7.27 (t, J = 7.5 Hz, 2H), 7.19 (d, J = 7.5 Hz, 4H), 6.32 (d, J = 8.0 Hz, 1H), 6.19 (d, J = 
8.0 Hz, 1H), 6.07 (dd, J = 17.5, 10.5 Hz, 1H), 5.29-5.23 (m, 2H), 1.34 (s, 6H); 
13
C NMR 
(125 MHz, CDCl3) ppm 174.9, 143.2, 141.6, 128.6, 127.4, 127.2, 114.9, 56.8, 45.4, 24.6; 
HRMS (EI) Exact mass calcd for C19H21NO [M]
+
 279.1623, found 279.1616. 
 
N-Benzhydryl-2,2-dimethylbut-3-en-1-amine (484). 
 To a 0 °C solution of LiAlH4 (1.73 g, 45.1 mmol) in tert-butyl methyl ether (150 mL) 
was added the amide (3.15 g, 11.3 mmol) in tert-butyl methyl ether (50 mL) dropwise 
over 20 minutes. The solution was stirred for 9 h at 55 °C. The reaction was quenched 
with sequential addition of NaF (7.58 g, 180.5 mmol) and water (2.44 mL, 135.4 mmol) 
at 0 °C, and stirring was continued for an additional 1 h. The resulting gray precipitate 
was filtered off through a pad of Celite, and the filtrate was concentrated. The resulting 
oil was column chromatographed (SiO2, 0-5% ethyl acetate in hexanes) to afford the title 
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compound as a colorless oil (2.86 g, 96%). Rf = 0.52 (10% EtOAc/hexanes); IR (film) 
3082, 3061, 3025, 2958, 2928, 2902, 2868, 2810, 1492, 1452 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 7.44 (d, J = 7.5 Hz, 4H), 7.33 (t, J = 7.5 Hz, 4H), 7.24 (t, J = 7.5 Hz, 2H), 5.84 
(dd, J = 17.5, 11.0 Hz, 1H), 5.07-5.03 (m, 2H), 4.80 (s, 1H), 2.46 (s, 2H), 1.49 (s, 1H), 
1.10 (s, 6H); 
13
C NMR (125 MHz, CDCl3) ppm 146.9, 144.6, 128.4, 127.2, 126.8, 112.0, 
67.9, 58.7, 37.8, 25.2; HRMS (EI) Exact mass calcd for C19H23N [M]
+
 265.1830, found 
265.1825. 
 
3,3-Dimethyl-4-nitrobutanenitrile (485).  
To a solution of isomeric nitriles (3.70 g, 45.6 mmol) in nitromethane (55.7 g, 912 mmol) 
was added DBU (1.39 g, 9.10 mmol) and the reaction was stirred at 103 °C for 12 h. The 
reaction mixture was cooled concentrated in vacuo. To the resulting residue, 
dichloromethane (30 mL) and 5% sulfuric acid (30 mL) were added and the solution was 
stirred for 30 minutes. The reaction was extracted with CH2Cl2 and the combined organic 
layers were dried, filtered, and concentrated. Column chromatography (SiO2, 20% ethyl 
acetate in hexanes) furnished the title product as a colorless oil (6.1 g, 87%). Rf = 0.22 
(20% EtOAc/hexanes); IR (film) 2974, 2940, 2246, 1553, 1472, 1379 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 4.36 (s, 2H), 2.55 (s, 2H), 1.21 (s, 6H); 
13
C NMR (100 MHz, 
CDCl3) ppm 116.7, 83.4, 34.5, 28.3, 24.8; HRMS (EI): Exact mass calcd for C6H11N2O2 
[M+H]
+
 143.0742, found 143.0815. 
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5-Bromo-1,1-dimethyl-4-(nitromethyl)-3,4-dihydronapthalen-2(1H)-one (489). 
To a solution of enone (38.0 mg, 152 µmol) in nitromethane (164 µL, 3.04 mmol) was 
added DBU (22.7 µL, 152 µmol) and the reaction was stirred at 70 °C for 1.5 h. The 
reaction was quenched with satd aq NH4Cl and extracted with CH2Cl2. The combined 
organic layers were dried, filtered, and concentrated. Column chromatography (SiO2, 
20% ethyl acetate in hexanes) furnished the ketone as a yellow solid (46.5 mg, 97%). Rf = 
0.33 (20% EtOAc/hexanes); mp 112-114 °C; IR (film) 2972, 2929, 1717, 1552, 1461, 
1280 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 8.0, 0.8 Hz, 1H), 7.36 (dd, J = 
8.0, 0.8 Hz, 1H), 7.24 (dd, 8.0, 8.0 Hz, 1H), 4.61 (ddd, J = 13.2, 3.2, 1.2 Hz, 1H), 4.50 
(dddd, J = 11.2, 5.6, 2.8, 2.8 Hz, 1H), 4.09 (dd, J =  13.6, 11.2 Hz, 1H), 3.10 (ddd, J = 
14.0, 6.0, 1.2 Hz, 1H), 2.72 (dd, J = 14.0, 2.4 Hz, 1H), 1.49 (s, 3H), 1.43 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) ppm 211.2, 147.6, 131.7, 130.9, 130.1, 127.2, 124.4, 76.1, 47.5, 
39.3, 38.9, 30.3, 29.7; HRMS (EI): Exact mass calcd for C13H14BrNO3 [M+H]
+
 
312.0235, found 312.0220. 
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2-(5-Bromo-2-hydroxy-1,1-dimethyl-1,2-dihydronaphthalen-2-yl)-3,3-dimethylpent-
4-enoic acid (491).  
To a -78 °C solution of diisopropylamine (137 µL, 0.98 mol) in THF (500 µL) was added 
n
BuLi (391 µL, 2.5 M solution in THF, 0.98 mol, ) dropwise  over 3 mins and the mixture 
was stirred at -78 °C for 30 mins and at 0 °C for additional 20 mins. After return of the 
reaction to -78 °C, enone (50.0 mg, 0.39 mmol) in THF (150 µL) was added dropwise 
over 5 mins. The solution was stirred at -78 °C for 30 mins and at 0 °C for additional 20 
mins. The reaction was quenched with satd aq NH4Cl, the layers were separated, and  the 
aqueous layer was extracted with Et2O. The combined organic layers were washed with 
brine, dried, filtered, and concentrated. The resulting residue was purified by flash 
column chromatography (SiO2, 20-40-60-80% ethyl acetate in hexanes) to afford the acid 
as a pale yellow oil (37.0 mg, 50%) in addition to the enone (21.0 mg, 42%). The acid 
was characterized as a 6.5:1 ratio of diastereomers by 
1
H NMR. Rf = 0.15 (80%  
EtOAc/hexanes); IR (film) 3418, 2966, 2926, 2853, 1714, 1454 cm
-1
. 
Data for major diastereomer: 
1
H NMR (600 MHz, CDCl3) δ 7.41 (dd, J = 7.8, 1.2 Hz, 
1H), 7.20 (d, J = 7.8 Hz, 1H), 7.05 (dd, J = 7.8, 7.8 Hz, 1H), 6.68 (d, J = 10.2 Hz, 1H), 
5.92 (d, J = 10.2 Hz, 1H), 5.76 (dd, J = 18.0, 10.8 Hz, 1H), 4.90 (d, J = 17.2 Hz, 1H), 
4.85 (d, J = 11.4 Hz, 1H), 1.38 (s, 3H), 1.27 (s, 3H), 1.25 (s, 3H), 1.23 (s, 3H); 
13
C NMR 
(125 MHz, CDCl3) ppm 180.7, 149.0, 146.2, 138.1, 131.4, 130.9, 129.0, 127.1, 123.5, 
122.4, 110.1, 79.3, 53.0, 46.7, 39.9, 29.7, 25.1, 24.5, 19.7; Exact mass calcd for 
C19H23BrO3Na [M+Na]
+ 
401.0728, found 401.0718. 
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tert-Butyl 5,5-dimethyl-4-oxo-1,2,2a,3,4,5-hexahydrobenzo[cd]indole-2-carboxylate 
(493).  
To a solution of indoline (320 mg, 653 µmol) in cyclohexene (7 mL) and ethanol (7 mL) 
was added aq 1 N HCI (0.65 mL) and 10% Pd/C (320 mg). The reaction was stirred at 80 
°C for 8 h and quenched with triethylamine (5 mL). The reaction was filtered through a 
pad of SiO2 and the solution was concentrated. Flash column chromatography (SiO2, 10-
15% ethyl acetate in hexanes) of the resulting oil furnished the disubstituted amine as a 
light yellow oil (152 mg, 72%). The product was characterized as 5:3 ratio of 
diastereomers. Rf  = 0.28 (20% EtOAc/hexanes); IR (film) 3328, 2957, 2924, 2853, 1707 
(br), 1457, 1368, 1253, 1155 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.13-7.09 (m, 2H), 
6.72-6.69 (m, 2H), 6.62 (d, J = 7.6 Hz,  1H), 6.58 (d, J = 7.6 Hz,  1H), 4.39 (d, J = 10.0 
Hz, 1H), 4.38 (br s, 1H), 4.29 (br s, 1H), 4.17 (d, J = 10.8 Hz, 1H), 3.95-3.88 (m, 1H), 
3.66 (ddd, J = 11.2, 11.2, 6.0 Hz, 1H), 3.06 (dd, J = 16.0, 5.6 Hz, 1H), 2.96 (dd, J = 14.4, 
5.2 Hz, 1H), 2.54 (dd, J = 16.0, 12.0 Hz, 1H), 2.39 (dd, J = 14.0, 14.0 Hz, 1H), 1.53 (s, 
9H), 1.46 (s, 3H), 1.45 (s, 9H), 1.42 (s, 3H), 1.33 (s, 3H), 1.31 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) ppm 214.2, 213.6, 171.6, 170.8, 149.1, 147.6, 140.5, 140.3, 129.5, 126.5, 
125.2, 115.7, 115.6, 107.8, 107.6, 82.6, 82.2, 70.5, 65.0, 46.8, 46.7, 43.1, 41.4, 39.9, 39.1, 
28.2, 28.1, 26.9, 26.8, 25.9, 24.5; HRMS (ESI): Exact mass calcd for C14H16NO3 [M-
C4H7]
+
 246.1130, found 246.0760. 
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tert-Butyl 6,6-dimethyl-7-oxo-2,6,7,8-tetrahydrobenzo[cd]indole-2-carboxylate (494).  
A solution of indoline (152 mg, 469 μmol) and DDQ (117 mg, 515 μmol) in toluene (7.5 
mL) was stirred for 2 h at 80 °C. The reaction mixture was filtered through a pad of SiO2 
and the solution was concentrated. The resulting yellow residue was purified by flash 
column chromatography (SiO2, 5-15% ether in hexanes) to afford the desired indole as a 
viscous oil (107 mg, 71%). Rf = 0.36 (20% EtOAc/hexanes); IR (film) 3332, 2962, 2926, 
2854, 1702 (br), 1455, 1159 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.98 (br s, 1H), 7.34 
(dd, J = 7.6, 7.6 Hz, 1H), 7.24 (d, J = 8.4 Hz, 1H), 7.02 (d, J = 7.6 Hz, 1H), 4.05 (s, 2H), 
1.64 (s, 9H), 1.53 (s, 6H); 
13
C NMR (125 MHz, CDCl3) ppm 210.7, 161.6, 139.9, 133.9, 
127.2, 124.6, 122.7, 115.6, 114.5, 109.4, 82.0, 62.4, 48.1, 36.9, 28.4, 26.2; HRMS (EI): 
Exact mass calcd for C18H21NO3 [M]
+ 
299.1521, found 299.1432. 
 
tert-Butyl 4-(tert-butyldimethylsilyloxy)-5,5-dimethyl -1,5-dihydrobenzo[cd]indole-
2-carboxylate (495).  
To a 0 °C solution of indole (16.0 mg, 49.7 µmol) and Et3N (20.7 µL, 149 µmol) in 
CH2Cl2 (0.8 mL) was added TBSOTf (12.5 µL, 54.7 µmol) dropwise over 2 minutes. The 
reaction was allowed to warm to room temperature and the reaction stirred for 2 h at rt. 
The reaction was quenched with satd aq NH4Cl, the layers were separated, and the 
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aqueous layer was extracted with CH2Cl2. The combined organic layers were washed 
with brine, dried, filtered, and concentrated. The resulting orange residue was purified by 
flash column chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the 
monosilylated product as a colorless oil (17.6 mg, 81%) in addition to (4.7 mg, 17%) of 
disilylated product 
Data for monosilylated product (495):  
Rf  = 0.54 (20% EtOAc/hexanes); IR (film) 3333, 2925, 2855, 1733, 1456, 1136 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.20 (br s, 1H), 7.28 (dd, J = 8.0, 7.6 Hz, 1H), 7.06 (d, J = 8.4 
Hz, 1H), 6.95 (d, J = 7.6 Hz, 1H), 6.18 (s, 1H), 1.64 (s, 9H), 1.51 (s, 6H), 1.03 (s, 9H), 
0.33(s, 6H); 
13
C NMR (150 MHz, CDCl3) ppm 163.5, 162.4, 142.2, 134.5, 127.3, 123.4, 
119.3, 118.9, 114.8, 108.0, 97.1, 80.9, 41.9, 29.7, 28.6, 25.8, 18.3, -4.5; HRMS (EI): 
Exact mass calcd for C24H35NO3Si [M]
+
 413.2386, found 413.2373. 
Data for disilylated product (496)  
Rf  = 0.70 (20% EtOAc/hexanes); IR (film) 2955, 2929, 2857, 1701, 1135 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 7.21 (d, J = 5.2 Hz, 1H), 7.20 (d, J = 2.8 Hz, 1H), 6.96 (dd, J = 5.2, 
2.8 Hz, 1H), 6.16 (s, 1H), 1.63 (s, 9H), 1.50 (s, 6H), 1.15 (s, 9H), 1.02(s, 9H), 0.43 (s, 
6H), 0.33(s, 6H); 
13
C NMR (150 MHz, CDCl3) ppm 163.0, 162.6, 141.9, 141.6, 126.0, 
125.9, 125.4, 122.8, 115.1, 112.5, 97.4, 80.4, 41.7, 29.8, 28.7, 27.9, 25.8, 20.1, 18.3, -
0.41, -4.5; HRMS (EI): Exact mass calcd for C30H49NO3Si2 [M]
+
 527.3251.
7
 
 
                                                          
7
 Highly unstable compound. HRMS could not be obtained 
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6,6-Dimethyl-7-oxo-2,6,7,8-tetrahydrobenzo[cd]indole-2-carboxylic acid (498).  
To a solution of trifluoroacetic acid (244 µL, 3.17 mmol) in CH2Cl2 (1.0 mL) was added 
the indoline (51.0 mg, 158 µmol) and the reaction was stirred for 8 h at rt. The reaction 
was quenched with satd aq NH4Cl, the layers were separated, and the aqueous layer was 
extracted with CH2Cl2. The combined organic layers were washed with brine, dried, 
filtered, and concentrated to afford the carboxylic acid as a red oil (41.9 mg, 100%). Rf = 
0.42 (50% EtOAc/hexanes); IR (film) 3306 (br), 2973, 2929, 1691, 1461, 1124 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.31-7.24 (m, 2H), 6.98 (d, J = 7.0 Hz, 1H), 4.05 (s, 2H), 1.48 
(s, 6H), -NH and –COOH peaks not observed; 13C NMR (125 MHz, CDCl3) ppm 212.8, 
164.9, 140.7, 136.2, 128.1, 125.4, 123.0, 117.3, 115.0, 110.9, 49.3, 37.9, 26.6; HRMS 
(EI): Exact mass calcd for C14H14ClNO3 [M+HCl]
+ 
279.0662, found 279.0612. 
 
(2R, 2aR)-tert-Butyl 1-benzhydryl-4-(tert-butyldimethylsilyloxy)-5,5-
dimethyl,1,2,2a,5-tetrahydrobenzo[cd]indole-2-carboxylate (S1).  
To a 0 °C solution of indoline (48.0 mg, 98.1 µmol) and Et3N (41.0 µL, 294 µmol) in 
CH2Cl2 (1.0 mL) was added TBSOTf (49.5 µL, 216 µmol) dropwise over 2 minutes. The 
reaction was allowed to warm to room temperature and stirred for 2 h. The reaction was 
quenched with satd aq NH4Cl, the layers were separated, and the aqueous layer was 
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extracted with CH2Cl2. The combined organic layers were washed with brine, dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the title product as a 
light yellow oil (20.5 mg, 36%) in addition to the indoline (28.1 mg, 59%).  Single 
diastereomers of the silylated product and recovered indoline were detected respectively 
by 
1
H NMR. Rf  = 0.60 (20% EtOAc/hexanes); IR (film) 2954, 2929, 2857, 1742, 1646, 
1456, 1216 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.60 (d, J = 7.2 Hz, 2H), 7.36 (t, J = 7.8 
Hz, 2H), 7.30-7.23 (m, 6H), 6.89 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 6.68 (d, J = 7.8 Hz, 1H), 
5.90 (d, J = 7.8 Hz, 1H), 5.47 (s, 1H), 4.98 (d, J = 1.8 Hz, 1H), 3.88 (d, J = 12.0 Hz, 1H), 
3.83 (dd, J = 12.0, 1.2 Hz, 1H), 1.42 (s, 3H), 1.36 (s, 9H), 1.29 (s, 3H), 0.97 (s, 9H), 0.20 
(s, 3H), 0.18(s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 172.3, 159.2, 149.4, 141.3, 141.0, 
139.1, 130.9, 128.5 (2C), 128.4, 128.2, 128.1, 127.9, 127.4, 127.1, 114.5, 106.7, 98.9, 
80.8, 74.3, 68.2, 42.5, 40.2, 28.5, 28.1, 25.7, 24.1, 18.3, -4.3, -4.9; HRMS (EI): Exact 
mass calcd for C37H47NO3Si [M]
+
 581.3325, found 581.3280. 
 
3-Methylbut-2-en-1-yl 1-benzhydryl-5,5-dimethyl-4-oxo-1,3,4,5-
tetrahydrobenzo[cd]indole-2-carboxylate (505).  
A solution of indoline (100 mg, 209 μmol) and DDQ (66.0 mg, 292 μmol) in toluene (5.0 
mL) was stirred for 3 h at 80 °C. The reaction mixture was filtered through a pad of SiO2 
and the solution was concentrated. The resulting yellow residue was purified by flash 
column chromatography (SiO2, 5-15% ether in hexanes) to afford the desired product as a 
 
 
 
 
75 
 
viscous oil (48.0 mg, 48%). Rf  = 0.54 (20% EtOAc/hexanes); IR (film) 3061, 3029, 2976, 
2928, 1707, 1659, 1448, 1278, 1176 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.27 (br s, 1H), 
7.32-7.27 (m, 6H),  7.20-7.18 (m, 4H), 7.02 (dd, J = 8.4, 7.2 Hz, 1H), 6.94 (d, J = 7.2 Hz, 
1H), 6.47 (d, J = 8.4 Hz, 1H), 5.45 (ddq, J = 7.2, 7.2, 1.2 Hz, 1H), 4.79 (d, J = 7.2 Hz, 
2H), 4.09 (s, 2H), 1.79 (s, 3H), 1.75 (s, 3H), 1.52 (s, 6H); 
13
C NMR (125 MHz, CDCl3) 
ppm 211.0, 162.4, 140.0, 139.8, 139.2, 137.6, 137.0, 132.4, 130.1, 128.5, 128.4, 128.3, 
127.5, 126.7, 123.6, 122.5, 119.5, 118.4, 114.4, 112.2, 62.7, 61.6, 48.2, 38.1, 29.7, 26.3, 
25.8, 18.2; Exact mass calcd for C32H31NO3 [M]
+ 
477.2332, found 477.2305. 
 
3-Methylbut-2-enyl 2-(diphenylmethyleneamino)acetate (506).  
To a solution of bromo acetate (2.40 g, 11.6 mmol), imine (2.21g, 12.2 mmol) in 
acetonitrile (15 mL) was added diisopropyl ethylamine (2.03 mL, 11.6 mmol) and the 
mixture was stirred at 80 °C for 10 h. The reaction mixture was then cooled to room 
temperature and diluted with H2O and Et2O. The layers were separated and the aqueous 
layer was extracted with Et2O. The combined organic layers were washed with brine, 
dried, filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (basic alumina, 5-10% ethyl acetate in hexanes) to afford the Schiff  
base as a colorless oil (2.65 g, 74%). Rf = 0.22 (basic alumina, 10% EtOAc/hexanes); IR 
(film) 3057, 3024, 2972, 2933, 1742, 1626, 1174 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 
7.67-7.66 (m, 2H), 7.47-7.43 (m, 3H), 7.40 (dddd, J = 7.2, 7.2, 1.2, 1.2 Hz, 1H), 7.35-
7.32 (m, 2H), 7.19-7.17 (m, 2H), 5.35 (tq, J = 7.2, 1.2 Hz, 1H), 4.64 (d, J = 7.2 Hz, 2H), 
4.21 (s, 2H), 1.75 (s, 3H), 1.71 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 171.8, 170.6, 
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139.3, 139.2, 136.0, 130.4, 128.7, 128.6, 128.0, 127.6, 118.4, 62.0, 55.6, 25.7, 18.0; 
HRMS (EI): Exact mass calcd for C20H21NO2Na [M+Na]
+ 
330.1470, found 333.1466. 
 
3-Methylbut-2-enyl 2-bromoacetate (507).  
To a solution of alcohol (3.02 mL, 29.7 mmol), triethylamine (3.73 mL, 26.7 mmol) and 
4-dimethyl aminopyridine (363 mg, 2.97 mmol) in benzene (40 mL) was added acyl 
bromide (0.65 mL) and the mixture was stirred at 80 °C for 1 h. The reaction mixture was 
then cooled to room temperature, filtered through a pad of SiO2, and the solution was 
concentrated. Flash column chromatography (SiO2, 0-5% ethyl acetate in hexanes) of the 
resulting oil furnished the ester as a light colorless oil (6.0 g, 78%). Analytical data was 
identical to that in the literature. 
 
3-Methylbut-2-enyl 2-(8-bromo-4,4-dimethyl-3-oxo-1,2,3,4-tetrahydronaphthalen-1-
yl)-2-(diphenylmethyleneamino)acetate (508).  
The enone (382 mg, 1.53 mmol), Schiff base (940 mg, 3.06 mmol), and benzyl triethyl 
ammonium chloride (87.0 mg, 0.38 mmol) were dissolved in CH2Cl2 (5.0 mL). 25% aq 
KOH (2.5 mL) was then added and the mixture was stirred vigorously for 14 h. The 
reaction mixture was diluted with CH2Cl2, and the organic layer was separated, washed 
with water, dried, filtered, and concentrated. Flash column chromatography (SiO2, 5-15% 
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ethyl acetate in hexanes) of the resulting oil furnished the Michael adduct as a colorless 
oil (596 mg, 70%) in addition to the enone (68.0 mg, 17.1%). The Michael adduct was 
chararacterized as a 5:4 ratio of diastereomers by 
1
H NMR. Rf  = 0.38 (20% 
EtOAc/hexanes); IR (film) 2974, 2931, 2911, 1734, 1717, 1180 cm
-1
; 
1
H NMR (600 
MHz, CDCl3) δ 7.65-7.64 (m, 2H), 7.48-7.46 (m, 1H), 7.45-7.43 (m, 2H), 7.41 (dd, J = 
7.8, 1.2 Hz, 1H), 7.37-7.34 (m, 2H), 7.34-7.32 (m, 1H), 7.31-7.27 (m, 4H), 7.26-7.23 (m, 
5H), 7.21-7.16 (m, 3H), 7.11 (dd, J = 7.8, 7.8 Hz, 1H), 6.67 (br d, J = 6.6 Hz, 2H), 6.33 
(br s, 2H), 5.35 (ddq, J = 7.2, 7.2, 1.2 Hz, 1H), 5.33 (ddq, J = 7.2, 7.2, 1.2 Hz, 1H), 4.68 
(dd, J = 12.0, 6.6 Hz, 1H), 4.63-4.61 (m, 3H), 4.56 (dd, J = 12.0, 6.6 Hz, 1H), 4.49 (ddd, 
J = 6.6, 1.8, 1.8 Hz, 1H), 4.42 (ddd, J = 5.4, 5.4, 3.0 Hz, 1H), 4.17 (d, J = 8.4 Hz, 1H), 
3.04-2.95 (m, 4H), 1.76 (s, 6H), 1.70 (s, 6H), 1.36 (s, 3H), 1.30 (s, 3H), 1.15 (s, 3H), 0.91 
(s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 212.2, 211.1, 173.0, 170.2, 170.0, 169.9, 
148.4, 147.4, 139.1 (2C), 139.0, 138.5, 135.9, 135.6, 134.1, 133.3, 130.9, 130.5, 130.3, 
129.6, 129.3, 128.8, 128.7, 128.6 (2C), 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 
127.7, 127.6, 127.1, 126.9, 126.8, 125.1, 124.9, 118.4 (2C), 69.7, 67.3, 62.2, 62.1, 47.3, 
47.0, 43.8, 43.2, 39.2, 38.2, 33.5, 32.2, 25.7 (2C), 25.6, 25.0, 18.1 (2C); HRMS (ESI): 
Exact mass calcd for C32H33BrNO3 [M+H]
+
 558.1638, found 558.1627. 
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3-Methylbut-2-enyl 1-benzhydryl-5,5-dimethyl-4-oxo-1,2,2a,3,4,5-
hexahydrobenzo[cd] indole-2-carboxylate (509).  
To a refluxing (90 °C) benzene (167 mL) solution of the ketimine  (930 mg, 1.67 mmol) 
and 
n
Bu3SnH (108 μL, 0.41 mmol) was added AIBN (219 mg, 1.36 mmol) and 
n
Bu3SnH 
(972 μL, 3.69 mmol) dissolved separately in benzene (10 mL) via a syringe pump over 4 
h. The solution was stirred for an additional 6 h at 90 °C and the solvent was removed in 
vacuo. The residue was treated with a 1:1 (v/v) solution of Et2O (75 mL) and satd aq KF,
8
 
and the mixture was stirred vigorously until a white solid precipitated. The organic layer 
was washed with water, dried (NaSO4), filtered, and concentrated. The resulting white 
residue was purified by flash column chromatography (SiO2, 10% ethyl acetate in 
hexanes) to afford the product as a viscous oil (568 mg, 75%). The indoline was 
characterized as a 3:1 ratio of diastereomers by 
1
H NMR. Rf  = 0.48 (20% 
EtOAc/hexanes); IR (film) 3060, 3027, 2970, 2931, 2870, 1741, 1710, 1622, 1595, 1493, 
1454, 1277, 1187 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.59 (d, J = 7.2 Hz, 2H), 7.50 (d, J 
= 7.8 Hz, 2H), 7.38 (t, J = 7.8 Hz, 2H), 7.35-7.26 (m, 10 H), 7.24-7.22 (m, 4H), 6.96 (dd, 
J = 7.8, 7.8 Hz, 1H), 6.92 (dd, J = 7.8, 7.8 Hz, 1H), 6.66 (d, J = 7.8 Hz, 1H), 6.60 (d, J = 
7.8 Hz, 1H), 5.98 (d, J = 7.8 Hz, 1H), 6.83 (d, J = 7.8 Hz, 1H), 5.57 (s, 1H), 5.50 (s, 1H), 
5.21 (ddq, J = 7.2, 7.2, 1.2 Hz, 1H), 5.12 (ddq, J = 7.2, 7.2, 1.2 Hz, 1H), 4.48 (dd, J = 
12.0, 7.2 Hz, 1H), 4.37 (dd, J = 12.0, 7.2 Hz, 1H), 4.34 (dd, J = 12.0, 7.2 Hz, 1H), 4.31 
(dd, J = 12.0, 7.2 Hz, 1H), 4.28 (d, J = 9.0 Hz, 1H), 4.00 (d, J = 10.2 Hz, 1H), 3.91 (ddd, 
J = 9.6, 9.6, 5.4 Hz, 1H), 3.66 (ddd, J = 11.4, 11.4, 5.4 Hz, 1H), 2.89 (dd, J = 15.6, 5.4 
Hz, 1H), 2.71 (dd, J = 14.4, 5.4 Hz, 1H), 2.52 (dd, J = 15.6, 12.0 Hz, 1H), 2.26 (dd, J = 
14.4, 14.4 Hz, 1H), 1.75 (s, 3H), 1.71 (s, 3H), 1.67 (s, 3H), 1.60 (s, 3H), 1.45 (s, 3H), 
                                                          
8
 Complete saturation by KF is necessary.   
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1.39 (s, 3H), 1.34 (s, 3H), 1.31 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 213.9, 213.2, 
172.7, 170.0, 149.8, 149.5, 142.3, 140.8, 140.2, 139.8 (2C), 139.5, 139.4, 138.6, 130.7, 
129.6, 129.4, 129.1, 128.7, 128.6, 128.5, 128.2, 128.1, 127.9, 127.7, 127.4, 127.1, 126.8, 
126.3, 125.9, 118.0 (2C), 115.0, 114.9, 107.7, 107.6, 74.1, 70.4, 68.4, 67.2, 62.0, 61.1, 
46.9, 46.5, 42.5, 40.9, 39.7, 38.2, 26.8, 26.7, 26.5, 25.7, 25.6, 24.7, 18.1, 18.0; HRMS 
(ESI): Exact mass calcd for C32H33NO3Na [M+Na]
+
 502.2358, found 502.2338. 
 
2,3-Dimethyl-1-(2-methyl-1H-indol-3-yl)but-2-en-1-one (520).  
To a 0 °C solution of the acid (550 mg, 5.00 mmol) in dichloromethane (0.5 M), was 
added oxalyl chloride (866 µL, 10.00 mmol) over 5 minutes. Dimethyl aminopyridine 
(6.40 mg, 0.05 mmol) was added and the solution was slowly warmed to room 
temperature and stirred until complete conversion was achieved, as evidenced by 
1
H 
NMR. The solvent was removed in vacuo to give the acyl chloride, which was used 
without further purification. 
  To a 0 °C solution of indole (150 mg, 810 µmol) in CH2Cl2 (3.5 mL) was added Et2AlCl 
(540 µL, 972 µmol, 1.8 M in toluene) dropwise. The reaction was stirred for 30 minutes 
at 0 °C, and acyl chloride (115 mg, 972 µmol) in CH2Cl2 (3.5 mL) was added dropwise to 
the solution. The reaction was stirred for 3 h at 0 °C, with the last 30 min having minimal 
ice within the ice/water bath. The reaction was quenched by slow dropwise addition of 
pH=7 buffer solution and then addition of satd aq NaHCO3 in the same fashion. The 
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layers were separated, and the aqueous layer was extracted with CH2Cl2. The combined 
organic layers were washed with brine, dried, filtered, and concentrated. The resulting 
residue was purified by flash column chromatography (SiO2, 10-20% ethyl acetate in 
hexanes) to afford the title product as a yellow oil (172 mg, 79%) in addition to the indole 
(19 mg, 13%). Rf = 0.37 (SiO2, 20% EtOAc/hexanes); IR (film) 3313, 2964, 2927, 2854, 
1647, 1601, 1421, cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.94 (br s, 1H), 7.82-7.76 (m, 
1H), 7.41-7.35 (m, 1H), 7.22-7.17 (m, 2H), 6.69 (s, 1H), 6.30 (dd, J = 17.6, 10.8 Hz, 1H), 
5.24 (d, J = 18.0 Hz, 1H), 5.22 (d, J = 10.4 Hz, 1H), 2.21 (s, 3H), 2.04 (s, 3H), 1.69 (s, 
6H); 
13
C NMR (100 MHz, CDCl3) ppm 190.8, 151.8, 148.9, 145.1, 133.3, 127.8, 127.7, 
121.9, 120.9, 120.3, 115.4, 113.2, 111.1, 39.5, 27.3, 26.4, 20.6; HRMS (EI): Exact mass 
calcd for C18H22NO [M+H]
+ 
268.1701, found 268.1696. 
 
2,3-Dimethyl-1-(2-methyl-1H-indol-3-yl)but-2-en-1-one (521).  
To a 0 °C solution of the acid (338 mg, 3.38 mmol) in dichloromethane (0.5 M), was 
added oxalyl chloride (586 µL, 6.76 mmol) over 5 minutes. Dimethyl aminopyridine 
(6.40 mg, 0.05 mmol) was added and the solution was slowly warmed to room 
temperature and stirred until complete conversion was achieved, as evidenced by 
1
H 
NMR. The solvent was removed in vacuo to give the acyl chloride, which was used 
without further purification. 
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  To a 0 °C solution of 2-methylindole (294 mg, 2.24 mmol) in CH2Cl2 (10 mL) was 
added Et2AlCl (1.91 mL, 3.44 mmol, 1.8 M in toluene) dropwise. The reaction was 
stirred for 30 minutes at 0 °C, and acyl chloride (400 mg, 3.37 mmol) in CH2Cl2 (6.0 mL) 
was added dropwise to the solution. The reaction was stirred for 3 h at 0 °C, with the last 
30 min having minimal ice within the ice/water bath. The reaction was quenched by slow 
dropwise addition of pH=7 buffer solution and then addition of satd aq NaHCO3 in the 
same fashion. The layers were separated, and the aqueous layer was extracted with 
CH2Cl2. The combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
10-20% ethyl acetate in hexanes) to afford the title product as a yellow solid (460 mg, 
96%). Rf = 0.42 (SiO2, 50% EtOAc/hexanes); mp = 188 °C; IR (film) 3158 (br), 2967, 
2937, 1653, 1564, 1456, 1378 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.62 (br s, 1H), 7.99 
(d, J = 7.8 Hz, 1H), 7.31 (d, J = 7.8 Hz, 1H), 7.20 (ddd, J = 7.2, 7.2, 1.2 Hz, 1H), 7.18 
(ddd, J = 7.2, 7.2, 1.2 Hz, 1H), 6.64 (s, 1H), 2.73 (s, 3H), 2.17 (s, 3H), 2.02 (s, 3H); 
13
C 
NMR (150 MHz, CDCl3) ppm 189.7, 151.0, 143.0, 134.6, 126.9, 126.4, 122.3, 121.7, 
120.9, 116.0, 110.7, 27.3, 20.7, 14.9; HRMS (EI): Exact mass calcd for C14H16NO 
[M+H]
+ 
214.1232. found 214.1237. 
 
1,6,6-Trimethyl-6,7-dihydrobenzo[cd]indol-8(2H)-one (522).  
The substrate (40.0 mg, 188 µmol) was added in one portion to a melt of AlCl3 (362 mg, 
1.88 mmol) and NaCl (99.0 mg, 1.69 mmol) at 135 °C. After 3 min, the reaction was 
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poured into ice cold water and the solution was made basic by the addition of satd aq 
NaHCO3. The solution was extracted with CH2Cl2 and the combined organic layers were 
dried, filtered, and concentrated to a brown oil. Column chromatography (SiO2, 20-30% 
ethyl acetate in hexanes) provided the tricyclic indole as a pale yellow solid (36.0 mg, 
90%). Rf = 0.34 (SiO2, 50% EtOAc/hexanes); mp = 138-140 °C; IR (film) 3241, 2957, 
2867, 1640, 1606, 1552, 1452 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 9.43 (br s, 1H), 7.23-
7.18 (m, 2H), 7.12 (dd, J = 6.0, 2.4 Hz, 1H), 2.77 (s, 3H), 2.73 (s, 2H), 1.42 (s, 6H); 
13
C 
NMR (100 MHz, CDCl3) ppm 194.8, 138.9, 137.9, 132.8, 128, 5, 123.5, 115.6, 110.5, 
108.6, 55.8, 38.9, 29.2, 13.3; Exact mass calcd for C14H16NO [M+H]
+ 
214.1232, found 
214.1231. 
 
2-Methyl-4-(2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl)butan-2-ol (524).  
To a 0 °C solution of 2-prenyl indole (100 mg, 540 µmol) in THF (1.0 mL), was added 
zinc powder (79.5 µL, mg, 1.22 mmol). The solution was slowly warmed to room 
temperature and stirred for 12 h. The reaction was quenched with satd aq NH4Cl, the 
layers were separated, and the aqueous layer was extracted with Et2O. The combined 
organic layers were washed with brine, dried, filtered, and concentrated. The resulting 
crude oil was used in the next step without any further purification. 
  To a solution of the crude allylation product (120 mg) in EtOH (1.0 mL) was added HCl 
(3 M, 1.0 mL) and the reaction stirred at 80 °C for 1 h. The reaction was quenched with 
satd aq NaOH (1.0 M), the layers were separated, and the aqueous layer was extracted 
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with Et2O. The combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
20-25-30% ethyl acetate in hexanes) to afford the title product as a pale yellow oil (29.2 
mg, 20%) in addition to the indole (60 mg, 60%). Rf = 0.15 (SiO2, 20% EtOAc/hexanes); 
IR (film) 3356,  (br), 2970, 2926 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.81 (br s, 1H), 
7.51 (d, J = 8.0 Hz, 1H), 7.29 (d, J = 8.0 Hz, 1H), 7.12 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 
7.07 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.14 (dd, J = 17.5, 10.5 Hz, 1H), 5.17 (d, J = 17.5 
Hz, 1H), 5.15 (d, J = 10.5 Hz, 1H), 2.90 (dt, J = 8.5, 4.5 Hz, 2H), 1.81 (dt, J = 8.5, 4.5 
Hz, 2H), 1.54 (s, 6H), 1.34 (s, 6H), -OH proton not observed ; 
13
C NMR (150 MHz, 
CDCl3) ppm 145.0, 137.6, 133.2, 128.5, 120.2, 118.1, 117.1, 110.8, 110.2, 109.4, 70.1, 
43.9, 37.9, 28.1, 26.6, 18.8; HRMS (EI): Exact mass calcd for C18H25NO [M]
+ 
271.1931, 
found 271.1938. 
 
1-(1H-Indol-3-yl)-3-methylbut-2-en-1-one (527).  
To a 0 °C solution of the acid (1.50 g, 15.0 mmol) in dichloromethane (0.5 M), was 
added oxalyl chloride (2.60 mL, 30.0 mmol) over 5 minutes. Dimethyl aminopyridine 
(6.40 mg, 0.05 mmol) was added and the solution was slowly warmed to room 
temperature and stirred until complete conversion was achieved, as evidenced by 
1
H 
NMR. The solvent was removed in vacuo to give the acyl chloride, which was used 
without further purification. 
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  To a 0 °C solution of  indole (1.17 g, 10.0 mmol) in CH2Cl2 (50 mL) was added Et2AlCl 
(8.33 mL, 15.0 mmol, 1.8 M in toluene) dropwise. The reaction was stirred for 30 
minutes at 0 °C, and acyl chloride (1.77 g, 15.0 mmol) in CH2Cl2 (32.4 mL) was added 
dropwise to the solution. The reaction was stirred for 3 h at 0 °C, with the last 30 min 
having minimal ice within the ice/water bath. The reaction was quenched by slow 
dropwise addition of pH=7 buffer solution followed by the addition of satd aq NaHCO3 
in the same fashion. The layers were separated, and the aqueous layer was extracted with 
CH2Cl2. The combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
10-20% ethyl acetate in hexanes) to afford the title product as a yellow solid (1.97 g, 
99%). Rf = 0.72 (SiO2, 50% EtOAc/hexanes); mp = 114-115 °C. IR (film) 3252, 2971, 
2932, 1645, 1589, 1520, 1434 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 9.57 (br s, 1H), 8.51 
(m, 1H), 7.85 (d, J = 3.2 Hz, 1H), 7.42 (m, 1H), 7.31-7.28 (m, 2H), 6.65 (m, 1H), 2.28 (d, 
J = 0.8 Hz, 3H), 2.01 (d, J = 0.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 188.1, 
152.7, 136.6, 131.4, 125.9, 123.5, 122.7, 122.4, 122.3, 119.5, 111.6, 27.7, 20.5; HRMS 
(EI): Exact mass calcd for C13H13NO [M]
+ 
199.0992, found 199.0986. 
 
6,6-Dimethyl-6,7-dihydrobenzo[cd]indol-8(2H)-one (528).  
The substrate (1.40 g, 7.03 mmol) was added in one portion to a melt of AlCl3 (14.2 g, 
73.8 mmol) and NaCl (3.7 g, 63.3 mmol) at 135 °C and the solution was stirred 
vigorously for 4 minutes. The reaction was poured into ice cold water and the solution 
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was made basic by the addition of satd aq NaHCO3. The solution was extracted with 
CH2Cl2 and the combined organic layers were dried, filtered, and concentrated to a brown 
oil. Column chromatography (SiO2, 20-30% ethyl acetate in hexanes) provided the indole 
as a pale yellow solid (1.31 g, 93%). Rf = 0.50 (SiO2, 50% EtOAc/hexanes); mp = 145 
°C; IR (film) 3239 (br), 2958, 2868, 1651, 1527, 1439, 1338 cm
-1
; 
1
H NMR (600 MHz, 
CDCl3) δ 9.21 (br s, 1H), 7.73 (d, J = 2.4 Hz, 1H), 7.32-7.28 (m, 2H), 7.18 (dd, J = 6.0, 
1.8 Hz, 1H), 2.77 (s, 2H), 1.44 (s, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 194.4, 138.9, 
133.8, 127.7, 124.5, 123.5, 116.0, 114.5, 109.4, 55.7, 39.1, 29.3; HRMS (EI): Exact mass 
calcd for C13H14NO [M+H]
+ 
200.1075, found 200.1068. 
 
6-Dimethyl-2-tosyl-6,7-dihydrobenzo[cd]indol-8(2H)-one (530).  
To a solution of the indole (420 mg, 2.11 mmol) and diisopropyl ethylamine (551 µL, 
3.17 mmol) in CH2Cl2 (10 mL) at 0 °C was added p-toluenesulfonyl chloride (523 mg, 
2.75 mmol) and dimethyl aminopyridine (9.8 mg, 80 µmol). The reaction was stirred for 
30 min before being warmed to rt and stirred for 15 h. The reaction was quenched with 
satd aq NH4Cl and extracted with CH2Cl2. The combined organic layers were dried, 
filtered, and concentrated to a yellow oil. Column chromatography (SiO2, 10-20% ethyl 
acetate in hexanes) provided the title product as a pale yellow oil (737 mg, 99%). Rf = 
0.62 (SiO2, 50% EtOAc/hexanes); mp =119-121 °C; IR (film) 3126, 2961, 2871, 1686, 
1544, 1379, 1190 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.04 (s, 1H), 7.86 (d, J = 8.4 Hz, 
2H), 7.78 (d, J = 8.4 Hz, 1H), 7.39 (dd, J = 7.8, 7.8 Hz, 1H), 7.29 (d, J = 7.8 Hz, 2H), 
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7.25 (d, J = 7.2 Hz, 1H), 2.70 (s, 2H), 2.38 (s, 3H), 1.37 (s, 6H); 
13
C NMR (150 MHz, 
CDCl3) ppm 194.1, 145.9, 139.7, 134.8, 133.2, 130.2, 128.7, 127.2, 126.5, 124.0, 118.5, 
117.8, 111.5, 55.7, 39.2, 29.4, 21.7; HRMS (EI): Exact mass calcd for C20H20NO3S 
[M+H]
+ 
354.1164, found 354.1152. 
 
6,6-Dimethyl-8-(2-methylbut-3-en-2-yl)-2-tosyl-2,6,7,8-tetrahydrobenzo[cd]indol-8-
ol (532).  
To a 0 °C solution of indole (80.0 mg, 226 µmol) in THF (2.0 mL) was added 3,3-
dimethylallyl magnesium chloride (847 µL, 678 µmol, 0.75 M in THF) dropwise over 2 
minutes. The reaction was allowed to warm to room temperature and stirred for 1 h. The 
reaction was quenched with satd aq NH4Cl, the layers were separated, and the aqueous 
layer was extracted with CH2Cl2. The combined organic layers were washed with brine, 
dried, filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 10-20% ethyl acetate in hexanes) to afford the title product as a 
colorless oil (73.0 mg, 76%) in addition to indole (18 mg, 23%). Rf = 0.65 (SiO2, 50% 
EtOAc/hexanes); IR (film) 3356, 2962, 2926, 2879, 1371, 1187, 1179, 1131 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.5 Hz, 2H), 7.71 (d, J = 8.5 Hz, 1H), 7.65 (s, 
1H), 7.29 (dd, J = 8.0, 8.0  Hz, 1H), 7.23 (d, J = 8.0 Hz, 2H), 7.16 (d, J = 7.0 Hz, 1H), 
6.39 (dd, J = 17.0, 11.0 Hz, 1H), 5.24 (d, J = 11.5 Hz, 1H), 5.23 (d, J = 16.5 Hz, 1H), 
2.34 (s, 3H), 1.97 (d, J = 14.0 Hz, 1H), 1.93 (d, J = 14.0 Hz, 1H), 1.82 (br s, 1H), 1.43 (s, 
3H), 1.38 (s, 3H), 1.25 (s, 3H), 1.14 (s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 145.4, 
 
 
 
 
87 
 
144.8, 141.1, 135.4, 133.0, 129.9, 128.1, 126.8, 125.5, 122.8, 120.8, 117.6, 114.1, 110.4, 
74.2, 45.6, 45.3, 34.8, 32.3, 29.8, 23.1, 22.9, 21.5; HRMS (EI): Exact mass calcd for 
C25H29NO3SNa [M+Na]
+ 
446.1766, found 446.1770. 
 
5-Dimethyl-3-(2-methylbut-3-en-2-yl)-1-tosyl-1,5-dihydrobenzo[cd]indole (534).  
To a 0 °C solution of indole (40.0 mg, 113 µmol) in CH2Cl2 (1.5 mL) was added TiCl4 
(18.7 µL, 170 µmol) dropwise and the reaction was stirred for 10 minutes. Grignard 
reagent (756 µL, 454 µmol, 0.8 M in THF) was then added and the mixture was stirred 
vigorously for 2h at 0 °C and an additional 2h at rt. The reaction was quenched with satd 
aq NaHCO3, the layers were separated, and the aqueous layer was extracted with CH2Cl2. 
The combined organic layers were washed with brine, dried, filtered, and concentrated. 
The resulting residue was purified by flash column chromatography (SiO2, 5-10% ethyl 
acetate in hexanes) to afford the title product as a white solid (17.4 mg, 38%) in addition 
to the the indole (23.1 mg, 58%). Rf = 0.68 (SiO2, 50% EtOAc/hexanes); mp = 139-140 
°C; IR (film) 2961, 2925, 2855, 1123 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 
8.4 Hz, 2H), 7.65 (d, J = 8.0 Hz, 1H), 7.29 (dd, J = 7.6, 7.6 Hz, 1H), 7.27 (d, J = 6.4 Hz, 
1H), 7.21 (d, J = 8.0 Hz, 2H), 7.11 (d, J = 7.6 Hz, 1H), 5.97 (dd, J = 17.6, 10.8 Hz, 1H), 
5.59 (s, 1H), 5.11 (dd, J = 17.6, 1.2 Hz, 1H), 5.08 (dd, J = 10.8, 1.2 Hz, 1H), 2.34 (s, 3H), 
1.36 (s, 6H), 1.33 (s, 6H); 
13
C NMR (125 MHz, CDCl3) ppm 147.0, 144.5, 139.3, 135.5, 
135.3, 133.7, 133.0, 129.7, 128.5, 126.8, 125.9, 119.5, 118.5, 117.3, 112.0, 110.6, 40.9, 
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38.1, 31.9, 27.1, 21.5; HRMS (EI): Exact mass calcd for C25H28NO2S [M+H]
+ 
406.1835, 
found 406.1817. 
 
5,5-Dimethyl-3-(2-methylbut-3-en-2-yl)-1-tosyl-1,5-dihydrobenzo[cd]indole (534).  
To a 0 °C solution of indole (40.0 mg, 113 µmol) in CH2Cl2 (1.5 mL) was added SnCl4 
(19.9 µL, 170 µmol) dropwise and the reaction was stirred for 10 minutes. Grignard 
reagent (756 µL, 454 µmol, 0.8 M in THF) was then added and the mixture was stirred 
vigorously for 2h at 0 °C and at rt for additional 2 h. The reaction was quenched with satd 
aq NaHCO3, the layers were separated, and the aqueous layer was extracted with CH2Cl2. 
The combined organic layers were washed with brine, dried, filtered, and concentrated. 
The resulting residue was purified by flash column chromatography (SiO2, 5-10% ethyl 
acetate in hexanes) to afford the title product as a white solid (19.7 mg, 43%) in addition 
to the the indole (22.3 mg, 57%). See above for the analytical data. 
 
5,5-Dimethyl-3-(2-methylbut-3-en-2-yl)-1-tosyl-1,5-dihydrobenzo[cd]indole (534).  
To a 0 °C solution of indole (40.0 mg, 113 µmol) in CH2Cl2 (1.5 mL) was added 
BF3•OEt2 (21.5 µL, 170 µmol) dropwise and the reaction was stirred for 10 minutes. 
Grignard reagent (756 µL, 454 µmol, 0.8 M in THF) was then added and the mixture was 
stirred vigorously for 2h at 0 °C and at rt for additional 22 h. The reaction was quenched 
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with satd aq NaHCO3, the layers were separated, and the aqueous layer was extracted 
with CH2Cl2. The combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
5-10% ethyl acetate in hexanes) to afford the title product as a white solid (40.4 mg, 
88%). See above for the analytical data. 
 
6,6-Dimethyl-7-methylene-2-tosyl-6,7-dihydrobenzo[cd]indol-8(2H)-one (535).  
To a 0 °C solution of indole (90.0 mg, 255 µmol) and paraformaldehyde (91.8 mg, 3.06 
mmol) in DMSO (2.1 mL) was added BF3•OEt2 (84.0 µL, 637 µmol) dropwise over 2 
minutes. The reaction was heated in microwave oven for 2 h at 140 °C. The reaction was 
quenched with H2O, the layers were separated, and the aqueous layer was extracted with 
Et2O. The combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
5-10-15% ethyl acetate in hexanes) to afford the title product as pale yellow oil (33.0 mg, 
35%) in addition to indole (30.0 mg, 33%). Rf = 0.29 (SiO2, 20% EtOAc/hexanes); IR 
(film) 2961, 2924, 2853, 1675, 1599, 1543, 1382, 1190 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 8.19 (s, 1H), 7.87 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 8.4 Hz, 1H), 7.40 (dd, J = 
8.0, 8.0 Hz, 1H), 7.29 (dd, J = 8.0, 8.0  Hz, 2H), 7.28 (d, J = 8.0 Hz, 1H), 6.32 (s, 1H), 
5.67 (s, 1H), 2.37 (s, 3H), 1.53 (s, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 184.1, 154.4, 
145.9, 138.4, 134.7, 133.1, 130.2, 127.5, 127.2, 126.6, 125.9, 121.4, 118.7, 117.2, 111.4, 
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42.3, 30.6, 21.6; HRMS (EI): Exact mass calcd for C21H20NO3S [M]
+ 
366.1158, found 
366.1148. 
 
6,6-Dimethyl-7-methylene-2-tosyl-6,7-dihydrobenzo[cd]indol-8(2H)-one (535).  
To a 0 °C solution of indole (70.0 mg, 198 µmol) in CH2Cl2 (1.3 mL) was added TiCl4 
(43.6 µL, 396 µmol). The reaction was stirred for 5 minutes at 0 °C and, diisopropyl 
ethylamine (51.7 µL, 297 µmol) was added dropwise to the solution. To the resulting 
orange solution was added tetramethyl methylamine (41.0 µL, 297 µmol) and the mixture 
was stirred for 1h at 0 °C. The reaction was quenched with satd aq NH4Cl, the layers 
were separated, and the aqueous layer was extracted with CH2Cl2. The combined organic 
layers were washed with brine, dried, filtered, and concentrated. The resulting residue 
was purified by flash column chromatography (SiO2, 5-10-15% ethyl acetate in hexanes) 
to afford the title product as a pale yellow oil (29.8 mg, 41%) in addition to indole (35.0 
mg, 50%). See above for the analytical data. 
 
6,6-Dimethyl-7-methylene-2-tosyl-6,7-dihydrobenzo[cd]indol-8(2H)-one (535).  
To a solution of indole (23.3 mg, 66.0 µmol) in CH3CN (0.5 mL) was added 
Eschenmoser’s salt (24.5 µL, 264 µmol) and the reaction stirred at 80 °C for 1 h. The 
reaction was quenched with H2O, the layers were separated, and the aqueous layer was 
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extracted with Et2O. The combined organic layers were washed with brine, dried, filtered, 
and concentrated. The resulting residue was purified by flash column chromatography 
(SiO2, 5-10-15% ethyl acetate in hexanes) to afford the title compound as a pale yellow 
compound (18.9 mg, 78%). See above for the analytical data. 
 
5,5-Dimethyl-1-tosyl-3-((trimethylsilyl)oxy)-1,3,4,5-tetrahydrobenzo[cd]indole-3-
carbonitrile (539).  
To a 0 °C solution of LiOMe (21.5 mg, 566 µmol) in THF (15.0 mL) was added TMSCN 
(604 µL, 4.53 mmol) and the reaction was allowed to warm to room temperature and 
stirred for 10 minutes. Ketone (1.00 g, 2.83 mmol) in THF (4.0 mL) was added and the 
reaction was stirred for an additional 4 h at rt. The reaction was quenched with satd aq 
KH2PO4, the layers were separated, and the aqueous layer was extracted with Et2O. The 
combined organic layers were washed with satd aq KH2PO4, dried, filtered, and 
concentrated. The resulting cyanohydrin was pure for analytical purpose (1.28 g, 99%). 
Rf = 0.40 (SiO2, 20% EtOAc/hexanes); IR (film) 2962, 2934, 1431, 1378, 1189 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.85 (d, J = 8.4 Hz, 2H), 7.75 (d, J = 8.0 Hz, 1H), 7.67 (s, 
1H), 7.35 (dd, J = 8.0, 8.0 Hz, 1H), 7.27 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 7.6 Hz, 1H), 
2.37 (s, 3H), 2.36 (d, J = 14.0 Hz, 1H), 2.21 (d, J = 14.0 Hz, 1H), 1.42 (s, 3H), 1.40 (s, 
3H), 0.11 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 145.4, 139.6, 135.3, 133.0, 130.1, 
127.0, 126.3, 125.2, 122.2, 121.1, 119.2, 118.1, 111.06, 64.3, 51.8, 35.3, 30.9, 29.7, 21.6, 
1.0; HRMS (EI): Exact mass calcd for C24H28N2O3SSi [M]
+ 
452.1584, found 452.1564. 
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5,5-Dimethyl-1-tosyl-1,5-dihydrobenzo[cd]indole-3-carbonitrile (540).  
To a 0 °C solution of cyanohydrin (200 mg, 450 µmol) in POCl3 (209 µL, 2.25 mmol) 
was added HF-pyridine (17.5 µL, 650 µmol) dropwise. The reaction was stirred for 60 
minutes at 0 °C and pyridine (563 µL, 7.00 mmol) was added. The reaction was stirred at 
80 °C for 2 h and then cooled to 0 °C. The reaction was quenched with 1.0 M HCl and 
the solution was stirred for 10 minutes. The layers were separated, and the aqueous layer 
was extracted with CH2Cl2. The combined organic layers were washed with satd aq 
NaHCO3, dried, filtered, and concentrated. The resulting residue was purified by flash 
column chromatography (SiO2, 10-15-20% ethyl acetate in hexanes) to afford the title 
product as a white solid (29.2 mg, 20%). Rf = 0.61 (SiO2, 50% EtOAc/hexanes); mp = 
118-120 °C; IR (film) 2965, 2924, 2229, 1596, 1437, 1369 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.82 (d, J = 8.4 Hz, 2H), 7.73 (d, J = 8.4 Hz, 1H), 7.48 (s, 1H), 7.38 (dd, J = 
8.0, 8.0 Hz, 1H), 7.27 (d, J = 7.8 Hz, 2H), 7.13 (d, J = 7.6 Hz, 1H), 6.46 (s, 1H), 2.37 (s, 
3H), 1.42 (s, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 152.6, 145.3, 136.8, 135.1, 133.3, 
130.1, 127.4, 127.0, 125.3, 119.0, 118.9, 116.1, 114.1, 111.6, 104.0, 39.4, 31.1, 21.6; 
HRMS (EI): Exact mass calcd for C21H19N2O2S [M+H]
+ 
363.1162, found 363.1151. 
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5,5-Dimethyl-1-tosyl-1,5-dihydrobenzo[cd]indole-3-carbonitrile (540).  
To a -15 °C solution of ketone (40.0 mg, 109 µmol) in toluene (0.7 mL) was added 
Et2AlCN (152 µL, 152 µmol, 1.0 M in toluene). The reaction was stirred for 1 h at -15 °C 
and 1 h at 5 °C. HCl-MeOH mixture (1.05 mL, 2:1) was added to the reaction at 5 °C and 
the reaction was stirred for an additional hour. The reaction was allowed to warm to rt 
and the layers were separated. The aqueous layer was extracted with CH2Cl2. The 
combined organic layers were dried, filtered, and concentrated. The crude cyanohydrin 
was immediately subjected to the dehydration reaction. 
  To a solution of the crude cyanohydrin  (47 mg) in DME (150 µL) was added KHSO4 
(52.0 mg, 382 µmol) and the reaction stirred at 90 °C for 1 h. The reaction was quenched 
with satd aq NaHCO3 and the resulting solution was stirred for 5 minutes. The layers 
were separated, and the aqueous layer was extracted with CH2Cl2. The combined organic 
layers were washed with brine, dried, filtered, and concentrated. The resulting residue 
was purified by flash column chromatography (SiO2, 10-15-20% ethyl acetate in 
hexanes) to afford the nitrile as a white solid (12.1 mg, 30%) in addition to the starting 
ketone (27.1 mg, 67%).  
 
5,5-Dimethyl-1-tosyl-1,5-dihydrobenzo[cd]indole-3-carbaldehyde (542).  
To a 0 °C solution of nitrile (6.6 mg, 18 µmol) in toluene (200 mL) was added DIBAL-H 
(17.8 µL, 26.6 µmol, 1.0 M in toluene) and stirred for 1 h at 0 °C. The reaction was 
quenched by the stepwise addition of H2O (200 µL) and 6M HCl (400 µL). The reaction 
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was allowed to warm to room temperature and stirred until the layers became clear (~6 
h). The layers were separated, and the aqueous layer was extracted with Et2O. The 
combined organic layers were dried, filtered, and concentrated. The resulting residue was 
purified by flash column chromatography (SiO2, 20% ethyl acetate in hexanes) to afford 
the enal as a brown solid (6.6 mg, 99%). Rf = 0.23 (SiO2, 20% EtOAc/hexanes); mp = 
180-182 °C; IR (film) 2961, 2922, 2850, 1688, 1370, 1188, 1176, 1164, 1116 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 9.67 (s, 1H), 7.98 (s, 1H), 7.83 (d, J = 8.4 Hz, 2H), 7.75 (d, J 
= 8.4 Hz, 1H), 7.36 (dd, J = 8.0, 8.0 Hz, 1H), 7.23 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 7.6 
Hz, 1H), 6.62 (s, 1H), 2.34 (s, 3H), 1.48 (s, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 
191.6, 158.1, 144.9, 137.1, 135.5, 133.0, 131.1, 130.6, 129.9, 126.9, 126.7, 121.1, 118.7, 
111.9, 111.4; 39.4, 31.0, 21.6 HRMS (EI): Exact mass calcd for C21H19NNaO3S [M+Na]
+ 
388.0983, found 388.0983. 
 
1-(1H-Indol-3-yl)-2,3-dimethylbut-2-en-1-one (545).  
To a 0 °C solution of the acid (12.3 g, 112 mmol) in dichloromethane (240 mL), was 
added oxalyl chloride (19.6 mL, 224 mmol) over 5 minutes. Dimethyl aminopyridine 
(12.8 mg, 0.10 mmol) was added and the solution was slowly warmed to room 
temperature and stirred until complete conversion was achieved, as evidenced by 
1
H 
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NMR. The solvent was removed in vacuo to give the acyl chloride (13.5 g, 91%), which 
was used without further purification.
9
 
  To a 0 °C solution of indole (9.24 g, 78.7 mmol) in CH2Cl2 (300 mL) was added 
Et2AlCl (56.8 mL, 102 mmol, 1.8 M in toluene) dropwise. The reaction was stirred for 30 
minutes at 0 °C, and acyl chloride (13.5 g, 102 mmol) in CH2Cl2 (50 mL) was added 
dropwise to the solution. The reaction was stirred for 3 h at 0 °C, with the last 30 min 
having minimal ice within the ice/water bath. The reaction was quenched by slow 
dropwise addition of pH=7 buffer solution followed by the addition of satd aq NaHCO3 
in the same fashion. The layers were separated, and the aqueous layer was extracted with 
CH2Cl2. The combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
10-20% ethyl acetate in hexanes) to afford the title product as a yellow solid (15.8 g, 
94%). Rf = 0.65 (SiO2, 50% EtOAc/hexanes); mp = 118-120 °C; IR (film) 3184 (br s), 
2983, 2926, 1597 (br s), 1517, 1436, 1376 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 10.11 (br 
s, 1H), 8.39 (ddd, J = 10.0, 4.0, 3.2 Hz, 1H), 7.73 (d, J = 3.2 Hz, 1H), 7.45 (ddd, J = 10.0, 
4.0, 3.2 Hz, 1H), 7.33-7.26 (m, 2H), 1.96 (br d, J = 1.2 Hz, 3H), 1.81 (s, 3H) 1.68 (br d, J 
= 1.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 198.0, 137.0, 134.6, 131.5, 130.5, 
125.5, 123.6, 122.6, 121.9, 117.0, 111.9, 22.4, 19.8, 17.0; HRMS (EI): Exact mass calcd 
for C14H16NO [M+H]
+ 
214.1226, found 214.1220. 
                                                          
9
 Due to the low boiling point (~145 °C), the acyl chloride should be put under high vacuum for longer 
duration of time (~2 minutes). 
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4,5,5-Trimethyl-4,5-dihydrobenzo[cd]indol-3(1H)-one (514).  
The indole (3.00 g, 14.1 mmol) was added in one portion to a melt of AlCl3 (27.1 g, 141 
mmol) and NaCl (4.11 g, 70.4 mmol) at 119 °C. After 3 min, the reaction was poured 
into ice cold water and the solution was made basic by the addition of satd aq NaHCO3. 
The solution was extracted with CH2Cl2 and the combined organic layers were dried, 
filtered, and concentrated to a brown oil. Column chromatography (SiO2, 15-20-25-30-
35% ethyl acetate in hexanes) provided the desired tricyclic indole as a pale yellow oil 
(2.17 g, 73%) and its regioisomer as a white solid (710 mg, 23%).  
Data for (514): Rf = 0.42 (SiO2, 50% EtOAc/hexanes); IR (film) 3238 (br), 2967, 2870, 
1651, 1607, 1525, 1451, 1338 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.87 (br s, 1H), 7.72 
(dd, J = 6.6, 3.6 Hz, 1H), 7.30 (s, 1H), 7.29 (dd, J = 10.1, 8.2 Hz, 1H), 7.16 (ddd, J = 7.8, 
4.8, 4.8 Hz, 1H), 2.64 (q, J = 7.2 Hz, 1H), 1.38 (s, 6H), 1.14 (d, J = 6.6 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3) ppm 198.3, 138.7, 133.5, 127.0, 124.6, 123.7, 116.7, 113.5, 
109.3, 56.8, 41.7, 29.9, 23.8, 13.1; Exact mass calcd for C14H16NO [M+H]
+ 
214.1226. 
found 214.1225.  
  A NOESY crosspeak was observed between the methyl protons 
and C5 aromatic proton. Other key observations, including HMBC 
correlation between C16 and H5, confirmed the assigned structure 
of the desired tricyclic indole. 
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Data for (546): Rf = 0.38 (SiO2, 50% EtOAc/hexanes); mp = 235-237 °C; IR (film) 3212 
(br), 2960, 2834, 1661,1471, 1450 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 10.16 (br s, 1H), 
7.87 (d, J = 7.6 Hz, 1H), 7.44 (d, J = 8.0 Hz, 1H), 7.27-7.19 (m, 2H), 2.87 (q, J = 7.6 Hz, 
1H), 1.53 (s, 3H), 1.37 (s, 3H), 1.29 (d, J = 7.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 
ppm 198.1, 173.8, 142.1, 123.6, 122.3, 121.5, 121.0, 117.1, 112.3, 59.1, 38.8, 27.5, 24.2, 
11.3; Exact mass calcd for C14H16NO [M+H]
+ 
214.1226, found 214.1224. 
 
6,6-Dimethyl-2-tosyl-6,7-dihydrobenzo[cd]indol-8(2H)-one (547).  
To a solution of the indole (3.05 g, 14.3 mmol) and diisopropyl ethylamine (4.0 mL, 22.9 
mmol) in CH2Cl2 (90 mL) at 0 °C was added p-toluenesulfonyl chloride (3.54 mg, 18.6 
mmol) and dimethyl aminopyridine (39.2 mg, 320 µmol). The reaction was stirred for 30 
min before being warmed to rt and stirred for 15 h. The reaction was quenched with satd 
aq NH4Cl and extracted with CH2Cl2. The combined organic layers were dried, filtered, 
and concentrated to a yellow oil. Column chromatography (SiO2, 10-20% ethyl acetate in 
hexanes) provided the N-tosylated indole as a white solid (5.2 g, 99%). Rf = 0.29 (SiO2, 
20% EtOAc/hexanes); mp = 142-144 °C; IR (film) 3127, 2969, 2925, 2870, 1690, 1544, 
1434, 1379, 1366 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.02 (s, 1H), 7.86 (d, J = 8.0 Hz, 
2H), 7.76 (d, J = 8.0 Hz, 1H), 7.38 (dd, J = 8.0, 8.0 Hz, 1H), 7.29 (d, J = 8.0 Hz, 2H), 
7.23 (d, J = 7.2 Hz, 1H), 2.64 (q, J = 7.2 Hz, 1H), 2.38 (s, 3H), 1.33 (s, 3H), 1.28 (s, 3H), 
1.09 (d, J = 7.2 Hz, 3H) ; 
13
C NMR (100 MHz, CDCl3) ppm 197.7, 145.8, 139.6, 134.8, 
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133.0, 130.2, 128.2, 127.2, 126.6, 124.3, 119.1, 117.0, 111.4, 56.7, 41.8, 29.3, 24.3, 21.7, 
12.0; HRMS (EI): Exact mass calcd for C21H22NO3S [M+H]
+ 
368.1315, found 368.1311. 
 
4,5,5-Trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indole-3-carbonitrile (549).  
To a -15 °C solution of ketone (136 mg, 371 µmol) in toluene (1.8 mL) was added 
Et2AlCN (1.6 mL, 1.67 mmol, 1.0 M in toluene). The reaction was stirred for 1 h at -15 
°C and 1 h at 5 °C. HCl-MeOH mixture (1.05 mL, 2:1) was added to the reaction at 5 °C 
and the reaction was stirred for an additional hour. The reaction was allowed to warm to 
rt and the layers were separated. The aqueous layer was extracted with CH2Cl2. The 
combined organic layers were dried, filtered, and concentrated. The crude cyanohydrin 
was immediately subjected to the dehydration reaction. 
  To a solution of the crude cyanohydrin (150 mg) in DME (600 µL) was added KHSO4 
(260 mg, 1.91 mmol) and the reaction stirred at 90 °C for 1 h. The reaction was quenched 
with satd aq NaHCO3 and the solution was stirred for 5 minutes. The layers were 
separated, and the aqueous layer was extracted with CH2Cl2. The combined organic 
layers were washed with brine, dried, filtered, and concentrated. The resulting residue 
was purified by flash column chromatography (SiO2, 10-15-20% ethyl acetate in 
hexanes) to afford the nitrile as a white solid (21.0 mg, 20%) in addition to the starting 
ketone (104 mg, 76%). See below for the characterization data. 
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4,5,5-Trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indole-3-carbonitrile (549).  
To a 0 °C solution of cyanohydrin (3.05 g, 6.54 mmol) in POCl3 (15.0 mL, 164 mmol) 
was added HF-pyridine (700 µL, 26.1 mmol) dropwise. The reaction was stirred for 60 
minutes at 0 °C and pyridine (33.0 mL, 410 mmol) was added. The reaction was stirred at 
80 °C for 2 h and then cooled to 0 °C. The reaction was quenched with 1.0 M HCl and 
the solution was stirred for 10 minutes. The layers were separated, and the aqueous layer 
was extracted with CH2Cl2. The combined organic layers were washed with satd aq 
NaHCO3, dried, filtered, and concentrated. The resulting residue was purified by flash 
column chromatography (SiO2, 10-15-20% ethyl acetate in hexanes) to afford the nitrile 
as a white solid (1.18 g, 48%). Rf = 0.29 (SiO2, 20% EtOAc/hexanes); mp =192 °C; IR 
(film) 2973, 2927, 2222, 1439, 1369, 1090 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.81 (d, J 
= 8.0 Hz, 2H), 7.72 (d, J = 8.4 Hz, 1H), 7.39 (s, 1H), 7.36 (dd, J = 8.0, 8.0 Hz, 1H), 7.25 
(d, J = 8.4 Hz, 2H), 7.14 (d, J = 7.6 Hz, 1H), 2.36 (s, 3H), 2.30 (s, 3H), 1.48 (s, 6H); 
13
C 
NMR (100 MHz, CDCl3) ppm 160.2, 145.1, 137.6, 135.2, 133.1, 130.0, 127.3, 126.9, 
125.0, 119.1, 117.7, 116.0, 115.0, 111.4, 102.0, 42.3, 29.9, 21.6, 18.7; HRMS (EI): Exact 
mass calcd for C22H21N2O2S [M+H]
+ 
377.1318, found 377.1309. 
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4,5,5-Trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indole-3-carbonitrile (549).  
To a degassed solution of enol triflate (3.90 g, 7.82 mmol) and zinc cyanide (1.10 g, 9.38 
mmol) in DMF (20 mL) was added Pd(Ph3)4 (451 mg, 0.39 mmol) and the reaction 
stirred at 100 °C for 4 h. The reaction was cooled to rt and quenched with H2O. The 
layers were separated, and the aqueous layer was extracted with CH2Cl2. The combined 
organic layers were washed with brine, dried, filtered, and concentrated. The resulting 
residue was purified by flash column chromatography (SiO2, 10-20% ethyl acetate in 
hexanes) to afford the nitrile as a white solid (2.79 g, 97%). The data matched with the 
earlier reported data for the cyanide. See above for the characterization data. 
 
4,5,5-Trimethyl-1-tosyl-3-((trimethylsilyl)oxy)-1,3,4,5-tetrahydrobenzo[cd]indole-3-
carbonitrile (550).  
To a 0 °C solution of LiOMe (1.0 mg, 27 µmol) in THF (1.1 mL) was added TMSCN 
(26.2 µL, 196 µmol) and the reaction was allowed to warm to room temperature and 
stirred for 10 minutes. Ketone (40.0 mg, 109 µmol) was added and the reaction was 
stirred for an additional 4 h at rt. The reaction was quenched with satd aq KH2PO4, the 
layers were separated, and the aqueous layer was extracted with Et2O. The combined 
organic layers were washed with satd aq KH2PO4, dried, filtered, and concentrated. The 
resulting cyanohydrin was sufficiently pure for analytical purposes (50.0 mg, 99%). The 
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cyanohydrin was isolated as a 1:1 mixture of diastereomers.
10
 Rf = 0.49 (SiO2, 20% 
EtOAc/hexanes); IR (film) 2971, 2926, 1376, 1253, 1189, 1175, 1124 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3, data for both diastereomers) δ 7.85 (d, J = 8.0 Hz, 2H), 7.83 (d, J = 
8.0 Hz, 2H), 7.77 (d, J = 8.0 Hz, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.68 (s, 1H), 7.63 (s, 1H), 
7.37 (dd, J = 8.0, 8.0 Hz, 1H), 7.35 (dd, J = 8.0, 8.0 Hz, 1H), 7.26 (d, J = 8.0 Hz, 2H), 
7.26 (d, J = 8.0 Hz, 2H), 7.20 (d, J = 7.2 Hz, 1H), 7.15 (d, J = 7.6 Hz, 1H), 2.36 (s, 3H), 
2.36 (s, 3H), 2.19 (q, J = 6.8 Hz, 1H), 2.03 (q, J = 6.8 Hz, 1H), 1.44-142 (m, 6H), 1.39 (s, 
3H), 1.35 (s, 3H), 1.21 (s, 3H), 1.12 (br s, 3H), 0.15 (s, 9H), 0.11 (s, 9H); 
13
C NMR (100 
MHz, CDCl3, data for both diastereomers) ppm 145.3, 140.9, 135.3 (2C), 133.1, 133.0, 
130.1 (2C), 127.0, 126.9, 125.5, 126.4, 124.9, 124.6, 122.3, 120.8, 119.6, 118.6, 111.1, 
110.9, 77.2, 68.3, 50.9, 49.1, 38.9, 37.9, 29.7, 29.6, 27.8, 27.7, 25.8, 21.6, 10.5 (2C), 1.3, 
0.7; HRMS (EI): Exact mass calcd for C24H28N2O3SSi [M]
+ 
489.1644, found 489.1642. 
 
4,5,5-Trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indol-3-yl trifluoromethanesulfonate 
(551).  
To a 0 °C solution of ketone (1.05 g, 2.86 mmol) and 4-methyl-2,6-di-
t
butylpyridine 
(1.06 g, 5.15 mmol) in CH2Cl2 (5.0 mL) was added trifluoromethanesulfonyl anhydride 
(0.77 mL, 4.58 mmol) dropwise. The reaction was allowed to warm to room temperature 
and stirred for 22 h. The reaction was quenched by slow dropwise addition of satd aq 
                                                          
10
 The cyanohydrin was found to hydrolyze upon exposure to SiO2 or upon storage for a longer duration of 
time (>7 days). As a result the crude cyanohydrin was subjected to the subsequent (elimination) reaction 
immediately after isolation. 
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NaHCO3 at 0 °C and the solution was stirred for 5 minutes at rt. The layers were 
separated, and the aqueous layer was extracted with CH2Cl2. The combined organic 
layers were washed with brine, dried, filtered, and concentrated. The resulting residue 
was purified by flash column chromatography (SiO2, 5-10% ethyl acetate in hexanes) to 
afford the enol triflate as a white solid (1.32 g, 53%). Rf = 0.42 (SiO2, 20% 
EtOAc/hexanes); mp = 101-103 °C; IR (film) 2969, 2926, 2855, 1428, 1378, 1246, 1190, 
1008 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.4 Hz, 2H), 7.70 (d, J = 8.4 Hz, 
1H), 7.37 (dd, J = 8.0, 8.0 Hz, 1H), 7.32 (s, 1H), 7.24 (d, J = 8.4 Hz, 2H), 7.14 (d, J = 7.6 
Hz, 1H), 2.35 (s, 3H), 2.03 (s, 3H), 1.49 (s, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 
145.1, 138.2, 137.4, 135.4, 135.0, 133.2, 130.0, 127.1, 126.9, 126.6, 119.3, 118.5 (q, 
1
JCF 
= 320 Hz), 116.7, 113.7, 111.4, 44.4, 29.9, 21.6, 12.4; HRMS (EI): Exact mass calcd for 
C22H21F3NO5S2 [M+H]
+ 
500.0808, found 500.0815. 
 
4,5,5-Trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indole-3-carbaldehyde (552).  
To a 0 °C solution of nitrile (2.45 g, 6.51 mmol) in toluene (30 mL) was added DIBAL-H 
(4.99 mL, 7.49 mmol, 1.5 M in toluene) and stirred for 1 h at 0 °C. The reaction was 
quenched by the stepwise addition of H2O (30 mL) and 6M HCl (100 mL). The reaction 
was allowed to warm to room temperature and stirred until the layers became clear (~6 
h). The layers were separated, and the aqueous layer was extracted with Et2O. The 
combined organic layers were dried, filtered, and concentrated. The resulting residue was 
purified by flash column chromatography (SiO2, 20% ethyl acetate in hexanes) to afford 
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the enal as a white solid (2.45 g, 99%). Rf = 0.16 (SiO2, 20% EtOAc/hexanes); mp =188 
°C; IR (film) 2972, 2925, 2871, 1672, 1438, 1370 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 
10.42 (s, 1H), 8.05 (s, 1H), 7.82 (d, J = 8.4 Hz, 2H), 7.73 (d, J = 7.8 Hz, 1H), 7.33 (dd, J 
= 8.4, 8.4 Hz, 1H), 7.21 (d, J = 8.4 Hz, 2H), 7.14 (d, J = 7.8 Hz, 1H), 2.44 (s, 3H), 2.33 
(s, 3H), 1.52 (s, 6H); 
13
C NMR (150 MHz, CDCl3) ppm 190.2, 161.9, 144.6, 137.8, 
135.6, 132.6, 129.8, 126.9, 126.4, 126.3, 126.1, 120.8, 118.7, 113.0, 111.1, 42.9, 29.7, 
21.6, 13.9; HRMS (EI): Exact mass calcd for C22H22NO3S [M+H]
+ 
380.1320, found 
380.1332. 
 
(Z)-3-(((tert-Butyldimethylsilyl)oxy)methylene)-5,5-dimethyl-4-methylene-1-tosyl-
1,3,4,5-tetrahydrobenzo[cd]indole (553).  
To a -10 °C solution of enal (1.03 g, 2.72 mmol) and triethylamine (833 µL, 5.98 mmol) 
in CH2Cl2 (13 mL) was added TBSOTf (808 µL, 4.62 mmol) dropwise and the reaction 
was stirred for 10 h at -10 °C. The reaction was quenched by slow dropwise addition satd 
aq NH4Cl and the solution was warmed to rt. The layers were separated, and the aqueous 
layer was extracted with CH2Cl2. The combined organic layers were washed with brine, 
dried, filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the diene as a colorless 
oil (1.26 g, 94%). Rf = 0.57 (SiO2, 20% EtOAc/hexanes); IR (film) 2955, 2927, 2856, 
1637, 1375, 1174 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 10.5 Hz, 2H), 7.74 (d, 
J = 10.5 Hz, 1H), 7.66 (s, 1H), 7.28 (dd, J = 10.0, 10.0 Hz, 1H), 7.18 (d, J = 10.5 Hz, 
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2H), 7.15 (d, J = 9.5 Hz, 1H), 6.83 (s, 1H), 5.06 (d, J = 0.5 Hz, 1H), 4.90 (d, J = 0.5 Hz, 
1H), 2.33 (s, 3H), 1.40 (s, 6H), 1.01 (s, 9H), 0.30 (s, 6H); 
13
C NMR (125 MHz, CDCl3) 
ppm 151.2, 144.5, 140.3, 137.9, 135.7, 132.9, 129.8, 127.1, 126.8, 125.6, 119.6, 116.8, 
116.3, 114.7, 111.1, 106.5, 40.2, 29.7, 28.4, 25.7, 21.5, 18.3, -5.2; HRMS (EI): Exact 
mass calcd for C22H21NO3S [M-C6H14Si]
+ 
379.1278, found 379.1278.
11
  
  A NOESY crosspeak was observed between the methylene 
proton of the exocyclic alkene and the methine proton, thus 
confirming the formation of requisite diene with the desired 
diene geometry.  
 
 
(9S,10R)-10-((tert-Butyldimethylsilyl)oxy)-6,6,9-trimethyl-2-tosyl-2,6,7,8,9,10-
hexahydronaphtho[1,2,3-cd]indole-9-carbaldehyde (558).  
To a -23 °C solution of diene (100 mg, 203 µmol) and methacrolein (335 µL, 4.06 mmol) 
in CH2Cl2 (850 µL) was added EtAlCl2 (112 µL, 203 µmol, 1.8 M in toluene) dropwise 
over 5 minutes.
12
 The reaction was stirred for 30 minutes at -23 °C and 1.5 h at 0 °C. The 
reaction was quenched by slow dropwise addition of satd aq NaHCO3 and and the 
solution was warmed to rt. The layers were separated, and the aqueous layer was 
                                                          
11
 TBS group was lost  
12
 Rapid addition leads to lower yields. 
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extracted with CH2Cl2. The combined organic layers were washed with brine, dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the Diels Alder adduct 
as a viscous oil (72 mg, 63%). The adduct was isolated as a single diastereomer as 
indicated by the NMR analysis. Rf = 0.40 (SiO2, 20% EtOAc/hexanes); IR (film) 2956, 
2928, 2856, 1729, 1368, 1172, 1118, 1100 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 9.70 (s, 
1H), 7.82 (d, J = 8.3 Hz, 2H), 7.72 (d, J = 8.1 Hz, 1H), 7.36 (dd, J = 7.8, 7.8 Hz, 1H), 
7.25 (s, 1H), 7.22 (d, J = 8.3 Hz, 2H), 7.15 (d, J = 7.5 Hz, 1H), 4.67 (s, 1H), 2.55 (ddd, 
11.5, 11.5, 2.5 Hz, 1H), 2.37-2.34 (m, 1H), 2.35 (s, 3H), 1.73-1.59 (m, 2H), 1.44 (s, 3H), 
1.41 (s, 3H), 0.92 (s, 3H), 0.74 (s, 9H), 0.00 (s, 3H), -0.29 (s, 3H); 
13
C NMR (125 MHz, 
CDCl3) ppm 205.2, 144.8, 144.7, 140.2, 135.7, 133.5, 129.9, 126.9, 126.7, 126.5, 121.4, 
119.8, 118.8, 115.7, 110.8, 70.8, 49.8, 49.3, 40.9, 31.0, 29.0, 25.7, 22.1, 21.9, 21.5, 18.3, 
16.0, -3.5, -4.1; HRMS (EI): Exact mass calcd for C32H41NNaO4SSi [M+Na]
+ 
586.2423, 
found 586.2426. 
  A complete 2D NMR analysis was carried out to elucidate the structure of Diels-Alder 
adduct. HSQC was effective in identifying peaks in the overlapping regions and allowed 
for NOESY correlations to these regions to be readily distinguishable. NOESY 
correlations from both H11 to H17 and H11 to 
aldehyde proton, and the absence of the 
NOESY correlations between H11 to either 
H13 and H14, strongly suggested that the H11 
proton is equatorial. Additionally, a NOESY correlation between TBS-methyl protons 
and H13α indicated that the -OTBS is in the axial position, thus confirming the 
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stereochemistry at C11. The stereochemistry at C12, which has an axial methyl group, 
could be relayed to both H14β and H18. These analyses confirmed the structure of the 
desired Diels-Alder adduct. 
 
(8S,10R)-10-((tert-Butyldimethylsilyl)oxy)-8-((E)-1-chloroprop-1-en-2-yl)-6,6-
dimethyl-2-tosyl-6,7,8,10-tetrahydro-2H-isochromeno[8,7,6-cd]indole (559).  
To a -78 °C solution of diene (25.0 mg, 50.7 µmol) and β-chloro methacrolein (52.5 µL, 
507 µmol) in CH2Cl2 (220 µL) was added EtAlCl2 (28 µL, 50.8 µmol, 1.8 M in toluene) 
dropwise over 5 minutes.
13
 The reaction was stirred for 30 minutes at -78 °C and 3.0 h at 
-23 °C. The reaction was quenched by slow dropwise addition of satd aq NaHCO3 and 
and the solution was warmed to rt. The layers were separated, and the aqueous layer was 
extracted with CH2Cl2. The combined organic layers were washed with brine, dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the Mukaiyama aldol 
product as a yellow oil (19.5 mg, 63%) in addition to the hydrolyzed enal (552, 5.3 mg, 
21%). Rf = 0.31 (SiO2, 20% EtOAc/hexanes); IR (film) 2956, 2928, 2886, 2857, 1675, 
1367, 1170, 1118, 1117, 1095 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 10.25 (s, 1H), 8.13 (s, 
1H), 7.78 (d, J = 8.4 Hz, 2H), 7.74 (d, J = 8.0 Hz, 1H), 7.34 (dd, J = 7.6, 7.6 Hz, 1H), 
7.19 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 7.6 Hz, 1H), 6.13 (d, J = 0.6 Hz, 1H), 4.22 (dd, J = 
                                                          
13
 Rapid addition leads to lower yields. 
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10.0, 2.4 Hz, 1H), 3.40 (dd, J = 14.0, 10.0 Hz, 1H), 2.59 (dd, J = 14.4, 2.4 Hz, 1H), 2.32 
(s, 3H), 1.88 (d, J = 1.2 Hz, 3H), 1.57 (s, 3H), 1.42 (s, 3H), 0.70 (s, 9H), -0.16 (s, 3H), -
0.32 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 190.9, 158.1, 144.5, 141.0, 137.5, 135.5, 
132.6, 129.7, 129.1, 126.8, 126.4, 126.3, 121.7, 118.5, 115.5, 113.3, 111.3, 75.3, 43.1, 
34.4, 32.6, 27.6, 25.6, 21.5, 18.0, 12.1; HRMS (EI): Exact mass calcd for C26H25ClNO3S 
[M-C6H150]
+ 
466.12, found 466.12.
14
 
 The appearance of a proton as doublet at 6.13 ppm, and the carbon connected to it at 
115.5 ppm as shown by HSQC analysis, indicated that this carbon is most probably sp
2
 
hybridized (C19). The 
1
H 
NMR showed three well 
resolved dd patterns at 
4.22, 3.40 and 2.59, which 
are the methine (C13) and 
methylene (C14) protons adjacent to each other. A weak IR stretch at 1675 cm-1, and the 
presence of 
1
H NMR and 
13
C NMR NMR peaks at 10.25 and 190.9 ppm indicated the 
presence of an α,β-unsaturated aldehyde. The presence of the enal was confirmed by a 
downfield shift of the C17 in the 
13
C NMR spectrum (158.1 ppm).  
 
                                                          
14
 Loss of TBSOH was observed, due to elimination, resulting in a highly conjugated system. 
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(9R,10S)-10-((tert-Butyldimethylsilyl)oxy)-6,6,9-trimethyl-2-tosyl-9-vinyl-
2,6,7,8,9,10-hexahydronaphtho[1,2,3-cd]indole (560).  
To a -78 °C solution of methyl triphenylphosphonium bromide (60.9 mg, 170 µmol) in 
THF (600 µL) was added 
n
BuLi (63.1 µL, 157 µmol) dropwise. The reaction was stirred 
for 10 minutes at -78 °C before being warmed to 0 °C and stirred for another 30 min. The 
reaction was cooled to -78 °C and a solution of aldehyde (24.0 mg, 42.6 µmol) in THF 
(400 µL) was added dropwise over 5 minutes. The reaction was stirred for 1 h at -78 °C 
before being warmed to rt and stirred for 10 h. The reaction was quenched with H2O and 
the layers were separated. The aqueous layer was extracted with Et2O and the combined 
organic layers were washed with brine, dried, filtered, and concentrated. The resulting 
residue was purified by flash column chromatography (SiO2, 8% ethyl acetate in 
hexanes) to afford the alkene as a yellow oil (21.4 mg, 89%). Rf = 0.55 (SiO2, 20% 
EtOAc/hexanes); IR (film) 2956, 2927, 2855, 1369, 1187, 1171, 1099, 1088 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.0 Hz, 2H), 7.70 (d, J = 8.0 Hz, 1H), 7.33 (dd, J 
= 8.0, 8.0 Hz, 1H), 7.21 (d, J = 8.0 Hz, 2H), 7.18 (s, 1H), 7.14 (d, J = 7.5 Hz, 1H), 6.07 
(dd, J = 17.5, 10.5 Hz, 1H), 5.04 (d, J = 12.0 Hz, 1H), 5.04 (d, J = 17.0 Hz, 1H),  4.13 (s, 
1H), 2.48 (dd, J = 19.0, 6.5 Hz, 1H), 2.38-2.27 (m, 1H), 2.34 (s, 3H), 2.20 (ddd, J = 12.0, 
10.5, 7.0 Hz, 1H), 1.48-1.45 (m, 1H), 1.44 (s, 3H), 1.40 (s, 3H), 0.89 (s, 3H), 0.74 (s, 
9H), 0.00 (s, 3H), -0.25 (s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 147.1, 144.6, 142.5, 
140.6, 135.7, 133.4, 129.7, 126.9, 126.8, 126.3, 123.1, 120.2, 118.6, 115.5, 111.4, 110.6, 
73.4, 40.6, 39.6, 31.1, 28.7, 26.4, 25.9, 22.6, 21.5, 20.0, 18.4, -3.6, -3.8; HRMS (EI): 
Exact mass calcd for C33H43NNaO3SSi [M+Na]
+ 
584.2631, found 584.2646. 
109 
 
 
(9R,10S)-6,6,9-Trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-hexahydronaphtho[1,2,3-
cd]indol-10-ol (561).  
To a 0 °C solution of the TBS ether (30.5 mg, 54.4 µmol) in THF (1.0 mL) was added 
TBAF (136 µL, 136 µmol, 1.0 M in THF). The reaction was warmed to rt and stirred for 
1 h. The reaction was quenched with satd aq NaHCO3 and the layers were separated. The 
aqueous layer was extracted with Et2O and the combined organic layers were washed 
with brine, dried, filtered, and concentrated. The resulting residue was purified by flash 
column chromatography (SiO2, 15% ethyl acetate in hexanes) to afford the alcohol as a 
white foam (22.9 mg, 95%). Rf = 0.28 (SiO2, 20% EtOAc/hexanes); IR (film) 3551, 2969, 
2926, 2870, 1436, 1362, 1188, 1170, 1116, 1098 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
7.80 (d, J = 8.5 Hz, 2H), 7.68 (d, J = 8.5 Hz, 1H), 7.42 (s, 1H), 7.31 (dd, J = 8.0, 8.0 Hz, 
1H), 7.20 (d, J = 8.0 Hz, 2H), 7.12 (d, J = 8.0 Hz, 1H), 6.04 (dd, J = 17.5, 11.0 Hz, 1H), 
5.26 (d, J = 11.0 Hz, 1H), 5.22 (d, J = 17.5 Hz, 1H),  4.16 (s, 1H), 2.49 (ddd, J = 19.0, 
5.0, 5.0 Hz, 1H), 2.39-2.35 (m, 1H), 2.35 (s, 3H), 1.94 (ddd, J = 12.5, 9.0, 6.0 Hz, 1H), 
1.75 (s, 1H), 1.58 (ddd, J =  13.0, 5.0, 5.0 Hz, 1H), 1.44 (s, 3H), 1.42 (s, 3H), 1.08 (s, 
3H); 
13
C NMR (125 MHz, CDCl3) ppm 144.5, 143.3, 142.8, 139.9, 135.7, 133.2, 129.8, 
127.2, 126.9 (2C), 126.2, 122.5, 118.8, 118.5, 117.2 (2C), 115.2, 110.7, 72.9, 40.8, 39.6, 
30.7, 29.7, 28.4, 22.4, 21.9, 21.5; HRMS (EI): Exact mass calcd for C27H29NNaO3S 
[M+Na]
+ 
470.1776, found 470.1776. 
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4-Chloro-3-methyl-but-3-en-2-one (231).  
A solution of methyl magnesium bromide (240 mL, 3.0 M in ether, 721 mmol), in ether 
(600 mL) was cooled to 0 °C and treated with a solution of β-chloro-α-methyl acrolein 
(68.5 g, 655 mmol) as a pre-dissolved solution in ether (80 mL). The mixture was 
warmed to room temperature and quenched with an ether-ice mixture, followed by an 
aqueous work-up to give the alcohol in sufficient purity for oxidation. 
The alcohol (55.5 g, 95.7 mmol) was added to a slurry of MnO2 (476 g, 5.48 mol) in 
pentane (1.5 L) and stirred vigorously for 36 hours. Additional MnO2 (119 g, 1.12 mol) 
was added and the mixture was stirred for an additional 12 h. The mixture was filtered 
over Celite and concentrated to a yellow oil that was purified by flash chromatography 
(SiO, 8% ether in hexanes) to furnish the ketone as a yellow oil (54 g, 74%). Analytical 
data was identical to that in the literature. 
 
(Z)-5,5-Dimethyl-4-methylene-1-tosyl-3-(((triisopropylsilyl)oxy)methylene)-1,3,4,5-
tetrahydrobenzo[cd]indole (563).  
To a -10 °C solution of enal (11.0 mg, 29.0 µmol) and triethylamine (12.0 µL, 87.0 
µmol) in CH2Cl2 (400 µL) was added TIPSOTf (23.4 µL, 87.0 µmol) dropwise and the 
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reaction was stirred for 10 h at -10 °C. The reaction was quenched by slow dropwise 
addition of satd aq NH4Cl and the solution was warmed to rt. The layers were separated, 
and the aqueous layer was extracted with CH2Cl2. The combined organic layers were 
washed with brine, dried, filtered, and concentrated. The resulting residue was purified by 
flash column chromatography (SiO2, 5% ethyl acetate in hexanes) to afford the diene as a 
colorless oil (13.0 mg, 84%). Rf = 0.56 (SiO2, 20% EtOAc/hexanes); IR (film) 2944, 
2925, 2866, 1375, 1174, 1096 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.77 (d, J = 8.4 Hz, 
2H), 7.74 (d, J = 7.8 Hz, 1H), 7.70 (s, 1H), 7.28 (dd, J = 8.4, 8.4 Hz, 1H), 7.18 (d, J = 7.8 
Hz, 2H), 7.15 (d, J = 7.2 Hz, 1H), 6.89 (s, 1H), 5.05 (d, J = 0.6 Hz, 1H), 4.90 (d, J = 0.6 
Hz, 1H), 2.33 (s, 3H), 1.40 (s, 6H), 1.32 (sept, J = 7.8 Hz, 3H), 1.16 (d, J = 7.2 Hz, 18H); 
13
C NMR (125 MHz, CDCl3) ppm 151.3, 144.5, 140.3, 138.5, 135.7, 132.9, 129.7, 127.1, 
126.8, 125.6, 119.7, 116.8, 116.3, 114.4, 111.1, 106.3, 40.2, 28.4, 21.5, 17.7, 11.8; 
HRMS (EI): Exact mass calcd for C22H22NO3S [M-C9H18Si]
+ 
380.1320, found 
380.1295.
15
 
  A NOESY crosspeak was observed between the methylene 
proton of the exocyclic alkene and the methine proton, thus 
confirming the formation of requisite diene with the desired 
diene geometry. 
                                                          
15
 TIPS group was lost 
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1-((8R,9S,10R)-10-((tert-Butyldimethylsilyl)oxy)-8-chloro-6,6,9-trimethyl-2-tosyl-
2,6,7,8,9,10-hexahydronaphtho[1,2,3-cd]indol-9-yl)ethanone (564).  
  EtAlCl2 (1.79 mL, 3.22 mmol, 1.8 M in toluene) was added dropwise to a -78 °C 
solution of the diene (1.59 g, 3.22 mmol) and the dienophile (2.66 g, 22.6 mmol) in 
CH2Cl2 (13.0 mL).
16
 The reaction was stirred for 30 minutes at -78 °C and 2.5 h at -23 
°C. The reaction was quenched by slow dropwise addition of satd aq NaHCO3 and the 
solution was warmed to rt. The layers were separated, and the aqueous layer was 
extracted with CH2Cl2. The combined organic layers were washed with brine, dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the Diels-Alder adduct 
(1.16 g, 59%) in addition to the Mukaiyama aldol product (96 mg, 7%).  
Diels-Alder adduct (564)  
The adduct was isolated as a single diastereomer (
1
H NMR). Rf = 0.36 (SiO2, 20% 
EtOAc/hexanes); mp 240-241 °C (decomp); IR (film) 2928, 2887, 2856, 1716, 1367, 
1186, 1170, 1117, 1091 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.81 (d, J = 8.4 Hz, 2H), 
7.73 (d, J = 8.4 Hz, 1H), 7.37 (dd, J = 7.8, 7.8 Hz, 1H), 7.25 (s, 1H), 7.23 (d, J = 8.4 Hz, 
2H), 7.16 (d, J = 7.8 Hz, 1H), 5.10 (dd, J = 9.6, 7.2 Hz, 1H), 4.76 (s, 1H), 3.15 (dd, J = 
                                                          
16
 Rapid addition leads to lower yields. 
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19.2, 7.2 Hz, 1H), 2.61 (dd, J = 18.6, 9.6 Hz, 1H), 2.35 (s, 3H), 2.33 (s, 3H), 1.48 (s, 3H), 
1.42 (s, 3H), 1.11 (s, 3H), 0.71 (s, 9H), -0.08 (s, 3H), -0.31 (s, 3H); 
13
C NMR (150 MHz, 
CDCl3) ppm 207.3, 144.9, 142.7, 139.7, 135.8, 133.6, 129.9 (2C), 126.9, 126.4, 121.7, 
119.2, 118.9, 116.3, 111.1, 74.5, 56.7, 56.1, 40.8, 34.9, 31.2, 28.8, 26.5, 25.6, 21.5, 18.2, 
13.8, -3.7, -4.2; HRMS (EI): Exact mass calcd for C33H42ClNO4SSi [M]
+ 
611.2287, found 
611.2306. 
  A complete 2D NMR analysis was carried out to elucidate the structure of Diels-Alder 
adduct. NOESY correlations from both 
H11 to H17
17
 and H11 to C19, and the 
absence of NOESY correlations between 
H11 to either H13 and H14, suggested that 
the H11 proton is equatorial. Additionally, a NOESY correlation between TBS-methyl 
protons and H13α indicated that the -OTBS is in the axial position, thus confirming the 
stereochemistry at C11. The stereochemistry at C12, which has an axial methyl group, 
could be relayed to both H14β and H19. These observations support the assignment of 
the Diels-Alder adduct as depicted.  
Mukaiyama aldol product (576)  
Rf = 0.23 (SiO2, 20% EtOAc/hexanes); mp 200-202 °C; IR (film) 2962, 2928, 2857, 
1674, 1437, 1367, 1187, 1169, 1095 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 9.83 (s, 1H), 
8.07 (s, 1H), 7.82 (d, J = 8.5 Hz, 2H), 7.77 (d, J = 8.5 Hz, 2H), 7.76 (d, J = 8.5 Hz, 1H), 
7.75 (d, J = 8.0 Hz, 1H), 7.57 (s, 1H), 7.36 (dd, J = 8.0, 8.0 Hz, 1H), 7.25 (s, 1H), 7.22 
(d, J = 8.5 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 7.5 Hz, 1H), 7.14 (d, J = 7.5 Hz, 
                                                          
17
 Heterocycle numbering used here throughout instead of IUPAC/CAS numbering. 
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1H), 4.99 (dd, J = 6.5, 6.5 Hz, 1H), 3.28 (br s, 2H), 2.33 (s, 6H), 1.65 (s, 3H), 1.64 (s, 
3H), 1.50 (s, 3H), 1.31 (s, 3H), 1.29 (s, 3H), 0.77 (s, 9H), -0.08 (s, 3H), -0.25 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) ppm 189.7, 159.0, 144.4, 144.3, 139.3, 137.4, 135.5, 135.3, 
132.8, 132.4, 129.6, 129.5, 128.4, 126.8, 126.5 (2C), 126.1, 126.0, 121.3, 118.6, 118.3, 
115.2, 113.1, 111.0, 110.4, 71.9, 43.1, 41.2, 34.5, 30.7, 27.4, 25.5, 21.3, 17.8, 15.0, -5.0, -
5.3; HRMS (EI): Exact mass calcd for C50H56N2Na O6S2Si [M]
+ 
895.3247, found 
895.3283. 
  The 
1
H NMR analysis showed one well resolved dd pattern at 4.95 in addition to two 
poorly resolved patterns at 3.30 and 
2.25, which are the methine (C11) 
and methylene (C12) adjacent to each 
other. A weak IR stretch at 1675 cm
-
1
, and the presence of 
1
H NMR and 
13C NMR NMR peaks at 9.82 and 189.8 ppm indicated the presence of an α,β-unsaturated 
aldehyde. The presence of enal was confirmed by the downfield shift of C17 in 
13
C NMR 
spectrum (159.0 ppm). 
 
(Z)-(5,5-Dimethyl-4-methylene-1-tosyl-4,5-dihydrobenzo[cd]indol-3(1H)-
ylidene)methyl 2-phenylacetate (566).  
To a 0 °C solution of phenylacetic acid (500 mg, 3.67 mmol) in CH2Cl2 (18.0 mL) was 
added (diethylamino)sulfur trifluoride (824 µL, 6.24 mmol) dropwise. The reaction was 
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stirred for 10 minutes before being warmed to rt and stirred for another 30 min. The 
organic layer was washed once with H2O and then brine and dried, filtered, and 
concentrated to a pale yellow oil. The crude acyl fluoride was used in the nest reaction 
without any further purification. 
  To a 0 °C solution of acyl fluoride (210 mg, 152 µmol) in THF (1.0 mL) was added 
diene (30.0 mg, 60.8 µmol) and TBAF (5.00 µL, 4.87 µmol, 1.0 M in THF). The reaction 
was stirred for 10 minutes at 0 °C before being warmed to rt and stirred for another 30 
min. The reaction was quenched by slow dropwise addition of satd aq NaHCO3. The 
layers were separated, and the aqueous layer was extracted with CH2Cl2. The combined 
organic layers were washed with brine, dried, filtered, and concentrated. The resulting 
residue was purified by flash column chromatography (SiO2, 10-20% ethyl acetate in 
hexanes) to afford the diene as a pale yellow oil (10.0 g, 34%). Rf = 0.41 (SiO2, 20% 
EtOAc/hexanes); IR (film) 3030, 2968, 2925, 1752, 1373, 1232, 1189, 1122 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.74 (d, J = 8.5 Hz, 2H), 7.72 (d, J = 8.5 Hz, 1H), 7.70 (s, 
1H), 7.56 (s, 1H), 7.49-7.45 (m, 4H), 7.37 (ddd, J = 9.0, 5.5, 2.0 Hz, 1H), 7.29 (dd, J = 
8.0, 8.0 Hz, 1H), 7.21 (d, J = 8.0 Hz, 2H), 7.16 (d, J = 7.0 Hz, 1H), 5.22 (s, 1H), 5.03 (s, 
1H), 3.94 (s, 2H), 2.34 (s, 3H), 1.40 (s, 6H); 
13
C NMR (125 MHz, CDCl3) ppm 168.0, 
150.0, 144.9, 139.9, 139.8, 132.8, 131.2, 129.9, 129.4, 129.1, 127.6, 126.8, 126.6, 126.0, 
121.0, 118.2, 117.4, 117.1, 114.8, 111.2, 109.5, 41.6, 40.2, 28.2, 21.6; HRMS (EI): Exact 
mass calcd for C22H21NO3S [M-C8H6O]
+ 
379.1242, found 379.1220.
18
 
                                                          
18
 Benzyl group was lost 
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(Z)-(5,5-Dimethyl-4-methylene-1-tosyl-4,5-dihydrobenzo[cd]indol-3(1H)-
ylidene)methyl trifluoromethanesulfonate (569).  
To a -10 °C solution of enal (42.0 mg, 111 µmol) and 4-methyl-2,6-di-
t
butylpyridine 
(68.3 mg, 333 µmol) in CH2Cl2 (700 µL) was added trifluoromethanesulfonyl anhydride 
(46.7 µL, 277 µmol) dropwise and the reaction was stirred for 2 h. The reaction was 
quenched with satd aq NaHCO3 at -10 °C and the solution was stirred for 5 minutes at rt. 
The layers were separated, and the aqueous layer was extracted with CH2Cl2. The 
combined organic layers were washed with brine, dried, filtered, and concentrated. The 
resulting residue was purified by flash column chromatography (SiO2, 5-10% ethyl 
acetate in hexanes) to afford the diene as a pale yellow oil (21.0 mg, 38%). The enol 
triflate was isolated as a 10:1 inseparable mixture of E and Z isomers.
19
 Rf = 0.44 (SiO2, 
20% EtOAc/hexanes); IR (film) 2969, 2926, 2855, 1428, 1378, 1246, 1213, 1190, 1175, 
1139 cm
-1
; 
1
H NMR (400 MHz, CDCl3, data for the major isomer) δ 7.83 (d, J = 8.4 Hz, 
2H), 7.77 (d, J = 8.0 Hz, 1H), 7.38 (s, 1H), 7.35 (dd, J = 8.0, 8.0 Hz, 1H), 7.25 (d, J = 8.0 
Hz, 2H), 7.19 (d, J = 7.2 Hz, 1H), 7.07 (s, 1H), 5.27 (s, 1H), 5.14 (s, 1H), 2.36 (s, 3H), 
1.43 (s, 6H); 
13
C NMR (100 MHz, CDCl3, data for the major isomer) ppm 148.4, 145.2, 
139.3, 135.1, 132.7, 130.7, 130.0, 127.0, 126.4, 126.0, 124.2, 122.0, 117.3, 112.4, 111.5, 
111.3, 40.2, 27.9, 27.3, 21.5, -CF3 carbon peaks not observed; HRMS (EI): Exact mass 
calcd for C23H21F3NO5S2 [M+H]
+ 
512.0808, found 512.0808. 
                                                          
19
 2D NMR analysis to determine the regioselectivity was not carried out. 
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(E)-1-Phenyl-N-((4,5,5-trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indol-3-
yl)methylene)methanamine (570).  
The benzylamine (25.0 mg, 65.9 µmol) was added to the flask containing the aldehyde 
(25.0 mg, 65.9 µmol) and 4 Å molecular sieves in toluene (300 µL) and the reaction was 
stirred for 1 h at 50 °C. The solution filtered through a pad of celite and concentrated to a 
pale yellow oil. The crude imine was sufficiently pure for all analytical purposes (31.3 
mg, 100%)
20
. Rf = 0.41 (SiO2, 20% EtOAc/hexanes); IR (film) 3028, 2971, 2925, 1637, 
1437, 1369, 1168, 1094 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.70 (s, 1H), 8.14 (s, 1H), 
7.77 (d, J = 8.4 Hz, 2H), 7.71 (d, J = 8.4 Hz, 1H), 7.43-7.39 (m, 4H), 7.32-7.29 (m, 2H), 
7.17 (d, J = 7.8 Hz, 2H), 7.13 (d, J = 7.8 Hz, 1H), 4.87 (s, 2H), 2.32 (s, 3H), 2.20 (s, 3H), 
1.46 (s, 6H); 
13
C NMR (150 MHz, CDCl3) ppm 159.2, 151.2, 144.3, 139.9, 138.7, 135.7, 
132.7, 129.7, 128.5, 127.8, 127.1, 126.8 (2C), 125.8, 123.1, 121.3, 118.6, 115.6, 110.8, 
65.8, 42.1, 29.8, 21.5, 14.6; HRMS (EI): Exact mass calcd for C29H29N2O2S [M+H]
+ 
469.1944, found 469.1934. 
 
                                                          
20
 The imine was found to hydrolyze on silica and upon storage for longer duration of time (>7 days). 
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(4,5,5-Trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indol-3-yl)methanaminehydrochloride 
(572).  
To a 0 °C solution of nitrile (260 mg, 691 µmol) in toluene (5.0 mL) was added DIBAL-
H (1.05 mL, 725 µmol, 1.5 M in toluene). The reaction was stirred for 30 min at 0 °C and 
an additional 30 min at rt. The reaction was cooled to 0 °C and propionic acid (55.2 µL, 
725 µmol) was added. The reaction was stirred for a minute and NaBH4 (104 mg, 2.76 
mmol) in MeOH (5.0) was added to the reaction. The reaction was stirred for 30 min at 0 
°C and an additional 30 min at rt. The reaction was quenched by slow dropwise addition 
of NH4OH. The layers were separated, and the aqueous layer was extracted with Et2O. 
The combined organic layers were washed once with NH4Cl and then brine and dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 10% MeOH in CH2Cl2) to afford the ammonium salt as a brown 
oil (116 mg, 42%). Rf = 0.14 (SiO2, 10% MeOH/CH2Cl2); IR (film) 3000 (br), 2970, 
2927, 1369, 1170, 1119 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.0 Hz, 2H), 
7.77 (s, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.25 (dd, J = 8.0, 8.0 Hz, 1H), 7.06 (br s, 3H), 7.05 
(d, J = 8.4 Hz, 2H), 7.03 (d, J = 7.6 Hz, 1H), 4.06 (br s, 2H), 2.12 (s, 3H), 1.90 (s, 3H), 
1.26 (s, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 146.8, 144.6, 139.8, 135.1, 133.2, 129.8, 
127.2, 126.5, 126.4, 118.9, 118.1, 117.8, 117.2, 110.5, 41.7, 38.1, 29.8, 21.3, 14.6; 
HRMS (EI): Exact mass calcd for C22H24N2OS [M]
+ 
380.1553, found 380.1560. 
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4,5,5-Trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indole-3-carbaldehyde (572).  
To a 0 °C solution of nitrile (20.0 mg, 53.2 µmol) in toluene (250 µL) was added 
DIBAL-H (159 µL, 157 µmol, 1.0 M in toluene). The reaction was warmed to rt and 
stirred for 2 h. The reaction was cooled to 0 °C and more DIBAL-H was added (106 µL, 
105 µmol, 1.0 M in toluene). The reaction was warmed to rt and stirred for an additional 
4 h. The reaction was quenched by the stepwise addition of H2O (1.0 mL) and 6M HCl (3 
mL). The reaction was stirred vigorously until the layers became clear (~6 h).  The layers 
were separated, and the aqueous layer was extracted with Et2O. The combined organic 
layers were dried, filtered, and concentrated. The resulting residue was purified by flash 
column chromatography (SiO2, 2%-5%-10% MeOH in CH2Cl2) to afford the amine (5.0 
mg, 25%) in addition to the enal (13.0 mg, 65%). See above for the characterization data. 
 
Methyl ((4,5,5-trimethyl-1-tosyl-1,5-dihydrobenzo[cd]indol-3-yl)methyl)carbamate 
(573).  
To a 0 °C solution of the amine salt (22.0 mg, 52.8 µmol) and triethyl amine (22.1 µL, 
158 µmol) in CH2Cl2 (700 µL) was added methyl chloroformate (5.30 µL, 68.6 µmol). 
The reaction was warmed to rt and stirred for 2 h. The reaction was quenched with satd 
aq NH4Cl and the layers were separated. The aqueous layer was extracted with CH2Cl2 
and the combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
30% ethyl acetate in hexanes) to afford the carbamate as a pale yellow foam (21.5 mg, 
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93%). Rf = 0.08 (SiO2, 20% EtOAc/hexanes); IR (film) 3396, 2969, 2928, 1704, 1524, 
1438, 1364, 1254, 1186, 1170, 1101 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 8.4 
Hz, 2H), 7.67 (d, J = 8.0 Hz, 1H), 7.32 (dd, J = 8.0, 8.0 Hz, 1H), 7.25 (s, 1H), 7.20 (d, J = 
8.4 Hz, 2H), 7.12 (d, J = 7.6 Hz, 1H), 4.70 (s, 1H), 4.21 (br d, J = 5.2 Hz, 1H), 3.72 (s, 
3H), 2.33 (s, 3H), 1.99 (s, 3H), 1.40 (s, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 157.0, 
144.6, 143.7, 139.9, 135.5, 133.5, 129.8, 126.8, 126.6, 126.5, 120.6, 119.3, 118.9, 116.2, 
110.8, 52.3, 41.5, 39.9, 29.9, 21.5, 14.2; HRMS (EI): Exact mass calcd for C24H26N2O4S 
[M]
+ 
438.1608, found 438.1406. 
 
1-((8R,9R,10R)-10-((tert-Butyldimethylsilyl)oxy)-8-chloro-6,6,9-trimethyl-2-tosyl-
2,6,7,8,9,10-hexahydronaphtho[1,2,3-cd]indol-9-yl)ethanol (577).  
DIBAL-H (1.70 mL, 2.54 mmol, 1.5 M in toluene) was added to a 0 °C solution of 
ketone (1.25 g, 2.05 mmol) in toluene (24 mL). The reaction was warmed to rt and stirred 
for 1 h. After return of the solution to 0 °C, additional DIBAL-H was added (1.70 mL, 
2.54 mmol, 1.5 M in toluene). The solution was warmed to rt and stirred for an additional 
1 h. The reaction was quenched by the stepwise addition of H2O (1.0 mL) and 1 M HCl. 
The layers were separated, and the aqueous layer was extracted with Et2O. The combined 
organic layers were dried, filtered, and concentrated. The resulting residue was purified 
by flash column chromatography (SiO2, 10-20% ethyl acetate in hexanes) to afford the 
alcohol as a viscous oil (1.04 g, 82%). The alcohol was isolated as an inseparable 1:1 
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mixture of diastereomers.
21
 Rf = 0.31 (SiO2, 20% EtOAc/hexanes); IR (film) 3568, 2928, 
2855, 1460, 1437, 1369, 1171, 1095 cm
-1
; 
1
H NMR (600 MHz, CDCl3, data for both 
diastereomers) δ 7.81 (d, J = 8.4 Hz, 2H), 7.80 (d, J = 7.8 Hz, 2H), 7.73 (d, J = 8.4 Hz, 
1H), 7.72 (d, J = 7.8 Hz, 1H), 7.38 (dd, J = 7.8, 7.8 Hz, 1H), 7.37 (dd, J = 7.8, 7.8 Hz, 
1H), 7.24 (s, 1H), 7.23 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 7.8 Hz, 2H), 7.22 (s, 1H), 5.07 
(dd, J = 10.2, 7.2 Hz, 1H), 4.94 (dd, J = 9.6, 6.6 Hz, 1H), 4.76 (s, 1H), 4.47 (s, 1H), 4.22 
(dd, J = 12.6, 6.0 Hz, 1H), 3.96 (ddd, J = 16.8, 6.0, 6.0 Hz, 1H), 3.14 (dd, J = 18.6, 7.2 
Hz, 1H), 3.04 (s, 1H), 3.03 (s, 1H), 3.14 (dd, J = 18.6, 7.2 Hz, 1H), 3.14 (dd, J = 16.2, 6.0 
Hz, 1H), 2.66 (ddd, J = 18.6, 9.6, 5.4 Hz, 1H), 2.35 (s, 3H), 2.35 (s, 3H), 1.47 (s, 3H), 
1.45 (s, 3H), 1.44 (s, 3H), 1.42 (d, J = 6.6 Hz, 3H), 1.41 (s, 3H), 1.34 (d, J = 7.2 Hz, 3H), 
0.86 (s, 3H), 0.80 (s, 9H), 0.80 (s, 9H), 0.73 (s, 3H), 0.25 (s, 3H), -0.02 (s, 3H), -0.33 (s, 
3H), -0.42 (s, 3H), –OH protons (2) not observed; 13C NMR (150 MHz, CDCl3) ppm 
145.0, 144.9, 143.6, 142.4, 139.7, 135.7, 135.6, 133.5, 129.9, 126.9, 126.8, 126.4, 126.3, 
123.1, 122.5, 119.7, 119.4, 119.0, 118.9, 116.1 (2C), 111.0, 75.1, 74.1, 73.3, 71.8, 64.1, 
58.9, 45.7, 44.3, 40.8, 40.5, 36.0, 35.0, 30.8, 29.7, 29.3, 28.9, 25.9, 25.7, 21.5, 18.4, 18.3, 
17.2, 14.1, 14.0, 9.6, -3.3, -3.6, -3.8, -4.3; HRMS (EI): Exact mass calcd for 
C33H44ClNO4SSi [M]
+ 
611.2443, found 611.2441. 
 
                                                          
21
 The alcohol is highly sensitive to the base, and should not be stored for an extended period of time. 
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(8R,9R,10R)-10-((tert-Butyldimethylsilyl)oxy)-8-chloro-6,6,9-trimethyl-2-tosyl-9-
vinyl-2,6,7,8,9,10-hexahydronaphtho[1,2,3-cd]indole (578).  
To a 0 °C solution of the alcohols (116 mg, 189 µmol) in CH2Cl2 (3.0 mL) was added 
Tf2O (63.7 µL, 378 µmol) and pyridine (40.8 µL, 567 µmol) and the reaction was stirred 
for 30 minutes at 0 °C. The solution was warmed to rt and more pyridine (183 µL, 2.27 
mmol) was added. The reaction was stirred for 12 h and quenched by slow dropwise 
addition of satd aq NaHCO3 at 0 °C. The layers were separated, and the aqueous layer 
was extracted with CH2Cl2. The combined organic layers were washed with brine, dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 5-10% ethyl acetate in hexanes) to afford the desired alkene as a 
viscous oil (61.6 mg, 55%). Rf = 0.52 (SiO2, 20% EtOAc/hexanes); IR (film) 2956, 2926, 
2855, 1371, 1171, 1120, 1099 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.80 (d, J = 8.4 Hz, 
2H), 7.71 (d, J = 7.8 Hz, 1H), 7.35 (dd, J = 7.8, 7.8 Hz, 1H), 7.22 (d, J = 8.4 Hz, 2H), 
7.17 (s, 1H), 7.15 (d, J = 7.2 Hz, 1H), 6.17 (dd, J = 17.4, 10.8 Hz, 1H), 5.25 (dd, J = 10.8, 
1.2 Hz, 1H), 5.22 (d, J = 18.0 Hz, 1H), 4.77 (dd, J = 10.2, 6.6 Hz, 1H), 4.27 (s, 1H), 3.06 
(dd, J = 18.6, 6.6 Hz, 1H), 2.60 (dd, J = 18.6, 10.8 Hz, 1H), 2.35 (s, 3H), 1.47 (s, 3H), 
1.40 (s, 3H), 1.01 (s, 3H), 0.73 (s, 9H), -0.08 (s, 3H), -0.21 (s, 3H); 
13
C NMR (150 MHz, 
CDCl3) ppm 144.8, 144.1, 141.3, 139.9, 135.7, 133.4, 129.9, 126.9, 126.6 (2C), 123.6, 
119.1, 118.7, 116.0, 114.3, 110.9, 76.5, 61.4, 45.6, 40.7, 34.6, 31.6, 28.3, 25.9, 21.5, 18.4, 
13.3, -3.82, -3.92 ; HRMS (EI): Exact mass calcd for C33H42ClNO3SSi [M]
+ 
595.2338, 
found 595.2310. 
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(8R,9R,10R)-8-Chloro-6,6,9-trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-
hexahydronaphtho[1,2,3-cd]indol-10-ol (579).  
To a 0 °C solution silyl ether (16.0 mg, 26.9 µmol) in THF (1.0 mL) was added TBAF 
(80.8 µL, 80.8 µmol, 1.0 M in THF). The solution was warmed to rt and stirred for 1 h. 
The reaction was quenched with satd aq NaHCO3 and the layers were separated. The 
aqueous layer was extracted with Et2O and the combined organic layers were dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 20% ethyl acetate in hexanes) to afford the alcohol as a yellow 
solid (10.5 mg, 82%). Rf = 0.27 (SiO2, 20% EtOAc/hexanes); mp 138-140 °C (decomp); 
IR (film) 3546, 2973, 2925, 1363, 1169, 1117, 1098 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 
7.80 (d, J = 8.4 Hz, 2H), 7.68 (d, J = 8.4 Hz, 1H), 7.37 (s, 1H), 7.33 (dd, J = 8.4, 8.4 Hz, 
1H), 7.22 (d, J = 8.4 Hz, 2H), 7.13 (d, J = 7.8 Hz, 1H), 6.11 (dd, J = 18.0, 10.8 Hz, 1H), 
5.43 (d, J = 10.8 Hz, 1H), 5.37 (d, J = 18.0 Hz, 1H), 4.52 (dd, J = 9.0, 5.4 Hz, 1H), 4.39 
(d, J = 4.8 Hz, 1H), 3.02 (dd, J = 18.6, 5.4 Hz, 1H), 2.66 (dd, J = 18.6, 9.0 Hz, 1H), 2.35 
(s, 3H), 1.98 (d, J = 4.8 Hz, 1H), 1.46 (s, 3H), 1.44 (s, 3H), 1.18 (s, 3H); 
13
C NMR (150 
MHz, CDCl3) ppm 144.7, 141.2, 140.8, 139.3, 135.6, 133.2, 126.9 (2C), 126.8, 126.5, 
122.2, 118.7, 118.0, 117.3, 117.2, 110.8, 74.5, 61.3, 45.3, 40.7, 33.6, 30.6, 29.4, 21.6, 
15.8; HRMS (EI): Exact mass calcd for C27H28ClNO3S [M]
+ 
481.1473, found 481.1471. 
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6,6,9-Trimethyl-2-tosyl-2,6-dihydronaphtho[1,2,3-cd]indole (580).  
To a 0 °C solution of alcohol (10.0 mg, 19.3 µmol) in THF (600 µL) was added TBAF 
(38.6 µL, 38.6 µmol, 1.0 M in THF). The reaction was warmed to rt and stirred for 1 h. 
The reaction was quenched with satd aq NaHCO3 and the layers were separated. The 
aqueous layer was extracted with Et2O and the combined organic layers were dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 10% ethyl acetate in hexanes) to afford the elimination product as 
a colorless oil (5.9 mg, 90%). Rf = 0.44 (SiO2, 20% EtOAc/hexanes); IR (film) 2966, 
2924, 2859, 1369, 1186, 1173, 1123, 1091, 1061 cm
-1
; 
1
H NMR (600 MHz, CDCl3) 7.81 
(d, J = 7.8 Hz, 2H), 7.74 (d, J = 8.4 Hz, 1H), 7.70 (s, 1H), 7.51 (s, 1H), 7.46 (d, J = 8.4 
Hz, 1H), 7.37 (dd, J = 7.8, 7.8 Hz, 1H), 7.24 (d, J = 7.2 Hz, 1H), 7.21 (d, J = 7.8 Hz, 2H), 
7.12 (dd, J = 8.4, 1.2 Hz, 1H), 2.38 (s, 3H), 2.33 (s, 3H), 1.62 (s, 6H); 
13
C NMR (150 
MHz, CDCl3) ppm 144.7, 142.4, 139.8, 135.9, 135.5, 133.7, 129.9, 129.0, 127.7, 126.8, 
126.6, 126.4, 126.1, 124.1, 119.1, 118.6, 116.8, 110.8, 39.1, 33.8, 21.6, 20.9; HRMS (EI): 
Exact mass calcd for C25H24NO2S [M+H]
+ 
402.1522, found 402.1516. 
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6,6,9-Trimethyl-2-tosyl-2,6-dihydronaphtho[1,2,3-cd]indole (580).  
To a 0 °C solution of alcohol (6.0 mg, 12.0 µmol) in THF (500 µL) was added TBAF 
(24.0 µL, 24.0 µmol, 1.0 M in THF). The reaction was warmed to rt and stirred for 1 h. 
The reaction was quenched with satd aq NaHCO3 and the layers were separated. The 
aqueous layer was extracted with Et2O and the combined organic layers were dried, 
filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 10% ethyl acetate in hexanes) to afford the elimination product as 
a colorless oil (4.3 mg, 84%). Rf = 0.44 (SiO2, 20% EtOAc/hexanes). Please see above for 
characterization data. 
 
 
1-((8R,9S,10R)-8-Chloro-10-hydroxy-6,6,9-trimethyl-2-tosyl-2,6,7,8,9,10-
hexahydronaphtho [1,2,3-cd]indol-9-yl)ethanone (582).  
To a 0 °C solution of silyl ether (18.6 mg, 30.4 µmol) in THF (1.5 mL) was added TBAF 
(60.8 µL, 60.8µmol, 1.0 M in THF) and the reaction stirred for 40 minutes at 0 °C. The 
reaction was quenched with satd aq NaHCO3 and the layers were separated. The aqueous 
layer was extracted with Et2O and the combined organic layers were dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
20-30% ethyl acetate in hexanes) to afford the alcohol as a yellow oil (8.3 mg, 55%). Rf = 
0.11 (SiO2, 20% EtOAc/hexanes); IR (film) 3503, 2970, 2924, 1704, 1366, 1187, 1170, 
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1119, 1094 cm
-1
; 
1
H NMR (600 MHz, CDCl3) 7.81 (d, J = 8.4 Hz, 2H), 7.69 (d, J = 8.4 
Hz, 1H), 7.38 (s, 1H), 7.34 (dd, J = 7.8, 7.8  Hz, 1H), 7.22 (d, J = 8.4 Hz, 2H), 7.13 (d, J 
= 7.2 Hz, 1H), 4.90 (dd, J = 9.6, 5.4 Hz, 1H), 3.00 (dd, J = 18.6, 5.4 Hz, 1H), 2.67 (s, 
1H), 2.60 (dd, J = 18.6, 9.6 Hz, 1H), 2.41 (s, 3H), 2.34 (s, 3H), 1.45 (s, 3H), 1.43 (s, 3H), 
1.30 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 144.8, 140.5, 139.1, 135.5, 133.2, 129.9, 
126.9, 126.7, 126.6, 122.0, 118.7, 117.5, 117.0, 111.0, 73.5, 57.7, 55.5, 40.7, 33.6, 30.8, 
29.1, 28.0, 21.6, 14.5; HRMS (EI): Exact mass calcd for C27H26ClNO3S [M-OH]
+ 
480.13, 
found 480.13.
22
 
 
(8R,9R,10R)-8-Chloro-9-(1-hydroxyethyl)-6,6,9-trimethyl-2-tosyl-2,6,7,8,9,10-
hexahydro naphtho[1,2,3-cd]indol-10-ol (583).  
To a 0 °C solution of ketone (15.0 mg, 30.2 µmol) in toluene (200 µL) was added 
DIBAL-H (20.1 µL, 30.2 µmol, 1.5 M in toluene). The reaction was warmed to rt and 
stirred for 1 h. The reaction was cooled to 0 °C and more DIBAL-H was added (20.1 µL, 
30.2 µmol, 1.5 M in toluene). The reaction was warmed to rt and stirred for an additional 
1 h and quenched by the stepwise addition of H2O (20 µL) and 1M HCl. The layers were 
separated, and the aqueous layer was extracted with Et2O. The combined organic layers 
were dried, filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 20-30% ethyl acetate in hexanes) to afford the alcohol as a 
                                                          
22
 Loss of a H2O molecule due to elimination was observed. 
 
 
 
 
127 
 
colorless oil (11.6 mg, 77%). The alcohol was isolated as a 5:4 mixture of 
diastereomers.
23
 Rf = 0.50 (SiO2, 50% EtOAc/hexanes); IR (film) 3418, 2972, 2927, 
1437, 1367, 1187, 1169, 1118, 1095 cm
-1
; 
1
H NMR (600 MHz, CDCl3, data for both 
diastereomers) δ 7.82 (d, J = 8.0 Hz, 2H), 7.81 (d, J = 8.4 Hz, 2H), 7.68 (d, J = 8.0 Hz, 
1H), 7.67 (d, J = 8.0 Hz, 1H), 7.36 (s, 1H), 7.35 (dd, J = 8.0, 8.0 Hz, 1H), 7.34 (s, 1H), 
7.34 (dd, J = 8.0, 8.0 Hz, 1H), 7.25 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 7.13 (d, 
J = 7.6 Hz, 2H), 5.94 (dd, J = 11.2, 6.0 Hz, 1H), 4.66 (dd, J = 10.8, 5.6 Hz, 1H), 4.64 (s, 
1H), 4.54 (s, 1H), 4.12-4.09 (m, 2H), 3.10 (s, 1H), 3.07 (dd, J = 18.4, 6.0 Hz, 1H), 3.00 
(s, 1H), 2.95 (dd, J = 18.0, 5.6 Hz, 1H), 2.66 (dd, J = 10.4, 10.4 Hz, 1H), 2.62 (dd, J = 
10.4, 10.4 Hz, 1H), 2.69-2.62 (m, 1H), 2.43-2.42 (m, 1H), 2.35 (s, 3H), 2.35 (s, 3H), 1.54 
(d, J = 6.8 Hz, 3H), 1.52 (d, J = 6.4 Hz, 3H), 1.46 (s, 3H), 1.45 (s, 3H), 1.44 (s, 3H), 1.43 
(s, 3H), 0.99 (s, 3H), 0.83 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 144.8, 141.7, 141.5, 
139.4, 139.3, 135.5, 133.3, 129.9, 126.9, 126.7, 126.6, 122.4, 122.3, 118.7, 118.0, 117.9, 
116.5, 116.3, 110.9, 75.0, 74.2, 73.2, 72.0, 60.5, 59.1, 44.4, 43.7, 40.8, 40.7, 34.4, 34.0, 
31.0, 29.1, 18.9, 21.6, 19.4, 17.8, 14.2, 13.9; HRMS (EI): Exact mass calcd for 
C25H24NO2S [M-C2H2ClO]
+ 
402.1522, found 402.1.
24
 
 
                                                          
23
 The alcohol is highly sensitive to the base, and should not be stored for an extended period of time. 
24
 The HRMS indicated that the product has gone a tandem Grob fragmentation/elimination sequence to 
give compound 580.  
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6,6,9-Trimethyl-2-tosyl-10-vinyl-2,6-dihydronaphtho[1,2,3-cd]indole (586).  
To a 0 °C solution of alcohol (10.0 mg, 20.9 µmol) in CH2Cl2 (300 µL) was added Tf2O 
(10.6 µL, 62.7 µmol) and Et3N (14.5 µL, 105 µmol). The reaction was stirred for 30 
minutes at 0 °C and at rt for 1 h. The reaction was quenched by slow dropwise addition of 
satd aq NaHCO3 and the layers were separated, and the aqueous layer was extracted with 
CH2Cl2. The combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
5-10% ethyl acetate in hexanes) to afford the rearranged tetracyclic product as a white 
foam (1.4 mg, 15%). Rf = 0.52 (SiO2, 20% EtOAc/hexanes); IR (film) 2959, 2924, 2853, 
1457, 1431, 1371, 1187, 1175, 1133, 1094 cm
-1
; 
1
H NMR (600 MHz, CDCl3) 7.90 (s, 
1H), 7.77 (d, J = 8.4 Hz, 2H), 7.73 (d, J = 8.4 Hz, 1H), 7.43 (d, J = 8.4 Hz, 1H), 7.37 (dd, 
J = 7.8, 7.8 Hz, 1H), 7.24 (d, J = 7.8 Hz, 1H), 7.20 (d, J = 7.8 Hz, 2H), 6.92 (dd, J = 27.0, 
18.0 Hz, 1H), 5.81 (dd, J = 16.8, 3.0 Hz, 1H), 5.42 (dd, J = 27.0, 3.0 Hz, 1H), 2.35 (s, 
3H), 2.32 (s, 3H), 1.63 (s, 6H); 
13
C NMR (150 MHz, CDCl3) ppm 144.7, 143.4, 139.5, 
137.2, 136.7, 135.4, 133.9, 132.9, 129.8, 129.5, 127.2, 126.7, 126.5, 126.2, 124.9, 121.7, 
120.7, 118.9, 117.8, 110.5, 39.4, 34.4, 21.5, 20.7; HRMS (EI): Exact mass calcd for 
C27H26NO2S [M+H]
+ 
428.1684, found 428.1688. 
 
6,6,9-Trimethyl-2-tosyl-10-vinyl-2,6-dihydronaphtho[1,2,3-cd]indole (586).  
To a 0 °C solution of alcohol (25.0 mg, 52.8 µmol) in CH2Cl2 (800 µL) was added Tf2O 
(21.2 µL, 126 µmol) and Et3N (29.0 µL, 210 µmol). The reaction was stirred for 30 
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minutes at 0 °C and at rt for 1 h. The reaction was quenched by slow dropwise addition of 
satd aq NaHCO3 and the layers were separated, and the aqueous layer was extracted with 
CH2Cl2. The combined organic layers were washed with brine, dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
5-10% ethyl acetate in hexanes) to afford the rearranged tetracyclic product as a white 
foam (1.0 mg, 4%). Please see above for the characterization data. 
 
(8R,9R)-8-Chloro-6,6,9-trimethyl-2-tosyl-9-vinyl-6,7,8,9-tetrahydronaphtho[1,2,3-
cd]indol-10(2H)-one (587).  
To a 0 °C solution of alcohol (6.0 mg, 12.0 µmol) in CH2Cl2 (500 µL) was added Dess-
Martin periodinane (12.6 mg, 30.0 µmol). The reaction was warmed to rt and stirred for 1 
h. The reaction was quenched by the addition of an aqueous solution containing 2:1 satd 
aq Na2S2O3:NaHCO3 and was stirred until both layers became clear (~20 min). The 
layers were separated and the aqueous layer was extracted with CH2Cl2 and the combined 
organic layers were dried, filtered, and concentrated. The resulting residue was purified 
by flash column chromatography (SiO2, 15% ethyl acetate in hexanes) to afford the enone 
as a pale yellow foam (5.8 mg, 96%). Rf = 0.27 (SiO2, 20% EtOAc/hexanes); IR (film) 
2974, 2928, 2359, 2342, 1677, 1369, 1187, 1171, 1116, 1096 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 8.13 (s, 1H), 7.84 (d, J = 8.4 Hz, 2H), 7.75 (d, J = 8.4 Hz, 1H), 7.34 (dd, J = 
8.0, 8.0 Hz, 1H), 7.22 (d, J = 8.4 Hz, 2H), 7.13 (d, J = 7.6 Hz, 1H), 5.86 (dd, J =  17.6, 
10.4 Hz, 1H), 5.23 (d, J = 10.8 Hz, 1H), 5.12 (d, J = 17.2 Hz, 1H), 4.49 (dd, J = 4.8, 4.0 
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Hz, 1H), 3.20 (dd, J = 18.4, 4.0 Hz, 1H), 3.04 (dd, J = 18.6, 5.2 Hz, 1H), 2.34 (s, 3H), 
1.51 (s, 3H), 1.49 (s, 3H), 1.44 (s, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 157, 144.7, 
137.9, 137.4, 135.7, 132.6, 129.9, 127.0, 126.7, 126.3, 124.0, 121.8, 118.5, 117.2, 112.7, 
111.2, 64.1, 54.0, 41.8, 33.5, 30.3, 28.9, 21.6, 19.5; HRMS (EI): Exact mass calcd for 
C27H27ClNO3S [M+H]
+ 
480.1400, found 480.1415. 
 
(8R,9R,10R)-8-Chloro-6,6,9-trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-
hexahydronaphtho[1,2,3-cd]indol-10-ol (588).  
To a 0 °C solution of ketone (29.3 mg, 62.1 µmol) in toluene (900 µL) was added 
DIBAL-H (80.8 µL, 124 µmol, 1.5 M in toluene). The reaction was warmed to rt and 
stirred for 1 h. The reaction was cooled to 0 °C and more DIBAL-H was added (40.4 µL, 
62.0 µmol, 1.5 M in toluene). The reaction was warmed to rt and stirred for an additional 
1 h and quenched by the stepwise addition of H2O (50 µL) and 1M HCl. The layers were 
separated, and the aqueous layer was extracted with Et2O. The combined organic layers 
were dried, filtered, and concentrated. The resulting residue was purified by flash column 
chromatography (SiO2, 10-20% ethyl acetate in hexanes) to afford the alcohol as a 
viscous oil (29.1 g, 99%). The alcohol was isolated as an inseparable 11:2 (β:α) mixture 
of diastereomers. Rf = 0.27 (SiO2, 20% EtOAc/hexanes); IR (film) 3547, 2926, 2925, 
1437, 1363, 1187, 1169, 1118, 1092 cm
-1
; 
1
H NMR (400 MHz, CDCl3, data for both 
isomers) δ 8.10 (d, J = 8.4 Hz, 2H), 8.09 (d, J = 8.4 Hz, 2H), 7.69 (d, J = 8.4 Hz, 1H), 
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7.68 (d, J = 8.0 Hz, 1H), 7.59 (s, 1H), 7.37 (s, 1H), 7.33 (dd, J = 8.0, 8.0 Hz, 1H), 7.32 
(dd, J = 8.0, 8.0 Hz, 1H), 7.20 (d, J = 8.4 Hz, 2H), 7.19 (d, J = 8.4 Hz, 2H), 7.13 (d, J = 
7.2 Hz, 1H), 7.12 (d, J = 7.6 Hz, 1H), 6.11 (dd, J = 17.6, 11.2 Hz, 1H), 5.80 (dd, J = 17.2, 
10.8 Hz, 1H), 5.43 (d, J = 10.8 Hz, 1H), 5.37 (d, J = 17.6 Hz, 1H), 5.32 (d, J = 10.8 Hz, 
1H), 5.27 (d, J = 17.6 Hz, 1H), 4.52 (dd, J = 9.2, 5.2 Hz, 1H), 4.44 (d, J = 6.0 Hz, 1H), 
4.39 (br s, 1H), 4.17 (dd, J = 9.2, 5.2 Hz, 1H), 3.02 (dd, J = 18.6, 5.4 Hz, 1H), 2.89 (ddd, 
J = 18.0, 5.2, 1.2 Hz, 1H), 2.73 (ddd, J = 18.0, 8.8, 2.4 Hz, 1H), 2.66 (dd, J = 18.4, 9.2 
Hz, 1H), 2.35 (s, 3H), 2.33 (s, 3H), 2.06 (br d, J = 6.8 Hz, 2H), 1.46 (s, 3H), 1.44 (s, 3H), 
1.42 (s, 3H), 1.26 (s, 3H), 1.24 (s, 3H), 1.18 (s, 3H); 
13
C NMR (100 MHz, CDCl3, data 
for both isomers) ppm 144.5, 142.6, 141.2, 139.1, 138.4, 135.6, 133.1, 132.8, 129.8 (2C), 
129.0, 128.2, 127.0, 126.8, 126.4, 126.1, 123.0, 119.4, 118.6, 118.5, 118.0, 117.2, 117.1, 
116.7, 116.4, 110.8, 110.7, 74.4, 73.5, 63.1, 61.3, 46.3, 45.3, 40.7, 40.6, 33.5, 33.2, 30.5, 
30.0, 29.6, 29.3, 21.5, 15.7, 12.4; HRMS (EI): Exact mass calcd for C27H28ClNNaO3S 
[M+Na]
+ 
504.1376, found 504.1387.  
 
(8R,9R,10R)-8-Chloro-10-methoxy-6,6,9-trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-
hexahydro naphtho[1,2,3-cd]indole (596).  
To a 0 °C solution of alcohols (24.0 mg, 50.4 µmol) in THF (750 µL) was added 
LiHMDS (202 µL, 202 µmol, 1.0 M in toluene) dropwise. The reaction was stirred for 1 
h at 0 °C, and MeOTf (34.0 µL, 302 µmol) was added dropwise to the solution. The 
reaction was stirred for 30 min at 0 °C and 30 min at rt. The reaction was quenched with 
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satd aq NH4Cl and the layers were separated. The aqueous layer was extracted with Et2O 
and the combined organic layers were dried, filtered, and concentrated. The resulting 
residue was purified by flash column chromatography (SiO2, 10% ethyl acetate in 
hexanes) to afford the methyl ether as a yellow oil (23.2 mg, 94%). Rf = 0.46 (SiO2, 20% 
EtOAc/hexanes); IR (film) 2973, 2929, 1437, 1368, 1187, 1170, 1120, 1097 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.0 Hz, 2H), 7.68 (d, J = 8.5 Hz, 1H), 7.33 (dd, J 
= 8.0, 8.0 Hz, 1H), 7.23 (s, 1H), 7.20 (d, J = 8.0 Hz, 2H), 7.13 (d, J = 7.5 Hz, 1H), 6.17 
(dd, J = 17.5, 11.0 Hz, 1H), 5.33 (d, J = 11.0 Hz, 1H), 5.28 (d, J = 17.5 Hz, 1H), 4.56 
(dd, J = 10.5, 6.0 Hz, 1H), 3.79 (s, 1H), 3.57 (s, 3H), 3.01 (dd, J = 18.5, 6.0 Hz, 1H), 2.58 
(dd, J = 18.5, 10.5 Hz, 1H), 2.35 (s, 3H), 1.45 (s, 3H), 1.44 (s, 3H), 1.08 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) ppm 144.8, 142.6, 141.5, 139.6, 135.5, 133.3, 129.9, 126.8 
(2C), 126.6, 121.8, 119.5, 118.7, 116.1, 115.1, 110.9, 85.1, 61.3, 61.2, 45.2, 40.7, 33.8, 
30.9, 29.3, 21.6, 13.9; HRMS (EI): Exact mass calcd for C28H30ClNNaO3S [M+Na]
+ 
518.1533, found 518.1520.  
 
(8R,9R,10S)-8-Chloro-10-methoxy-6,6,9-trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-
hexahydro naphtho[1,2,3-cd]indole (597).   
To a 0 °C solution of alcohols (20.4 mg, 42.7 µmol, α:β = 2:11) in THF (500 µL) was 
added LiHMDS (138 µL, 138 µmol, 1.0 M in toluene) dropwise. The reaction was stirred 
for 1 h at 0 °C, and MeOTf (19.3 µL, 171 µmol) was added dropwise to the solution. The 
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reaction was stirred for 30 min at 0 °C and 30 min at rt. The reaction was quenched with 
satd aq NH4Cl and the layers were separated. The aqueous layer was extracted with Et2O 
and the combined organic layers were dried, filtered, and concentrated. The resulting 
residue was purified by flash column chromatography (SiO2, 10% ethyl acetate in 
hexanes) to afford the methyl ether as a yellow oil (19.3 mg, 92%). The alcohol was 
isolated as an inseparable 11:2 (β:α) mixture of diastereomers. Rf = 0.46 (SiO2, 20% 
EtOAc/hexanes); IR (film) 2969, 2925, 2852, 1367, 1187, 1170, 1120, 1100 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3, data for both isomers) δ 7.79 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 
8.4 Hz, 2H), 7.67 (d, J = 8.0 Hz, 1H), 7.66 (d, J = 8.0 Hz, 1H), 7.32 (dd, J = 8.0, 8.0 Hz, 
1H), 7.30 (dd, J = 8.0, 8.0 Hz, 1H), 7.25-7.19 (m, 6 H), 7.13 (d, J = 7.6 Hz, 1H), 7.11 (d, 
J = 7.6 Hz, 1H), 6.16 (dd, J = 18.0, 11.2 Hz, 1H), 5.90 (dd, J = 17.6, 10.8 Hz, 1H), 5.35 
(d, J = 10.4 Hz, 1H), 5.33 (d, J = 10.8 Hz, 1H), 5.32 (d, J = 16.8 Hz, 1H), 5.28 (d, J = 
17.6 Hz, 1H), 4.58 (dd, J = 10.4, 5.6 Hz, 1H), 4.14 (br d, J = 1.6 Hz, 1H), 4.06 (dd, J =  
10.4, 5.6 Hz, 1H), 3.79 (s, 1H), 3.69 (s, 3H), 3.57 (s, 3H), 3.01 (dd, J = 18.4, 6.0 Hz, 1H), 
2.89 (ddd, J = 18.0, 5.2, 0.8 Hz, 1H), 2.66 (ddd, J = 17.6, 10.8, 3.2 Hz, 1H), 2.57 (dd, J = 
18.4, 10.8 Hz, 1H), 2.35 (s, 6H), 1.45 (s, 3H), 1.44 (s, 3H), 1.43 (s, 3H), 1.42 (s, 3H), 
1.22 (s, 3H), 1.08 (s, 3H); 
13
C NMR (100 MHz, CDCl3, data for β-isomer) ppm 144.6, 
144.4, 139.4, 139.2, 135.7, 132.7, 129.9, 127.2, 126.9, 126.8, 126.1, 123.6, 118.6, 118.4, 
116.4, 116.1, 85.2, 62.5, 61.3, 47.0, 40.8, 33.2, 30.6, 29.7, 21.6, 10.5; HRMS (EI): Exact 
mass calcd for C28H30ClNNaO3S [M+Na]
+ 
518.1533, found 518.1533.  
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(8R,9R,10R)-10-Azido-8-chloro-6,6,9-trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-
hexahydro naphtho[1,2,3-cd]indole (598).  
To a -78 °C solution of methyl ether (9.9 mg, 20 µmol) in CH2Cl2 (700 µL) was added 
SnCl4 (5.0 µL, 61 µmol) and stirred for 5 min. The reaction was allowed to warm to 0 °C 
and stirred for 30 min and an additional 30 min at rt. The reaction was quenched with 
satd aq NaHCO3 and the layers were separated. The aqueous layer was extracted with 
Et2O and the combined organic layers were dried, filtered, and concentrated. The 
resulting residue was purified by flash column chromatography (SiO2, 10% ethyl acetate 
in hexanes) to afford the azide as a yellow oil (7.1 mg, 70%). Only one diastereomer 
could be detected by NMR analysis. Rf = 0.49 (SiO2, 20% EtOAc/hexanes); IR (film) 
2970, 2923, 2851, 2096, 1369, 1171, 1120 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.80 (d, J 
= 8.4 Hz, 2H), 7.69 (d, J = 8.4 Hz, 1H), 7.35 (dd, J = 7.8, 7.8 Hz, 1H), 7.28 (s, 1H), 7.23 
(d, J = 7.8 Hz, 2H), 7.14 (d, J = 7.2 Hz, 1H), 6.13 (dd, J = 17.4, 10.8 Hz, 1H), 5.38 (d, J 
= 10.8 Hz, 1H), 5.33 (d, J = 17.4 Hz, 1H), 4.39 (dd, J = 10.2, 5.4 Hz, 1H), 4.10 (s, 1H), 
3.04 (dd, J = 18.6, 5.4 Hz, 1H), 2.63 (dd, J = 18.6, 10.2 Hz, 1H), 2.35 (s, 3H), 1.48 (s, 
3H), 1.46 (s, 3H), 1.19 (s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 144.9, 142.5, 141.4, 
139.1, 135.3, 133.4, 129.9, 126.9, 126.8, 126.3, 119.4, 118.8, 118.2, 116.7, 116.3, 111.1, 
67.7, 60.4, 44.6, 41.1, 33.7, 31.6, 28.9, 21.6, 15.0; HRMS (EI): Exact mass calcd for 
C27H27ClN4NaO2S [M+Na]
+ 
529.1441, found 529.1451.  
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  A complete 2D NMR analysis was 
carried out to determine the 
stereochemistry at C11. NOESY 
correlations from both H11 to H17 and 
H11 to H19, and the absence of the NOESY correlations between H11 to either H13 and 
H14, strongly suggested that the H11 proton is equatorial.  
 
(8R,9R,10R)-10-Azido-8-chloro-6,6,9-trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-
hexahydro naphtho[1,2,3-cd]indole (598).  
To a -78 °C solution of methyl ether (4.9 mg, 9.9 µmol) in CH2Cl2 (300 µL) was added 
SnCl4 (2.5 µL, 3.0 µmol) and stirred for 5 min. The reaction was allowed to warm to 0 °C 
and stirred for 30 min and an additional 30 min at rt. The reaction was quenched with 
satd aq NaHCO3 and the layers were separated. The aqueous layer was extracted with 
Et2O and the combined organic layers were dried, filtered, and concentrated. The 
resulting residue was purified by flash column chromatography (SiO2, 10% ethyl acetate 
in hexanes) to afford the azide as a yellow oil (2.0 mg, 40%). Only one diastereomer 
could be detected by NMR analysis. Please see above for the charaterization data. 
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(8R,9R,10R)-8-Chloro-6,6,9-trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-
hexahydronaphtho[1,2,3-cd]indol-10-yl acetate (600).  
H2SO4 (8.0 µL, 0.15 mmol)
25
 was added dropwise to a 0 °C solution of alcohol (8.0 mg, 
17 µmol) in AcOH (170 µL). The reaction was stirred for 30 min at 0 °C and 30 min at rt. 
The reaction was cooled to 0 °C and quenched by the sequential addition of satd aq 
Na2CO3 followed by 1.0 M NaOH. The solution was warmed to rt and stirred for 10 min. 
The layers were separated, the aqueous layer was extracted with CH2Cl2, and the 
combined organic layers were dried, filtered, and concentrated. The resulting residue was 
purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to afford 
the acetate as a pale yellow foam (7.7 mg, 94%). The acetate was isolated as a 7:1 ratio of 
diastereomers (
1
H NMR). Rf = 0.35 (SiO2, 20% EtOAc/hexanes); IR (film) 2971, 2927, 
1734, 1558, 1506, 1457, 1369 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.4 Hz, 
2H), 7.70 (d, J = 8.0 Hz, 1H), 7.33 (dd, J = 8.0, 8.0 Hz, 1H), 7.23 (s, 1H), 7.22 (d, J = 8.0 
Hz, 2H), 7.12 (d, J = 7.6 Hz, 1H), 5.83 (dd, J = 17.2, 11.2 Hz, 1H), 5.76 (s, 1H), 5.30 (d, 
J = 10.8 Hz, 1H), 5.29 (d, J = 18.0 Hz, 1H), 4.55 (dd, J = 10.4, 5.6 Hz, 1H), 3.06 (dd, J = 
18.4, 6.0 Hz, 1H), 2.58 (dd, J = 18.0, 10.8 Hz, 1H), 2.35 (s, 3H), 2.03 (s, 3H), 1.47 (s, 
3H), 1.46 (s, 3H), 1.17 (s, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 170.1, 144.7, 143.0, 
140.0, 139.0, 135.6, 133.4, 129.8, 127.0, 126.6, 126.5, 119.9, 118.6, 117.7, 117.4, 116.7, 
                                                          
25
 95-98% EMD 
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111.0, 74.1, 60.3, 44.0, 40.9, 33.6, 30.8, 29.3, 21.6, 21.0, 14.5; HRMS (EI): Exact mass 
calcd for C27H27ClNO2S [M-C2H3O2]
+ 
464.1451, found 464.1465.
26
  
   The stereochemistry at C11 was determined by comparing the NMR of 16a with the 
acetylated product of the α-alcohol (15). The consistency between coupling constants of 
these two compounds in 
1
H NMR analysis suggested similar configuration.  
   Procedure for alcohol acylation: To a 0 °C solution of α-alcohol (4.0 mg, 8.4 µmol) in 
THF (200 µL) was added LHMDS (37 µL, 37 µmol, 1.0 M in toluene) dropwise. The 
reaction was stirred for 1 h at 0 °C, and acetyl bromide (2.5 µL, 34 µmol) was added to 
the solution. The reaction was stirred for 30 min at 0 °C and 30 min at rt. The reaction 
was quenched with satd aq NH4Cl and the layers were separated. The aqueous layer was 
extracted with Et2O and the combined organic layers were dried, filtered, and 
concentrated. The resulting acetate was pure for analytical purposes. 
 
N-((8R,9R,10R)-8-Chloro-6,6,9-trimethyl-2-tosyl-9-vinyl-2,6,7,8,9,10-
hexahydronaphtha [1,2,3-cd]indol-10-yl)formamide (601).  
  H2SO4 (225 µL, 4.20 mmol) was added dropwise to a 0 °C solution of alcohol (100 mg, 
210 µmol) in TMSCN (420 µL, 3.15 mmol). The reaction was stirred for 30 min at 0 °C 
and 30 min at rt. The solution was cooled to 0 °C and quenched by the sequential 
                                                          
26
 Elimination of AcOH observed. 
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addition of satd aq Na2CO3 followed by 1.0 M NaOH. The solution was warmed to rt and 
stirred for 10 min. The layers were separated, the aqueous layer was extracted with 
CH2Cl2, and the combined organic layers were dried, filtered, and concentrated. The 
resulting residue was purified by flash column chromatography (SiO2, 20-30-40% ethyl 
acetate in hexanes) to afford the formamide as a yellow oil (52 mg, 48%). Only one 
diastereomer could be detected by NMR analysis. Rf = 0.39 (SiO2, 50% EtOAc/hexanes); 
IR (film) 3276, 2962, 2924, 2853, 1663, 1368, 1170, 1119 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 8.26 (s, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.71 (d, J = 8.0 Hz, 1H), 7.33 (dd, J = 
8.0, 8.0 Hz, 1H), 7.24 (d, J = 7.6 Hz, 2H), 7.23 (s, 1H), 7.14 (d, J = 7.6 Hz, 1H), 5.90 (dd, 
J = 17.6, 10.8 Hz, 1H), 5.44 (br d, J = 8.8 Hz, 1H), 5.34 (d, J = 16.8 Hz, 1H), 5.33 (d, J = 
11.6 Hz, 1H), 5.09 (d, J = 10.4 Hz, 1H), 4.23 (dd, J = 9.6, 5.6 Hz, 1H), 3.04 (dd, J = 18.4, 
5.2 Hz, 1H), 2.68 (dd, J = 18.4, 9.2 Hz, 1H), 2.35 (s, 3H), 1.45 (s, 3H), 1.44 (s, 3H), 1.24 
(s, 3H); 
13
C NMR (125 MHz, CDCl3) ppm 160.5, 144.7, 140.6, 139.9, 138.9, 135.5, 
129.9, 129.8, 126.9 (2C), 126.4, 121.1, 118.5, 117.2, 117.1, 116.9, 110.9, 70.5, 61.2, 
52.2, 44.0, 40.8, 33.3, 30.6, 29.4, 21.5; HRMS (EI): Exact mass calcd for C28H30ClN2O3S 
[M+H]
+ 
509.1666 found 509.1664.  
   A NOESY experiment was carried out to determine the stereochemistry at C11. 
NOESY correlations from both H1117 to 
H17 and H11 to H19, and the absence of 
crosspeaks between H11 to either H13 and 
H14, suggested that the H11 proton is  
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equatorial. Additionally, a NOESY crosspeak between H13 and H20 was observed which 
indicated the axial orientation of the formamide functionality. These two observations are 
consistent with the formation of the α-formamide. 
 
N-((8R,9R,10R)-8-Chloro-6,6,9-trimethyl-9-vinyl-2,6,7,8,9,10-
hexahydronaphtho[1,2,3-cd indol-10-yl)formamide (605).  
To a solution of formamide (13.0 mg, 25.6 µmol) in MeOH (3.6 mL) was added Mg 
turnings (56.0 mg, 2.30 mmol) and the reaction and stirred for 4 h at rt. The reaction was 
quenched with satd aq NH4Cl and the solution was stirred for 30 min at rt. The layers 
were separated, the aqueous layer was extracted with CH2Cl2, and the combined organic 
layers were dried, filtered, and concentrated. The resulting detosylated product was 
isolated as a mixture of cis- and trans-rotamers and found to be pure for all analytical 
purposes (9.0 mg, 100%). Rf = 0.24 (SiO2, 50% EtOAc/hexanes); IR (film) 3357, 3278, 
2962, 2924, 2850, 1684, 1679, 1669, 1653 cm
-1
; 
1
H NMR (400 MHz, CDCl3, data for the 
major diastereomer) δ 8.21 (s, 1H), 7.91 (br s, 1H), 7.23 (dd, J = 7.8, 7.8 Hz, 1H), 7.11 
(d, J = 8.0 Hz, 1H), 7.00 (d, J = 7.2 Hz, 1H), 6.95 (d, J = 2.1 Hz, 1H), 5.93 (dd, J = 17.6, 
11.0 Hz, 1H), 5.62 (br d, J = 10.4 Hz, 1H), 5.34 (d, J = 17.5 Hz, 1H), 5.33 (d, J = 11.0 
Hz, 1H), 5.09 (d, J = 10.4 Hz, 1H), 4.30 (dd, J = 10.2, 5.4 Hz, 1H), 3.06 (dd, J = 18.1, 5.5 
Hz, 1H), 2.71 (dd, J = 18.1, 10.1 Hz, 1H), 1.51 (s, 3H), 1.48 (s, 3H), 1.27 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3, data for both isomers) ppm 164.9, 160.8, 140.7, 140.6, 140.4, 
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138.8, 138.7, 136.9, 136.1, 133.9, 133.7, 124.7, 124.5, 124.4, 122.3, 118.0, 116.6, 116.4, 
114.9 (2C), 114.8, 112.2, 112.1, 111.9, 108.0, 107.9, 62.5, 61.7, 58.4, 53.0, 44.7, 44.0, 
41.1, 40.9, 33.3, 31.9, 31.1, 30.7, 30.0, 29.6, 17.2, 15.8; HRMS (EI): Exact mass calcd 
for C21H24ClN2O [M+H]
+ 
355.1577, found 355.1572.  
 
(±)–Hapalindole K (602).  
  To a 0 °C solution of formamide (1.9 mg, 5.4 µmol) and Et3N (14.4 µL, 107 µmol) in 
CH2Cl2 (0.4 mL) was added phosgene (9.3 µL, 19 µmol, 20% in toluene). The reaction 
was stirred for 15 min at 0 °C and quenched with satd aq NaHCO3. The solution was 
warmed to rt and stirred for 10 min. The layers were separated and the aqueous layer was 
extracted with CH2Cl2 and the combined organic layers were dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
20-30% ethyl acetate in hexanes) to afford hapalindole A (1.6 mg, 85%). Rf = 0.70 (SiO2, 
50% EtOAc/hexanes); IR(film) 3411, 2958, 2920, 2850, 2134 cm
-1
; 
1
H NMR (600 MHz, 
CDCl3) δ 7.93 (br s, 1H), 7.25 (dd, J = 7.8, 7.8 Hz, 1H), 7.17 (d, J = 1.8 Hz, 1H), 7.14 (d, 
J = 7.8 Hz, 1H), 7.01 (d, J = 7.2 Hz, 1H), 6.16 (dd, J = 17.4, 10.8 Hz, 1H), 5.43 (d, J = 
10.8 Hz, 1H), 5.38 (d, J = 17.4 Hz, 1H), 4.50 (s, 1H), 4.43 (dd, J = 7.8, 5.4 Hz, 1H), 3.08 
(ddd, J = 18.0, 4.8, 0.6 Hz, 1H), 2.68 (br dd, J = 18.4, 9.2 Hz, 1H), 1.50 (s, 3H), 1.49 (s, 
3H), 1.33 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 158.5, 139.9, 138.6, 136.6, 133.8, 
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124.7, 124.4, 118.8, 117.6, 116.3, 114.9, 111.5, 108.0, 61.4, 60.3, 43.3, 41.1, 32.9, 30.5, 
30.1, 16.7; LRMS (EI): Exact mass calcd for C21H22ClN2 [M+H]
+ 
357.15, found 357.20. 
 
N-((6aS,8R,9R,10R,10aR)-8-Chloro-6,6,9-trimethyl-9-vinyl-2,6,6a,7,8,9,10,10a-
octahydronaphtho[1,2,3-cd]indol-10-yl)formamide (603).  
LiAlH4 (452 µL, 678 µmol, 1.5 M in THF) was added to a 0 °C solution of formamide 
(17.0 mg, 33.9 µmol) in THF (3.0 mL) and the reaction was stirred for 13 h at 0 °C. The 
reaction was quenched with sequential addition of H2O (100 µL) and 0.5 M NaOH and 
the solution was stirred for 5 min at rt. The layers were separated and the aqueous layer 
was extracted with Et2O and the combined organic layers were dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
30-40-50-60-70% ethyl acetate in hexanes) to afford the formamide as a yellow oil in 
addition to the side products 604 and 605. 
Formamide 603 
 (isolated as a mixture of cis- and trans-rotamers):
27
 yellow oil (4.6 mg, 39%). Rf = 0.15 
(SiO2, 50% EtOAc/hexanes); IR (film) 3396, 3287, 2961, 2923, 2853, 1679 (br s) cm
-1
; 
1
H NMR (400 MHz, CDCl3, data for the both isomer) δ 8.23 (s, 1H), 8.16 (s, 1H), 8.13 
(br s, 1H), 8.08 (br s, 1H), 7.23-7.18 (m, 4H), 7.08 (dd, J = 2.0, 2.0 Hz, 1H), 6.97-6.95 
(m, 2H), 6.94 (dd, J = 6.8, 0.8 Hz, 1H), 6.39 (dd, J = 8.8, 8.8 Hz, 1H), 5.91 (br d, J = 8.8 
                                                          
27
 The assigned structure was confirmed after the compound was converted to (±)-hapalindole A 
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Hz, 1H), 5.83 (dd, J = 16.6, 11.2 Hz, 1H), 5.84 (dd, J = 16.6, 11.2 Hz, 1H), 5.30 (d, J = 
17.0, 10.8 Hz, 1H), 5.30 (d, J = 10.8 Hz, 1H), 5.22 (d, J = 16.8 Hz, 1H), 5.21 (d, J = 11.6 
Hz, 1H), 5.17 (d, J = 17.6 Hz, 1H), 4.94 (dd, J = 9.2, 1.2 Hz, 1H), 4.19 (dd, J = 12.4, 4.4 
Hz, 1H), 4.16 (dd, J = 10.4, 3.6 Hz, 1H), 3.64 (br s, 1H), 3.63 (br s, 1H), 2.14 (ddd, J = 
12.8, 7.6, 7.6 Hz, 1H), 2.00-1.96 (m, 2H), 1.94 (ddd, J = 13.2, 4.0, 4.0 Hz, 1H), 1.55 (s, 
3H), 1.55-1.52 (m, 1H), 1.54 (s, 3H), 1.51 (dd, J = 7.6, 4.0 Hz, 1H), 1.17 (s, 3H), 1.15 (s, 
3H), 1.00 (s, 3H), 0.97 (s, 3H); 
13
C NMR (100 MHz, CDCl3, data for both rotamers) ppm 
165.1, 160.1, 144.7, 143.1, 137.7 (2C), 133.6, 133.5, 124.3, 124.0, 123.5, 123.1, 119.5, 
118.9, 115.8, 114.8, 113.9, 113.6, 112.0, 111.7, 108.6, 108.5, 64.4, 64.0, 60.9, 55.3, 46.2, 
45.8, 45.7, 45.4, 38.1, 38.0, 37.7, 36.4, 32.1, 31.5, 31.1, 24.6 (2C), 22.7, 21.3, 20.0; 
HRMS (EI): Exact mass calcd for C21H25ClN2NaO [M+Na]
+ 
379.1553, found 379.1557.  
Alcohol 604  
(isolated as a mixture of cis- and trans- rotamers): pale yellow oil (1.7 mg, 14%). Rf = 
0.07 (SiO2, 50% EtOAc/hexanes); IR (film) 3356 (br s), 2961, 2923, 2852, 1669 (br s) 
cm
-1
; 
1
H NMR (600 MHz, CDCl3, data for the both isomer) δ 8.12 (s, 1H), 8.16 (br s, 
1H), 8.02 (s, 1H), 8.00 (s, 1H), 7.42 (br d, J = 9.6 Hz, 1H), 7.37 (br d, J = 9.6 Hz, 1H), 
7.23 (d, J = 8.4 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 7.20 (dd, J = 7.8, 7.8 Hz, 1H), 7.18 
(dd, J = 8.4, 8.4 Hz, 1H), 7.09 (dd, J = 1.8, 1.8 Hz, 1H), 6.98 (d, J = 7.8 Hz, 1H), 6.97 
(dd, J = 1.8, 1.8 Hz, 1H), 6.96 (d, J = 7.2 Hz, 1H), 5.86 (dd, J = 16.8, 10.8 Hz, 2H), 5.30 
(d, J = 11.4 Hz, 1H), 5.18 (d, J = 10.8 Hz, 1H), 5.17 (d, J = 18.6 Hz, 1H), 5.02 (d, J = 9.6 
Hz, 1H), 4.59 (dd, J = 12.6, 4.2 Hz, 1H), 4.54 (dd, J = 12.6, 4.2 Hz, 1H), 4.15 (br d, J = 
7.2 Hz, 1H), 3.58 (br s, 1H), 3.44 (br d, J = 0.8 Hz, 1H), 2.13 (ddd, J = 13.8, 3.6, 1.2 Hz, 
1H), 2.13-2.12 (m, 1H), 2.01 (s, 2H), 1.90 (dd, J = 13.8, 12.6 Hz, 1H), 1.86 (dd, J = 13.8, 
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12.6 Hz, 1H), 1.52 (s, 3H), 1.51 (s, 3H), 1.14 (s, 6H), 0.82 (s, 3H), 0.80 (s, 3H); 
13
C NMR 
(150 MHz, CDCl3, data for both isomers) ppm 165.0, 159.9, 145.1, 143.0, 138.4, 138.0, 
133.4, 133.3, 123.7, 123.5, 123.4 (2C), 119.9, 119.0, 115.9, 114.8, 113.8, 113.6, 111.9, 
111.8, 109.0 (2C), 80.6, 80.2, 62.0, 61.6, 61.1, 55.2, 45.6, 43.5, 42.3, 42.1, 37.2, 36.8, 
31.9, 26.7, 26.9 (2C), 22.7, 20.3, 19.7, 18.6; HRMS (EI): Exact mass calcd for 
C21H25ClN2NaO2 [M+Na]
+ 
395.1502, found 395.1503.  
  The 
1
H NMR analysis indicated a 5:1 mixture of cis- and trans-rotamers and as a result, 
the NMR peaks in general were broadened. First, HSQC was used to assign the 
formamide –NH and –OH protons and then NOESY correlations were used to assign the 
stereochemistry of newly formed quaternary center (C15). The alcohol proton shows 
strong correlations to formamide –NH, H13, and H10. As previously elucidated, the 
formamide functionality is α which indicates that the newly formed quaternary center has 
α-OH. Additionally, the formamide –NH was observed to shift downfield (δ 7.37 ppm) 
which also suggests the possibility of hydrogen bonding with α-OH. The presence of 
NOESY correlation between H2, H11 and H2, H17 also supports the assigned chair 
conformation of the cyclohexane core. 
 
Formamide 605 (isolated as a mixture of cis- and trans-isomer): Please see above for 
characterization data. 
 
 
 
 
144 
 
 
(±)–Hapalindole A (606).  
  To a 0 °C solution of the formamide (3.8 mg, 10.7 µmol) and Et3N (29.8 µL, 214 µmol) 
in CH2Cl2 (0.8 mL) was added phosgene (18.5 µL, 37.5 µmol, 20% in toluene). The 
reaction was stirred for 15 min at 0 °C and quenched with satd aq NaHCO3. The solution 
was warmed to rt and stirred for 10 min. The layers were separated, the aqueous layer 
was extracted with CH2Cl2, and the combined organic layers were dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
20% ethyl acetate in hexanes) to afford hapalindole A (3.4 mg, 90%) as a oil. Rf = 0.60 
(SiO2, 50% EtOAc/hexanes); IR (film) 3417, 2964, 2924, 2853, 2134, 1439 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 8.07 (br s, 1H), 7.22-7.19 (m, 2H), 6.98 (dd, J = 5.4, 2.2 Hz, 
1H), 6.89 (dd, J = 1.7, 1.7 Hz, 1H), 6.11 (dd, J = 17.5, 11.0 Hz, 1H), 5.35 (d, J = 11.0 Hz, 
1H), 5.24 (d, J = 17.5 Hz, 1H), 4.38 (br s, 1H), 4.23 (dd, J = 12.5, 4.0 Hz, 1H), 3.88 (br s, 
1H), 2.32 (ddd, J = 13.4, 4.2, 4.2 Hz, 1H), 2.15 (dddd, J = 13.5, 3.5, 3.5, 0.7 Hz, 1H), 
1.56 (s, 3H), 1.48 (ddd, J = 13.0, 13.0, 13.0 Hz, 1H), 1.20 (s, 3H), 0.89 (s, 3H); 
13
C NMR 
(125 MHz, CDCl3) ppm 157.9, 143.3, 138.0, 133.5, 124.0, 123.6, 118.7, 116.2, 114.1, 
110.7, 108.6, 63.9, 63.2, 44.7, 44.2, 38.1, 37.1, 32.0, 31.1, 24.4, 18.9; HRMS (EI): Exact 
mass calcd for C21H24ClN2 [M+H]
+ 
339.1628, found 339.1617.  
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(6aS,8R,9R,10R,10aR)-8-Chloro-6,6,9-trimethyl-9-vinyl-2,6,6a,7,8,9,10,10a-
octahydro naphtho[1,2,3-cd]indol-10-ol (607).  
  To a 0 °C solution of alcohol (45.0 mg, 94.3 µmol) in THF (6.0 mL) was added LiAlH4 
(1.56 mL, 2.37 mmol, 1.5 M in THF) and the reaction was stirred for 36 h at 10 °C. The 
reaction was quenched with sequential addition of H2O (500 µL) and 0.5 M NaOH and 
the solution was stirred for 5 min at rt. The layers were separated and the aqueous layer 
was extracted with Et2O and the combined organic layers were dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
10-20-25% ethyl acetate in hexanes) to afford the desired reduced product as a viscous oil 
(14.3 mg, 47%) in addition to the detosylated side co-product (2.4 mg, 8%). Rf = 0.60 
(SiO2, 50% EtOAc/hexanes); IR (film) 3364 (br), 2959, 2923, 2851, 1457, 1441 cm
-1
; 
1
H 
NMR (600 MHz, CDCl3) δ 7.98 (br s, 1H), 7.20-7.16 (m, 2H), 6.95 (dd, J = 6.6, 1.2 Hz, 
1H), 6.90 (dd, J = 1.8, 1.8 Hz, 1H), 5.98 (dd, 18.0, 10.8 Hz, 1H), 5.40 (dd, J = 11.4, 0.6 
Hz, 1H), 5.33 (d, J = 18.0 Hz, 1H), 4.53 (dd, J = 12.0, 4.2 Hz, 1H), 4.43 (br s, 1H), 3.74 
(br s, 1H), 2.28 (ddd, J = 13.2, 4.2, 4.2 Hz, 1H), 2.18 (br d, J = 1.2 Hz, 1H), 2.10 (dddd, J 
= 13.2, 3.6, 3.6, 0.6 Hz, 1H), 1.53 (s, 3H), 1.48 (ddd, J = 13.2, 13.2, 13.2 Hz, 1H), 1.20 
(s, 3H), 0.86 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 143.9, 138.6, 133.5, 124.5, 
123.2, 118.7, 116.3, 113.7, 112.2, 108.3, 64.0, 47.7, 44.5, 37.7, 36.3, 32.1, 31.6, 29.7, 
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24.6, 20.17; HRMS (EI): Exact mass calcd for C20H25ClNO [M+H]
+ 
330.1619, found 
330.1607.  
  A complete 2D NMR analysis was performed to ascertain the stereochemical outcome 
of reduction step. First, HSQC was used to assign the –OH proton and also differentiate 
between H15 and H14α, H14β protons, as the latter is connected to a secondary carbon. 
Then NOESY correlations were used to assign the stereochemistry of newly formed 
chiral center (C15 and C10). The 
alcohol proton shows strong  NOESY 
correlations to H13, and H15. As 
previously elucidated, the alcohol 
functionality is α which means that the newly formed chiral centers have α-protons. The 
presence of NOESY correlations between H2, H11 and H2, H17 also confirms the 
assigned chair conformation of the cyclohexane core. 
Data for 609:  
Rf = 0.06 (SiO2, 20% EtOAc/hexanes); IR (film) 3401 (br), 2963, 2923, 2851, 1460, 1444 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.86 (br s, 1H), 7.23 (dd, J = 8.0, 8.0 Hz, 1H), 7.10 
(d, J = 8.0 Hz, 1H), 7.01 (s, 1H), 7.00 (d, J = 7.2 Hz, 1H), 6.18 (dd, J = 18.0, 11.2 Hz, 
1H), 5.40 (d, J = 11.2 Hz, 1H), 5.35 (d, J = 18.0 Hz, 1H), 4.59 (dd, J = 9.6, 5.6 Hz, 1H), 
4.42 (s, 1H), 3.05 (dd, J = 18.0, 5.6 Hz, 1H), 2.70 (dd, J = 18.0, 9.6 Hz, 1H), 1.51 (s, 3H), 
1.49 (s, 3H), 1.20 (s, 3H), (-OH proton not observed); 
13
C NMR (100 MHz, CDCl3) ppm 
141.9, 139.1, 136.5, 134.0, 124.6, 123.3, 116.4, 115.8, 114.8, 113.1, 107.8, 77.2, 75.2, 
61.8, 45.3, 40.7, 33.6, 31.1, 29.6, 15.3; HRMS (EI): Exact mass calcd for C20H23ClNO 
[M+H]
+ 
328.1468, found 328.1455.  
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(8R,9R,10R)-8-Chloro-6,6,9-trimethyl-9-vinyl-2,6,7,8,9,10-hexahydronaphtho[1,2,3-
cd]indol -10-ol (609).  
To a solution of alcohol (10.0 mg, 21.0 µmol) in MeOH (3.0 mL) was added Mg turnings 
(45.8 mg, 1.88 mmol) and the reaction was stirred for 4 h at rt. The reaction was 
quenched with satd aq NH4Cl and the solution was stirred for 30 min at rt. The layers 
were separated and the aqueous layer was extracted with CH2Cl2 and the combined 
organic layers were dried, filtered, and concentrated. The resulting detosylated product 
was found to be pure for all analytical purposes (6.8 mg, 99%). See above for the 
characterization data. 
 
(6aS,8R,9R,10R,10aR)-Allyl 10-(((allyloxy)carbonyl)oxy)-8-chloro-6,6,9-trimethyl-9-
vinyl-6a,7,8,9,10,10a-hexahydronaphtho[1,2,3-cd]indole-2(6H)-carboxylate (610).  
To a -10 °C solution of alcohol (4.0 mg, 12.1 µmol) in THF (200 µL) was added 
LiHMDS (61 µL, 61 µmol, 1.0 M in toluene) dropwise. The reaction was stirred for 1 h 
at -10 °C, and allyl chloroformate (5.2 µL, 48 µmol) was added dropwise to the solution. 
The reaction was stirred for 30 min at -10 °C and 30 min at 0 °C. The reaction was 
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quenched with satd aq NH4Cl and the layers were separated. The aqueous layer was 
extracted with Et2O and the combined organic layers were dried, filtered, and 
concentrated. The resulting residue was purified by flash column chromatography (SiO2, 
10% ethyl acetate in hexanes) to afford the desired product as a colorless oil (2.8 mg, 
47%). Rf = 0.44 (SiO2, 20% EtOAc/hexanes); IR (film) 2955, 2925, 2853, 1742 (br s), 
1439, 1394, 1252 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.85 (br s, 1H), 7.46 (br s, 1H), 
7.31 (dd, J = 7.8, 7.8 Hz, 1H), 7.10 (d, J = 7.2 Hz, 1H), 6.10 (dddd, 17.4, 10.2, 6.0, 6.0 
Hz, 1H), 5.96 (dddd, 17.4, 10.8, 6.0, 6.0 Hz, 1H), 5.91 (dd, J = 17.4, 10.8 Hz, 1H), 5.47 
(d, J = 17.4 Hz, 1H), 5.45 (d, J = 2.4 Hz, 1H), 5.38 (dd, J = 17.4, 1.2 Hz, 1H), 5.37 (dd, J 
= 10.2, 1.2 Hz, 1H), 5.31 (dd, J = 10.8, 1.2 Hz, 1H), 5.23 (d, J = 12.0 Hz, 1H), 5.21 (d, J 
= 18.0 Hz, 1H), 4.95 (dd, 12.6, 6.0 Hz, 1H), 4.91 (dd, 13.2, 6.0 Hz, 1H), 4.69 (ddd, 12.6, 
6.0, 0.6 Hz, 1H), 4.65 (ddd, 13.2, 6.0, 0.6 Hz, 1H), 4.20 (dd, 12.6, 3.6 Hz, 1H), 3.58 (s, 
1H), 2.24 (ddd, 13.2, 4.2, 4.2 Hz, 1H), 2.15 (ddd, 13.2, 3.6, 3.6 Hz, 1H), 1.46 (ddd, 13.2, 
13.2, 13.2 Hz, 1H), 1.52 (s, 3H), 1.14 (s, 3H), 0.97 (s, 3H); 
13
C NMR (150 MHz, CDCl3) 
ppm 165.4, 154.3, 142.3, 138.5, 131.5, 125.9, 120.5, 120.4, 119.5, 119.1, 117.7, 117.6, 
116.1, 115.7, 112.9, 82.9, 68.7, 67.6, 63.7, 46.0, 44.4, 37.5, 35.2, 32.2, 31.2, 24.5, 19.1; 
HRMS (EI): Exact mass calcd for C28H32ClNO5 [M]
+ 
497.1969, found.
28
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 Decomposition of the compound was observed. The desired mass of the compound or its fragment could 
not be obtained in HRMS. 
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(6aS,8R,9R,10aR)-8-Chloro-6,6,9-trimethyl-9-vinyl-6,6a,7,8,9,10a-
hexahydronaphtho[1,2,3-cd]indol-10(2H)-one (611).  
  To a 0 °C solution of alcohol (5.9 mg, 17.9 µmol) in CH2Cl2 (600 µL) was added Dess-
Martin periodinane (19.0 mg, 44.8 µmol) and the reaction was stirred for 1 h. The 
reaction was quenched by the addition of an aqueous solution containing 2:1 satd aq 
Na2S2O3:NaHCO3 and was stirred until both layers became clear (~20 min). The layers 
were separated, the aqueous layer was extracted with CH2Cl2, and the combined organic 
layers were dried, filtered, and concentrated. The resulting residue was purified by flash 
column chromatography (SiO2, 15% ethyl acetate in hexanes) to afford the enone as a 
pale yellow foam (3.8 mg, 65%). Rf = 0.60 (SiO2, 40% EtOAc/hexanes); IR (film) 3399 
(br), 2923, 2953, 1698 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 8.07 (br s, 1H), 7.23-7.19 (m, 
2H), 6.99 (dd, J = 6.6, 1.2 Hz, 1H), 6.76 (dd, J = 1.8, 1.8 Hz, 1H), 5.93 (dd, J = 17.4, 
10.8 Hz, 1H), 5.38 (d, J = 10.8 Hz, 1H), 5.23 (d, J = 17.4 Hz, 1H), 4.24 (dd, J = 12.6, 3.6 
Hz, 1H), 4.23 (br s, 1H), 2.27 (dddd, J = 13.8, 3.6, 3.6, 1.8 Hz, 1H), 2.18 (ddd, J = 13.2, 
3.6, 3.6 Hz, 1H), 1.76 (ddd, J = 13.2, 13.2, 13.2 Hz, 1H), 1.58 (s, 3H), 1.20 (s, 3H), 1.11 
(s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 211.3, 139.7, 137.3, 133.8, 123.6, 123.5, 
120.0, 116.5, 113.9, 108.8, 108.4, 64.9, 57.2, 46.5, 45.8, 37.5, 31.6, 30.7, 24.6, 20.1; 
HRMS (EI): Exact mass calcd for C20H23ClNO [M+H]
+ 
328.1468, found 328.1391.  
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(6aS,8R,9R,10aS) Allyl 8-chloro-6,6,9-trimethyl-10-oxo-9-vinyl-6a,7,8,9,10,10a-
hexahydro naphtho[1,2,3-cd]indole-2(6H)-carboxylate (612).  
  To a -10 °C solution of indole (4.5 mg, 13.7 µmol) in THF (500 µL) was added 
LiHMDS (34.2 µL, 34.2 µmol, 1.0 M in toluene). The reaction was stirred for 1 h at -10 
°C, and allyl chloroformate (3.6 µL, 34 µmol) was added dropwise to the solution. The 
solution was stirred for 30 min at -10 °C and 30 min at 0 °C. The reaction was quenched 
with satd aq NH4Cl and the layers were separated. The aqueous layer was extracted with 
Et2O and the combined organic layers were dried, filtered, and concentrated to provide a 
yellow oil. The crude Alloc protected indole was carried on to the next step without 
further purification. 
  To a solution of the crude indole (2.6 mg) in CH2Cl2 (300 µL) was added triethyl amine 
(30.0 µL, 73.5 µmol) and the reaction was stirred for 4 h at 40 °C. The reaction was 
concentrated and the resulting residue was purified by flash column chromatography 
(SiO2, 10% ethyl acetate in hexanes) to afford the desired product as a colorless oil (2.2 
mg, 40%). The NMR data matched that in the literature.
29
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 Fukuyama, T.; Chen, X. Q. J. Am. Chem. Soc. 1994, 116, 3125. 
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Figure 1. 1H NMR Spectrum (500 MHz, CDCl3) of 33aa 
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Figure 2. 
13
C NMR Spectrum (125 MHz, CDCl3) of 33a 
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Figure 3. 135 DEPT Spectrum (125 MHz, CDCl3) of 33a 
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Figure 4. HSQC Spectrum (125 MHz, CDCl3) of 33a 
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Figure 5. COSY Spectrum (125 MHz, CDCl3) of 33a 
 
 
156 
 
Figure 6. HMBC Spectrum (125 MHz, CDCl3) of 33a 
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Figure 7. NOESY Spectrum (500 MHz, CDCl3) of 33a 
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Figure 8. 
1
H NMR Spectrum (500 MHz, CDCl3) of 33ab 
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Figure 9. 
13
C NMR Spectrum (125 MHz, CDCl3) of 33ab 
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Figure 10. 135 DEPT Spectrum (125 MHz, CDCl3) of 33ab 
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Figure 11. HSQC Spectrum (125 MHz, CDCl3) of 33ab 
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Figure 12. COSY Spectrum (125 MHz, CDCl3) of 33ab 
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Figure 13. HMBC Spectrum (125 MHz, CDCl3) of 33ab 
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Figure 14. NOESY Spectrum (500 MHz, CDCl3) of 33ab 
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Figure 15. 
1
H NMR Spectrum (600 MHz, CDCl3) of 33ba 
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Figure 16. 
13
C NMR Spectrum (150 MHz, CDCl3) of 33ba 
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Figure 17. 135 DEPT Spectrum (150 MHz, CDCl3) of 33ba 
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Figure 18. HSQC Spectrum (150 MHz, CDCl3) of 33ba 
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Figure 19. COSY Spectrum (150 MHz, CDCl3) of 33ba 
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Figure 20. HMBC Spectrum (125 MHz, CDCl3) of 33ba 
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Figure 21. NOESY Spectrum (600 MHz, CDCl3) of 33ba 
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Figure 22. 
1
H NMR Spectrum (600 MHz, CDCl3) of 33bb 
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Figure 23. 
13
C NMR Spectrum (150 MHz, CDCl3) of 33bb 
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Figure 24. 135 DEPT Spectrum (125 MHz, CDCl3) of 33bb 
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Figure 25. HSQC Spectrum (150 MHz, CDCl3) of 33bb 
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Figure 26. . COSY Spectrum (150 MHz, CDCl3) of 33bb 
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Figure 27. HMBC Spectrum (150 MHz, CDCl3) of 33bb 
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Figure 28. NOESY Spectrum (600 MHz, CDCl3) of 33bb 
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Figure 29. 
1
H NMR Spectrum (600 MHz, CDCl3) of 36ab 
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Figure 30. 
13
C NMR Spectrum (150 MHz, CDCl3) of 36ab 
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Figure 31. 135 DEPT Spectrum (150 MHz, CDCl3) of 36ab 
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Figure 32. HSQC Spectrum (150 MHz, CDCl3) of 36ab 
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Figure 33. COSY Spectrum (150 MHz, CDCl3) of 36ab 
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Figure 34. HMBC Spectrum (150 MHz, CDCl3) of 36ab 
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Figure 35. NOESY Spectrum (600 MHz, CDCl3) of 36ab 
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Figure 36. 
1
H NMR Spectrum (400 MHz, CD3OD) of Serratezomine A (37) 
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Figure 37. 
13
C NMR Spectrum (125 MHz, CD3OD) of Serratezomine A (37) 
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Figure 38. 
1
H NMR Spectrum (600 MHz, CDCl3) of 277 
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Figure 39. 
13
C NMR Spectrum (150 MHz, CDCl3) of 277 
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Figure 40. 
1
H NMR Spectrum (600 MHz, CDCl3) of 251 
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Figure 41. 
13
C NMR Spectrum (150 MHz, CDCl3) of 251 
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Figure 42. 
1
H NMR Spectrum (500 MHz, CDCl3) of 263 
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Figure 43. 
13
C NMR Spectrum (125 MHz, CDCl3) of 263 
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Figure 44. 
1
H NMR Spectrum (600 MHz, CDCl3) of 264 
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Figure 45. 
13
C NMR Spectrum (150 MHz, CDCl3) of 264 
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Figure 46. 
1
H NMR Spectrum (600 MHz, CDCl3) of 266 
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Figure 47. 
13
C NMR Spectrum (150 MHz, CDCl3) of 266 
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Figure 48. HSQC Spectrum (150 MHz, CDCl3) of 266 
  
 
 
 
 
199 
 
Figure 49. COSY Spectrum (600 MHz, CDCl3) of 266 
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Figure 50. NOESY Spectrum (600 MHz, CDCl3) of 266 
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Figure 51. 
1
H NMR Spectrum (500 MHz, CDCl3) of 269 
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Figure 52. 
13
C NMR Spectrum (150 MHz, CDCl3) of 269 
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Figure 53. 
1
H NMR Spectrum (600 MHz, CDCl3) of 270 
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Figure 54. 
13
C NMR Spectrum (150 MHz, CDCl3) of 270  
 
 
 
 
 
 
205 
 
Figure 55. 
1
H NMR Spectrum (600 MHz, CDCl3) of 279 
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Figure 56. 
13
C NMR Spectrum (125 MHz, CDCl3) of 279 
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Figure 57. 
1
H NMR Spectrum (500 MHz, CDCl3) of 249 
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Figure 58. 
13
C NMR Spectrum (125 MHz, CDCl3) of 249 
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Figure 59. 
1
H NMR Spectrum (600 MHz, CDCl3) of 280 
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Figure 60. 
13
C NMR Spectrum (150 MHz, CDCl3) of 280 
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Figure 61. 
1
H NMR Spectrum (600 MHz, CDCl3) of 281 
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Figure 62. 
13
C NMR Spectrum (150 MHz, CDCl3) of 281 
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Figure 63. 
1
H NMR Spectrum (600 MHz, CDCl3) of 286 
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Figure 64. 
13
C NMR Spectrum (150 MHz, CDCl3) of 286 
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Figure 65. HSQC Spectra (150 MHz, CDCl3) of 286 
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Figure 66. HMBC Spectra (150 MHz, CDCl3) of 286 
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Figure 67. COSY Spectrum (600 MHz, CDCl3) of 286 
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Figure 68. NOESY Spectra (600 MHz, CDCl3) of 286 
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Figure 69. 
1
H NMR Spectrum (500 MHz, CDCl3) of 448 
 
 
220 
 
Figure 70. 
13
C NMR Spectrum (125 MHz, CDCl3) of 448 
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Figure 71. 
1
H NMR Spectrum (500 MHz, CDCl3) of 463 
  
222 
 
Figure 72. 
13
C NMR Spectrum (125 MHz, CDCl3) of 463 
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Figure 73.
1
H NMR Spectra (500 Hz, CDCl3) of 464 
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Figure 74. 
13
C NMR Spectrum (125 MHz, CDCl3) of 464 
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Figure 75. 
1
H NMR Spectrum (500 MHz, CDCl3) of 466 
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Figure 76. 
13
C NMR Spectrum (125 MHz, CDCl3) of 466 
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Figure 77. 
1
H NMR Spectrum (500 MHz, CDCl3) of 472 
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Figure 78. 
13
C NMR Spectrum (125 MHz, CDCl3) of 472 
  
 
 
 
 
229 
 
Figure 79. 
1
H NMR Spectrum (500 MHz, CDCl3) of 473 
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Figure 80. 
13
C NMR Spectrum (125 MHz, CDCl3) of 473 
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Figure 81. 
1
H NMR Spectrum (500 MHz, CDCl3) of 474 
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Figure 82. 
13
C NMR Spectrum (125 MHz, CDCl3) of 474 
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Figure 83. 
1
H NMR Spectrum (400 MHz, CDCl3) of 489 
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Figure 84. 
13
C NMR Spectrum (100 MHz, CDCl3) of 489 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 85. 
1
H NMR Spectrum (600 MHz, CDCl3) of 491 
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Figure 86. 
13
C NMR Spectrum (150 MHz, CDCl3) of 491 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 87. 
1
H NMR Spectrum (600 MHz, CDCl3) of 505 
 
 
238 
 
Figure 88. 
13
C NMR Spectrum (150 MHz, CDCl3) of 505 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 89. 
1
H NMR Spectrum (600 MHz, CDCl3) of 508 
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Figure 90. 
13
C NMR Spectrum (150 MHz, CDCl3) of 508 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
 
241 
 
Figure 91. 
1
H NMR Spectrum (600 MHz, CDCl3) of 509 
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Figure 92. 
13
C NMR Spectrum (150 MHz, CDCl3) of 509 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 93. 
1
H NMR Spectrum (400 MHz, CDCl3) of 520 
 
 
244 
 
Figure 94. 
13
C NMR Spectrum (100 MHz, CDCl3) of 520 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 95. 
1
H NMR Spectrum (600 MHz, CDCl3) of 530 
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Figure 96. 
13
C NMR Spectrum (150 MHz, CDCl3) of 530 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 97. 
1
H NMR Spectrum (500 MHz, CDCl3) of 532 
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Figure 98. 
13
C NMR Spectrum (125 MHz, CDCl3) of 532 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 99. 
1
H NMR Spectrum (500 MHz, CDCl3) of 534 
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Figure 100. 
13
C NMR Spectrum (125 MHz, CDCl3) of 534 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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 Figure 101. 
1
H NMR Spectrum (400 MHz, CDCl3) of 535 
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Figure 102. 
13
C NMR Spectrum (125 MHz, CDCl3) of 534 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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  Figure 103.  
1
H NMR Spectrum (500 MHz, CDCl3) of 539 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 104. 
13
C NMR Spectrum (100 MHz, CDCl3) of 539 
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 Figure 105. 
1
H NMR Spectrum (400 MHz, CDCl3) of 540 
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Figure 106. 
13
C NMR Spectrum (100 MHz, CDCl3) of 540 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 107.  
1
H NMR Spectrum (500 MHz, CDCl3) of  514 
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 Figure 108. 
13
C NMR Spectrum (125 MHz, CDCl3) of 514 
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Figure 109. 
1
H NMR Spectrum (400 MHz, CDCl3) of 546 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 110. 
13
C NMR Spectrum (100 MHz, CDCl3) of 546 
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Figure 111. 
1
H NMR Spectrum (400 MHz, CDCl3) of 547 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 112. 
13
C NMR Spectrum (100 MHz, CDCl3) of 547 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 113. 
1
H NMR Spectrum (600 MHz, CDCl3) of 552 
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 Figure 114. 
13
C NMR Spectrum (150 MHz, CDCl3) of 552 
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Figure 115. 
1
H NMR Spectrum (500 MHz, CDCl3) of 553 
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Figure 116. 
13
C NMR Spectrum (125 MHz, CDCl3) of 533 
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Figure 117. 
1
H NMR Spectrum (500 MHz, CDCl3) of 558 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 118. 
13
C NMR Spectrum (125 MHz, CDCl3) of 534 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 119. HSQC Spectrum (125 MHz, CDCl3) of 558 
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Figure 120. NOESY (500 MHz, CDCl3) of 558 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 121. 
1
H NMR Spectrum (600 MHz, CDCl3) of 559 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 122. 
13
C NMR Spectrum (150 MHz, CDCl3) of 559 
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Figure 123. HSQC Spectrum (150 MHz, CDCl3) of 559 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 124. HMBC Spectrum (150 MHz, CDCl3) of 559 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 125. NOESY Spectrum (600 MHz, CDCl3) of 559 
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Figure 126. 
 1
H NMR Spectrum (400 MHz, CDCl3) of  560 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 127. 
13
C NMR Spectrum (125 MHz, CDCl3) of 534 
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Figure 128. 
 1
H NMR Spectrum (500 MHz, CDCl3) of 561 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 129. 
13
C NMR Spectrum (125 MHz, CDCl3) of 561 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 130. 
1
H NMR Spectrum (600 MHz, CDCl3) of 564 
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Figure 131. 
13
C NMR Spectrum (150 MHz, CDCl3) of 564 
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Figure 132. NOESY Spectrum (600 MHz, CDCl3) of 564 
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Figure 133. 
1
H NMR Spectrum (600 MHz, CDCl3) of 576 
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Figure 134. 
13
C NMR Spectrum (150 MHz, CDCl3) of 576 
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Figure 135. HSQC Spectrum (150 MHz, CDCl3) of 576 
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Figure 136. HMBC Spectrum (150 MHz, CDCl3) of 576 
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Figure 137. NOESY Spectrum (600 MHz, CDCl3) of 576 
  
 
 
 
 
288 
 
Figure 138. 
1
H NMR Spectrum (600 MHz, CDCl3) of 577 
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Figure 139. 
13
C NMR Spectrum (150 MHz, CDCl3) of 577 
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Figure 140. 
1
H NMR Spectrum (600 MHz, CDCl3) of 578 
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Figure 141. 
13
C NMR Spectrum (150 MHz, CDCl3) of 578 
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Figure 142. 
1
H NMR Spectrum (600 MHz, CDCl3) of 579 
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Figure 143. 
13
C NMR Spectrum (150 MHz, CDCl3) of 579 
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Figure 144. 
1
H NMR Spectrum ( 400 MHz, CDCl3) of 587 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 145. 
13
C NMR Spectrum (100 MHz, CDCl3) of 587 
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Figure 146. 
1
H NMR Spectrum ( 400 MHz, CDCl3) of 588 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 147. 
13
C NMR Spectrum (100 MHz, CDCl3) of 588 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 148. 
1
H NMR Spectrum ( 500 MHz, CDCl3) of 596 
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Figure 149. 
13
C NMR Spectrum (125 MHz, CDCl3) of 596 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 150. 
1
H NMR Spectrum ( 400 MHz, CDCl3) of 597 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 151. 
13
C NMR Spectrum (100 MHz, CDCl3) of 597 
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Figure 152. 
1
 H NMR Spectrum (600 MHz, CDCl3) of 598 
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Figure 153. 
13
C NMR Spectrum (150 MHz, CDCl3) of 598 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 154. HSQC Spectrum (150 MHz, CDCl3) of 598 
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Figure 155. HMBC Spectrum (150 MHz, CDCl3) of 598 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 156. NOESY Spectrum (600 MHz, CDCl3) of 598 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 157. 
1
H NMR Spectrum (400 MHz, CDCl3) of 600 
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Figure 158. 
13
C NMR Spectrum (100 MHz, CDCl3) of 600 
 
 
 
309 
 
Figure 159. 
1
H NMR Spectrum (400 MHz, CDCl3) of 601 
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Figure 160. 
13
C NMR Spectrum (125 MHz, CDCl3) of 601 
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Figure 161. 
1
H NMR Spectrum (600 MHz, CDCl3) of 602 (hapalindole K) 
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Figure 162. 
13
C NMR Spectrum (150 MHz, CDCl3) of 602 (hapalindole K) 
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Figure 163. 
1
H NMR Spectrum (500 MHz, CDCl3) of 603 
  
314 
 
Figure 164. 
13
C NMR Spectrum (125 MHz, CDCl3) of 603 
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Figure 165. 
1
H NMR Spectrum (600 MHz, CDCl3) of 604 
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Figure 166. 
13
C NMR Spectrum (150 MHz, CDCl3) of 604 
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Figure 167. HSQC Spectrum (150 MHz, CDCl3) of 604 
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Figure 168. NOESY Spectrum (600 MHz, CDCl3) of 604 
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Figure 169. 
1
H NMR Spectrum (400 MHz, CDCl3) of 605 
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Figure 170. 
13
C NMR Spectrum (100 MHz, CDCl3) of 605 
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Figure 171. 1H NMR Spectrum (600 MHz, CDCl3) of 606 (hapalindole A) 
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Figure 172. 
13
C NMR Spectrum (150 MHz, CDCl3) of 606 (hapalindole A) 
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Figure 173. 
1
H NMR Spectrum (600 MHz, CDCl3) of 607 
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Figure 174. 
13
C NMR Spectrum (150 MHz, CDCl3) of 607 
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Figure 175. HSQC Spectrum (150 MHz, CDCl3) of 607 
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Figure 176. NOESY Spectrum (600 MHz, CDCl3) of 607 
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Figure 177. 
1
H NMR Spectrum (400 MHz, CDCl3) of 609 
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Figure 178. 
13
C NMR Spectrum (100 MHz, CDCl3) of 609 
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Figure 179. 
1
H NMR Spectrum (600 MHz, CDCl3) of 610 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
 
330 
 
Figure 180. 
13
C NMR Spectrum (150 MHz, CDCl3) of 610 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. 
13
C NMR Spectrum (150 MHz, CDCl3) of 21 
 
 
 
Figure 43. 
1
H NMR Spectrum (500 MHz, CDCl3) of 23 
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Figure 181. 
1
H NMR Spectrum (600 MHz, CDCl3) of 611 
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Figure 182. 
13
C NMR Spectrum (150 MHz, CDCl3) of 611 
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Figure 183. 
1
H NMR Spectrum (500 MHz, CDCl3) of 612 
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